

















































greater" efficacy" for"weight" loss" than" gastric" banding" (BAND)" surgery." The" superior"weight"
loss" seen" after" RYGB" may" result" from" profoundly" different" effects" on" food" hedonics" and"
reward"brought" about"by"physiological" changes" secondary" to" the"distinct"manipulations"of"
gut"anatomy.""
AIMS+
+To" compare" body" mass" index" (BMI)" matched" patients" after" RYGB" or" BAND" surgery" and"
unoperated" controls" using" comprehensive" phenotyping" of" brain" structure" and" function,"
eating"behaviour"and"metabolism."
METHODS+
+In" these" cross)sectional" studies," un)operated" controls" and" patients" after" RYGB" and" BAND"
surgery" had" functional" and" anatomical" neuroimaging" of" food" reward" systems." Reward"
responses"to"food"were"assessed"with"a"functional"magnetic"resonance"imaging"(fMRI)"food"
picture" evaluation" task." Anatomical" differences" in" grey" and" white" matter" were" assessed"
using"voxel)based"morphometry"(VBM)"and"diffusion"tensor"imaging"(DTI)."Eating"behaviour,"
food"appeal"and"palatability,"potential"mediators,"and"post)ingestive"effects"were"compared"
between" groups" using" questionnaires," test" meals," food" diaries" and" assay" of" plasma"
hormones" and" metabolites." Surgical" patients" were" compared" in" both" the" fasted" and" fed"
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Over" 300"million" people"worldwide" are" obese," and" nearly" 1" billion" adults" are" overweight,"
with" huge" associated" medical" and" socio)economic" costs," including" diabetes" mellitus,"
cardiovascular" disease," certain" cancers" and" psychiatric" morbidity" (van" Hout" et" al." 2004;"
Haslam" et" al." 2005;" WHO" 2005;" Kopelman" 2007)." The" Department" of" Health" predicts"











in" developing" societies" too," is" complex" and" beyond" the" remit" of" this" thesis." Increasingly,"
however," the" interaction" between" an" “obesogenic”" environment" where" an" abundance" of"
highly" palatable," high)calorie" foods" are" readily" available" and" factors" which" make" certain"









Currently" the"only" successful" long)term"strategy" to" treat"obesity" is"bariatric" surgery."More"




Studies" of" behavioural" and" dietary" interventions" show" weight" loss" of" about" 8)10%" is"
achieved" in" 6" )12" months," but" that" weight" regain" is" common" and" about" half" of" patients"
return"to"baseline"weight"at"5"years"(Shaw"et"al."2005;"Wadden"et"al."2007;"Middleton"et"al."
2012;"Wadden"et"al."2012)."Data"from"the"National"Health"and"Nutrition"Examination"Survey"
(NHANES)," a" home)interview" based" national" survey," with" demographics" representative" of"
the"United"States"of"America"(USA)"population,"reflect"these"long)term"results."In"this"study,"
whilst"about"one"out"of"every"six"adults"(17.3%)"who"had"ever"been"overweight"or"obese"has"




more" than" 5%" of" their" body" weight" 2" years" later" (Weiss" et" al." 2007)." Similarly," a" meta)
analysis"of"dietary" intervention" studies" in" the"USA" in"obese" individuals" found"only"modest"






Large" studies" conducted" in" Europe" and" USA" aimed" at" diabetes" prevention," usually" in"
overweight"or"obese"patients"have"found"similar"results"to"the"above.""The"Finnish"Diabetes"
Prevention" Study," found" 3.5kg" weight" loss" in" intensive" lifestyle" interventions" and" in" the"




Most" dietary" interventions," regardless" of" regime," appear" to" be" similar" in" the" degree" of"
weight"loss"they"achieve,"with"only"the"Mediterranean"diet"showing"greater"weight"loss"than"
control" diets" (Mean"difference" in"weight" loss" )1.84" kg" (95%"CI:" 2.54," 21.15" kg;" P<0.00001)"
(Ajala" et" al." 2013)." On" the" other" hand" high)protein," low" glycaemic" index" diets" appear" to"
promote"weight"maintenance"after"weight"loss.""In"a"large"European"study"(773"participants),"
participants" randomized" to" high" protein" and" low" glycaemic" index" diets" had" lower" study"
dropout" rates," and" improved"weight"maintenance" over" 6"months" after" (high)protein" diets"





for" most" obese" patients," except" in" specific" circumstances" (pre)bariatric" surgery," or" as" a"
catalyst" for" change" in" severely" obese" patients" with"multiple" comorbidity" prior" to" lifestyle"







year" follow"up" (Elder"et"al."2007;"Sjostrom"2008)."Roux)en)Y"gastric"bypass" surgery" (RYGB)"




is" the"National"Weight)Control"Registry" (NWCR)" in"the"USA."Entry"onto"the"NWCR"requires"
members" to"be"≥"18"years"of"age"and"to"have" lost"and"maintained"at" least"13.6"kg" for"≥"1"
year." Its"more"than"4,000"members"are"predominately"white"(95%),"married"(64%),"college"
educated" (82%)" women" (77%)" in" their" late" 40’s." Entrants" lost" an" average" of" 33" kg" and"
maintained" the"minimum"weight" loss" (13.6" kg)" for" an"average"of"5.7" years."Data" from" the"
NWCR" are" not" representative" of" the" general" population," and" the" demographics" differ"
considerably"from"bariatric"surgery"patient"populations"in"general." In"addition,"entry"to"the"
register"is"dependent"on"successful"weight"loss"in"the"first"place."However"it"does"provide"a"













loss" found" that" low)fat," low)calorie"diets" (1500)1800"kCal/day"and"<7%"saturated" fat/day),"
vigorous" exercise" (200)300"minutes/week)," regular"monitoring" of" food" intake" and"weight,"
and"regular"contact"with"group"or"individual"therapist"to"reinforce"dietary"restraint,"were"key"
components" to"maintaining"weight" loss" of" between" 4" and" 7%" for" 1" year" (Anderson" et" al."
2001)."""
"
By" contrast," bariatric" surgery" patients" engage" in" negligible" strenuous" physical" activity" and"
remain" largely" sedentary"after" surgery," though"even"a" small" increase" in"physical" activity" is"
associated" with" improved" weight" loss" (Egberts" et" al." 2012;" Liu" et" al." 2012)." Although"
significant"dietary"changes"are"reported"after"bariatric"surgery,"these"are"not"associated"with"




When" 105" bariatric" surgery" patients" (58%" RYGB," 18%" BAND," 24%" unspecified)" were"
compared"with"210"dieting"patients"from"the"NWCR"who"had"lost"and"maintained"a"similar"
amount" of" weight" (>13.6kg" over" approximately" 5" years)," surgical" patients" engaged" in"
significantly" less" exercise" and" employed" less" dietary" restraint" than" their" non)surgical"
counterparts"(Bond"et"al."2009).""
"
Pharmaceutical" interventions" are" also" not" as" effective" as" bariatric" surgery." Currently" only"
Orlistat,"a"lipase"inhibitor"is"licensed"for"treatment"of"overweight"and"obesity."This"achieves"
around" 3kg" more" weight" loss" than" placebo" by" preventing" the" absorption" of" fat" in" the"
intestine." Steatorrhoea," faecal" urgency" and" faecal" incontinence" occur" if" fat" is" consumed,"
36"
"
thereby" acting" as" a" dramatic" behavioural" deterrent" to" their" ingestion" (Padwal" et" al." 2004;"
Ara" et" al." 2012)." Orlistat" has" also" shown" beneficial" effects" on" cardiovascular" risk" factors"
including" fasting"cholesterol," low"density" lipoprotein" (LDL)"and"glucose"and"blood"pressure"
(Zhou"et"al."2012).""Agents"which"act"on"the"central"nervous"system"to"reduce"appetite,"such"
as"Sibutramine"(a"serotonin"and"nor)adrenalin"reuptake"inhibitor)"and"Rimonobant"(selective"
cannabinoid" receptor" CB1" antagonist)" have" been" withdrawn" from" the" market" due" to"
unacceptable" side" effects" (Christensen" et" al." 2007;" James" et" al." 2010)." " Sibutramine" and"
Rimonobant" achieved" similar" weight" loss" (3.73kg" and" 3.66kg" more" than" placebo"
respectively),"(Burch"et"al."2009;"Zhou"et"al."2012)"whereas"Sibutramine"appeared"more"cost)
effective"than"either"Rimonobant"or"Orlistat" in"the"longer"term"(Ara"et"al."2012;"Gray"et"al."
2012)." " Even" drugs" that" are" in" development" and" may" soon" be" licensed," including"
combination"and"gut"hormone"therapies"do"not"appear"to"result"in"the"degree"of"weight"loss"
that"is"seen"in"bariatric"surgery.""For"example,"Qnexa"(Phentermine)Topiramate)"results"in"7)





rare," (ii)" in" those" individuals"where" successful"weight" loss"and" its"maintenance" is"achieved"
without" surgery," regular" strenuous"physical"exercise"and"a"high"degree"dietary"and"weight"
vigilance" are" required," (iii)" bariatric" surgery," and" in" particular" RYGB," achieves" superior"
sustained"weight" loss" to" both" traditional"weight" loss"methods" and"medication," and" (iv)" in"







The" four" most" commonly" performed" bariatric" surgery" procedures" are:" Roux)en)Y" gastric"
bypass"(RYGB)"surgery,"laparoscopic"gastric"banding"surgery"(BAND),"sleeve"gastrectomy"and"
biliopancreatic"diversion/duodenal"switch."In"2011,"nearly"half"of"all"weight"loss"procedures"
performed" worldwide" were" RYGB" and" 18%" BAND" (Buchwald" et" al." 2009;" Buchwald" et" al."
2013)."In"Europe"there"has"been"a"sharp"decline"in"the"use"of"BAND"surgery,"from"63"to"43"to"
18%"of"all"bariatric"procedures"performed" in"2003,"2008"and"2011" respectively." "RYGB,"on"








RYGB" is" the" oldest" form" of" bariatric" surgery," invented" by" Cesar" Roux" in" 1897." It" was" first"
performed" for" the" purpose" of"weight" loss" in" 1969" (Mason" et" al." 1969)," after" observations"
that"patients"who"had"undergone"partial"gastrectomy"for"other"illnesses"such"as"peptic"ulcer"









to" have" important" and" dramatic" effects" on" appetitive" gut" hormone" secretion" which" are"
elaborated" on" below" (le" Roux" et" al." 2006;" Dixon" et" al." 2012;" Pournaras" et" al." 2012)." In"
addition,"since"the"gallbladder"continues"to"secrete"bile"into"the"duodenum,"bile"is"delivered"
via"the"entero)entero"anastomosis"(also"known"as"the"Roux)en)Y"anastomosis)"into"the"small"
intestine" undiluted" by" food." This" alteration" of" bile" flow" is" recognized" to" have" important"
effects"on" intestinal"pH,"gut" intestinal" flora"and"may"also"have"effects"on" satiety"hormone"
secretion" (Li" et" al." 2011;" Pournaras" et" al." 2012)." The" vagus" nerve" is" also" disrupted" by" the"











In" BAND" surgery," a" silicon" saline)filled" band" is" placed" around" the" proximal" pouch" of" the"





its" digestion" is" not" altered." Horizontal" gastroplasty" (HGP)," where" the" proximal" stomach" is"
stapled" horizontally," and" vertical" banded" gastroplasty" (VBG)," where" it" is" stapled" vertically"
and" a" permanent" band" placed" around" the" entrance" to" the" distal" stomach," both" create" a"
smaller"stomach"pouch"connected"to"the"distal"stomach"by"a"narrow"stoma"(Doherty"2001)."
They" have" been" superseded" by" BAND" due" to" its" lower" complication" rate" (Chapman" et" al."








The" sleeve" gastrectomy" was" initially" only" performed" as" part" of" a" two)stage" operation" in"
patients"with"severe"morbid"obesity"(BMI">60"kg/m2),"where"a"complete"RYGB"was"deemed"
too" dangerous" (Brethauer" et" al." 2009)." Partial" gastrectomy" was" performed" to" reduce"
stomach"volume,"whilst"maintaining"the"normal"anatomy"of"the"rest"of"the"gastrointestinal"
tract,"including"the"pylorus."The"operation"was"performed"to"aid"initial"weight"loss"so"that"a"
full" RYGB" or" duodenal" switch" could" follow." " However" it" has" gained" popularity" as" a" stand)
alone"operation"in"view"of"its"low"surgical"risk,"and"similar"favourable"metabolic"effects"and"









The" original" form" of" this" complex" operation" (biliopancreatic" diversion)" has" been" largely"
replaced"by"a"modification"known"as"duodenal"switch" (BPS/DS)." In" this"operation,"a"partial"
















have" recorded" weight" loss" of" 27%" of" their" original" body" mass" and" LAGB" patients" 14%"
(Sjostrom"2013).""In"sleeve"gastrectomy"surgery"and"BPS/DS"respectively,"the"longest"studies"








In" a"meta)analysis"of" approximately"44,000"patients," entered" into"5" trials"of"RYGB" surgery"
and"3"of"BAND"or"VBG" surgery" compared" to"non)surgical" controls," surgery"was"associated"
with"a"reduced"risk"of"global"mortality"(odds"ratio"(OR)"=0.55,"CI=0.49)0.63)"(Pontiroli"et"al."




A"Cochrane" review" (Colquitt"et"al."2009)" " included"26"studies"comparing"different" types"of"




to" 15" years" in" the" largest" study," although" many" studies" only" reported" 2" year" follow" up."
Improvements" in" metabolic" disease," including" diabetes," hypertriglyceridaemia" and"
hypertension" were" statistically" significant" for" patients" undergoing" surgery" compared" with"
conventional" treatment." Most" studies" showed" improvements" in" physical" and" emotional"
aspects"of"quality"of" life" in" the" first" 2" years" for" surgery"patients" above" those" treated"non)





procedures," but" in" the" longer" term" 2" studies" found" high" rates" of" conversion" to" other"
procedures"in"patients"who"underwent"VBG"(Colquitt"et"al."2009)."
"
Sleeve" gastrectomy" has" similar" outcomes" to" RYGB" surgery" in" 2" year" follow" up" studies"








loss"and" improvement" in"metabolic" illness"may"be"explained"by" the"way" that" the"differing"
44"
"
anatomical" manipulations" result" in" different" effects" on" appetite," eating" behaviour" and"




mechanisms" underlying" their" effectiveness." Rats" have" strikingly" similar" gastrointestinal"






predictable"manner," so" that" food" preference" and" progressive" ratio" task" paradigms" can" be"
used"to"assess"eating"behaviour"and"food"reward"(Mathes"et"al."2012)."Rat"models"of"gastric"
sleeve"and"BAND"have"also"been"developed,"although" in"the"case"of"BAND"these"are"more"





gastric" sleeve" and" BAND" due" to" fewer" side" effects." Sleeve" gastrectomy" as" a" standalone"
procedure" is" relatively" new," and" has" not" been" evaluated" in" the" longer" term" to" the" same"
extent" as" RYGB" and" BAND" surgery," although" it" provides" an" intriguing" model" for" gastric"







has" favourable" effects" on" glycaemic" control," that" have" been" shown" to" be" independent" of"
weight" loss,"at" least" initially" (Laferrere"et"al."2008)."The"mechanism"underlying" the"greater"
weight" loss" seen" in" RYGB" are" not" fully" understood," but" are" thought" to" involve" important"
neuroendocrine" pathways" regulating" eating" behaviour" and" glucose" homeostasis."





Originally" it" was" thought" that" both" RYGB" and" BAND" surgery" functioned" primarily" as" a"
restrictive"procedures."However" it"has"been" increasingly" recognized"that" if" restriction"does"












this" assumption." Decreased" food" intake," increased" feeding" frequency," and" compensatory"











an" important" mechanism" for" weight" loss" in" BAND" surgery," although" the" exact" pathway"
remains" obscure" (Burton" et" al." 2010;" Burton" et" al." 2011)." " However," soft" foods" are"more"
easily"consumed"than"coarse"after"BAND"surgery,"and"larger"boluses"of"food"tend"to"induce"
regurgitation"even" in"weight"stable"BAND"patients," suggesting" that"mechanical"obstruction"
of"certain"foods"may"play"a"role"in"modifying"eating""behaviour"after"BAND"surgery"(Burton"
et" al." 2010)." In" VBG" patients," but" not" RYGB," the" size" of" intestinal" stoma" (although" similar"
between" groups)" and" gastric" pouch," was" only" related" to" weight" loss" in" the" VBG" group"







Alterations" in" gastric" emptying" could" contribute" to" weight" loss" in" both" RYGB" and" BAND"
surgery." For" instance" in" BAND," delay" in" emptying" of" the" small" gastric" pouch" by" the" band"
might" result" in" increased" satiety," via" mechanisms" such" as" stretch" receptors" that" activate"





However," studies" have" shown" no" change" in" gastric" emptying" after" VBG" (although" the"
proximal"pouch"is"emptied"quickly)"(Mistiaen"et"al."2000)"or"BAND"(de"Jong"et"al."2009),"and"
no"relation"between"weight" loss"and"satiety"with"gastric"emptying"rate"following"BAND"(de"
Jong" et" al." 2009)." In" RYGB" surgery," the" presence" of" dumping" syndrome" supports" the"
possibility"of"increased"gastric"transit,"but"in"studies"directly"measuring"gastric"emptying,"one"
has" shown" decreased" gastric" emptying" (Suzuki" et" al." 2005)," whilst" two" others" showed"
increased"gastric"emptying"of"liquids,"but"not"solids"(Horowitz"et"al."1986;"Wang"et"al."2012)."
These" reported" inconsistencies"may"be"a" result"of"different" surgical" techniques"and"pouch"
sizes,"but"also"may"be"due"to"possible"disruption"of"the"vagus"nerve"by"the"various"surgeries.""





satiety"or" increased"vasovagal" release"of" gastrin,"which"may" influence"gastric"emptying." In"
48"
"
addition," the"vagus"nerve"appears" to"be" important" in" the"effect"of"anorexigenic"ghrelin"on"
the" central"nervous" system" (Huda"et" al." 2010)."However," in" surgical" techniques"where" the"
vagus" nerve" is" deliberately" spared" in" RYGB" surgery," no" difference" in" satiety" is" observed,"
suggesting"that"it"plays"a"minor"role"if"at"all"(Bueter"et"al."2010)."In"BAND"surgery,"the"vagus"
nerve" is" not" usually" affected." However," although" the" experimental" addition" of" truncal"
vagotomy" to" the" surgical" technique" did" not" lead" to" more" weight" loss," it" did" reduce" the"
number" of" patients" requiring" band" adjustments" to" produce" weight" loss" in" the" first" year"















There" are" surprisingly" few" studies" in" humans" examining"malabsorption" of"macronutrients"




al." 2007;" Marinella" 2008;" Dewey" et" al." 2011)." A" recent" study" showed" no" carbohydrate"
malabsorption" after" RYGB" surgery" (Wang" et" al." 2012)," and" another" examining" faecal" fats"
found"little"evidence"of"fat"malabsorption"(MacLean"et"al."2001)."However,"a"study"linking"fat"
malabsorption" to" the" side" effect" of" nephrolithiasis" after" RYGB" surgery" suggests" otherwise"
(Kumar"et"al."2011)."Surgeons"have"developed"modified"versions"of"RYGB"surgery"specifically"
to" introduce" significant"malabsorption" in"order"achieve"greater"weight" loss" in" super)obese"
patients."In"these"modifications,"bile"and"pancreatic"secretions"are"introduced"more"distally"
into"the"ileum"via"a"longer"jejunal"limb"(Brolin"et"al."1992;"Brolin"et"al."2002)."In"patients"with"
a" BMI" <50" kg/m2," the" length" of" the" common" channel" being" less" than" 100cm" is" the"most"
important" determinant" of" additional" weight" loss," suggesting" that" for"most" ordinary" RYGB"
surgeries,"where"the"common"channel"is"well"over"100cm,"malabsorption"plays"a"minor"role"





Leptin," a" hormone" secreted" mainly" by" white" adipose" tissue," received" much" attention"
following" its" discovery" due" to" the" observed" resolution" of" obesity" in" treatment" of" leptin)
deficient" children" suggesting" a" potential" therapeutic" target" for" obesity." In" normal" adults"














weight)matched"controls,"becoming"comparable"to" lean"controls."The"reduction" in" leptin" is"
also" greater" than" that" seen" in" BAND" patients," which" may" simply" reflect" greater" loss" of"
adipose"tissue.""However,"the"reduction"in"leptin"is"also"observed"over"a"longer"period"(up"to"








Such" large" decreases" in" leptin" would" ordinarily" increase" hunger," but" RYGB" patients" lose"
weight" and" describe" decreased" hunger." It" has" been" postulated" that" RYGB" may" therefore"
induce"a"mechanism"to"increase"leptin"sensitivity,"similarly"to"increased"insulin"sensitivity,"or"












chronic" vascular" inflammation," oxidative" stress," and" activation" of" the" renin)angiotensin"
system"(RAS),"eventually"leading"to"type"2"diabetes"mellitus"(T2DM).""
"
A" reduction" in" metabolically" active" visceral" adipose" tissue" and" adipocyte" size" have" been"
observed" following" bariatric" surgery" as" in" other" forms" of"weight" loss" (Lofgren" et" al." 2005;"
Pontiroli"et"al."2009).""This"reduction"in"visceral"adiposity,"as"well"as"a"reduction"in"lipotoxic"
free"fatty"acids,"and"reduction"in"inflammatory"markers"generated"by"pathogenic"adipocytes,"
are" thought" to" contribute" to" improvements" in" metabolic" parameters" (Bays" et" al." 2009)."
Although" leptin" has" been" studied" in" some" depth," less" is" known" about" the" function" of" the"
many" other" adipokines." These" include" adiponectin," resistin," chemerin," interleukin)6" (IL)6),"
plasminogen" activator" inhibitor)1" (PAI)1)," retinol" binding" protein" 4" (RBP4)," tumor" necrosis"
factor)alpha" (TNFα)" and" visfatin." Not" much" is" known" about" how" different" bariatric"
procedures" affect" secretion" of" adipokines," other" than" leptin." However," reduced" adiposity"
and" improved" adipocyte" function" on" a" cellular" level" contributes" to" normalized" adipokine"
secretion," which" may" be" important" in" the" resolution" of" metabolic" disease" after" RYGB"
surgery."Most"other"adipokines"decrease"after"surgery,"as"with"leptin,"probably"as"a"function"





lower" in" obese"people" normalizes" after" RYGB" surgery" (Whitson" et" al." 2007;"Guijarro" et" al."
2008)," although" one" study" showed" it" to" decrease" (Woelnerhanssen" et" al." 2011)."
Improvements" in" inflammatory"signaling"after"bariatric"surgery"has"not"fully"been"explored"
as"yet,"but" inflammatory"cytokines"are" likely" to"mirror" fat"mass" loss"after"bariatric" surgery"
(Kohli"et"al."2011)."Upregulation"of"the"RAS)related"gene"expressions"in"adipose"tissue"seen"















appetite" and" food" intake" (Schwartz" et" al." 2000;" Schwartz" et" al." 2002;"Riediger" et" al." 2004;"
Sloth"et"al."2007).""Furthermore"it"also"increases"ghrelin"levels"which"may"enhance"anorexia"
(Batterham" et" al." 2003)," and" reduces" gastrointestinal" motility" and" increases" water"
absorption" in" the"gut,"which"may"also" induce" satiety" (Wang"et" al." 2010)." In"obese"people,"
53"
"
post)prandial" PYY" secretion" is" attenuated" compared" with" lean" individuals" (le" Roux" et" al."
2006)" and" PYY" given" intravenously" to" lean" and" obese" humans" reduces" food" intake" and"
increases"satiety"(Batterham"et"al."2002;"Batterham"et"al."2003)."Following"RYGB"surgery,"but"
not"BAND"surgery,"post)prandial"secretion"of"PYY"is"increased"(Bose"et"al."2010;"Jacobsen"et"




rats" causes" increased"weight" loss" (Fenske" et" al." 2012)." " RYGB" in" PYY" knock)out" (KO)"mice"
induces" less"weight" loss"than"gastric"bypass" in"wild"type"mice." "Furthermore," there"was"no"
difference" in" weight" loss" between" sham)operated" and" gastric" bypass" PYY" KO" mice,"
suggesting" that" PYY" is" an" important" mediator" of" weight" loss" in" RYGB" (Chandarana" et" al."
2011)." " Reduction" of" PYY" secretion" by" administration" of" somatostatin" or" an" analogue"
increases" food" intake" in" rats" (le"Roux"et"al." 2006)"and"humans" that"have"undergone"RYGB"









produced" by" differential" splicing" of" the" products" of" the" preproglucagon" gene" by"




al." 2013)." GLP)1" and" oxyntomodulin" are" secreted" by" ileal" L)cell" after" a" meal," and" GLP)1"













GLP)1" is" also" a" potent" anti)hyperglycemic" hormone," which" acts" by" stimulating" insulin"
secretion"and"suppressing"glucagon"secretion,"in"a"glucose"dependent"manner"(Kreymann"et"
al." 1987)." When" plasma" glucose" concentration" is" in" the" normal" fasting" range," GLP)1" no"
longer"stimulates" insulin"so"that"reactive"hypoglycemia"does"not"result."GLP)1"also"appears"
to"restore"the"glucose"sensitivity"of"pancreatic"β)cells" (D'Alessio"et"al."1995)."Alterations" in"
GLP)1" positively" affect" glucose" metabolism" after" RYGB" surgery" (Laferrere" et" al." 2008;"
Pournaras"et"al."2010;"Van"der"Schueren"et"al."2012).""
"




foregut" (gastric" fundus," duodenum" and" jejunum)" nutrient)dependent" actions" that" would"
negatively"affect"glucose"metabolism"and"limit"gut"hormone"responses"are"prevented"(Pories"
et" al." 1982;" Rubino" et" al." 2004)." In" support" of" this" theory," an" intraluminal" sheath" that" is"
attached" to" the" pylorus" of" the" stomach" and" extends" to" the" jejunum," thereby" delivering"








nutrients" to" the"distal" ileum" that" results" in" the" release"of"GLP)1" and"PYY,"which" improves"
glucose"metabolism,"and"that"shunting"of"the"duodenum"is"not"important."This"is"supported"
by" studies" using" ileal" interposition" surgery," where" the" distal" ileum" is" repositioned" to" the"
proximal"jejunum,"whilst"maintaining"continuity"of"the"gastrointestinal"tract"and"preserving"
neurovascular"connections,"thereby"isolating"this"part"of"the"mechanism."Ileal" interposition"
results" in" exaggerated" postprandial" PYY" and" GLP)1" release," improved" glucose"metabolism"
and" weight" loss" in" rodents" (Kohli" et" al." 2010)." Studies" which" show" gastric" emptying" is"
increased"in"RYGB"surgery"support"this"theory"(Wang"et"al."2012)."The"success"of"the"gastric"














of" the"stomach"and"duodenum"and" is"released" in"response"to"fasting"and"chronic"negative"
energy" balance." The" active" form" is" created" by" acylation" by" the" ghrelin" O)acyltransferase"
(GOAT)" enzyme" (Cummings" et" al." 2002;" Korbonits" et" al." 2004;" Goldstone" et" al." 2005;"
Sumithran" et" al." 2011)." Ghrelin" stimulates" hunger" and" food" intake" in" normal" weight" and"
obese"subjects"and"patients"with"cancer)"and"renal"dialysis)associated"anorexia"(Neary"et"al."
2004;"Druce"et"al."2005;"Druce"et"al."2006;"Ashby"et"al."2009)"and"is"thought"to"play"a"role"in"




Obese" people" have" lower" circulating" levels" of" ghrelin" (Tschop" et" al." 2001)," and" the" post)
prandial" release" of" ghrelin" in" obese" people" is" not" suppressed" to" the" same" degree" as" in"
normal"weight"people"(le"Roux"et"al."2005).""
"




RYGB" and" BAND" surgery." Therefore" the" finding" of" paradoxically" low" 24" hour," fasting" and"
post)prandial"ghrelin"levels"after"RYGB"surgery"in"three"pre)"vs."post)RYGB"longitudinal"and"
three" cross)sectional" studies" (RYGB" vs." matched" obese" patients)" sparked" interest" in" a"





but" they" appear" to" be" largely" explained" by" inaccurate" measurement" techniques." For"
instance," only" acyl" ghrelin" is" reduced" by" prolonged" fasting," whereas" the" inactive" form"
increases."Therefore"these"forms"need"to"be"measured"separately,"which"the"above"studies"
did"not"always"do"(Cummings"et"al."2002;"Faraj"et"al."2003;"Geloneze"et"al."2003;"Leonetti"et"
al." 2003;" Lin" et" al." 2004;"Morinigo" et" al." 2004;" Chan"et" al." 2006;" Sundbom"et" al." 2007)." In"
those" that"did"measure"active"ghrelin," two" showed" reduced" fasting"active"ghrelin"2"weeks"
and" 6"months" post)surgery" (Fruhbeck" et" al." 2004;" Jacobsen" et" al." 2012)" and" one" showed"
increased"fasting"active"ghrelin"at"6"and"12"months"post)surgery"(Holdstock"et"al."2003)""
"
The" handling" of" particularly" acyl" ghrelin" requires" temperature" control," chelation" and"
protease" inhibitors" to" ensure" accuracy,"which"was" variably" performed." Furthermore," since"
ghrelin"is"inversely"proportionate"to"fat"mass,"determining"whether"an"effect"was"dependent"
















In" gastric" sleeve" surgery," the"mucosa" of" the" stomach" is" resected," and" ghrelin" levels" have"









satiating"effects," delays" intestinal" transit," and" is" a" catalyst" for" the"digestion"of" fat," protein"
and"carbohydrates"in"the"duodenum."It"may"also"act"centrally"to"promote"satiation,"and"can"
cause"nausea"and"anxiety"via"central"or"vagal"stimulation." Its"satiating"effects"appear"to"be"
reduced" in" obesity" (Fink" et" al." 1998)." In" total" gastrectomy," CCK" is" increased" and"has" been"
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2010)."One"study" showed" that"although" there"was"no"change" in"baseline" levels,"after"VBG"





Amylin" is" co)secreted" by" the" pancreas" with" insulin" and" plays" a" role" in" satiety," and" the"
development" of" T2DM." Following" RYGB" surgery," no" change" in" post)operative" fasting"
secretion"of"amylin"has"been"seen"at"2"weeks" (Jacobsen"et"al."2012),"whilst"another" study"
showed"decreased"post)prandial"amylin" levels" in"RYGB"but"not"banding" (Bose"et"al."2010)."
Post)prandial"amylin"secretion"is"increased"both"in"pre)clinical"(Shin"et"al."2010)"and"clinical"
































are" decreased" caloric" intake" and" improved" β)cell" function" due" to" decreased" lipotoxic,"
glucotoxic" and" inflammation" effects" of" obesity" resulting" from" weight" loss" (Wajchenberg"
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study" suggested" that" the" delivery" of" undiluted" bile" (not" bound" up" in" micelles" created" by"








found" in" the" rat" hypothalamus" and" their" expression" is" reduced" in" high" fat" fed" animals"
compared"to"lean."Acute"administration"of"intracranial"FGF19"reduces"food"intake"and"body"













expenditure" is" increased" (Stylopoulos" et" al." 2009)" and" another" did" not" find" the" expected"
decrease,"but"found"no"change"(Zheng"et"al."2009).""
"
Overall," rodent" models" seem" to" support" either" an" increase" in" energy" expenditure," or" a"





The"suggested"mechanism"for" increased"energy"expenditure" is"diet" induced"thermogenesis"
and" gut" hypertrophy"which" has" been" observed" in" RYGB" compared" to" sham)operated" rats"
(Bueter"et"al."2010).""
"
In" human" studies," a" recent" prospective" study" of" 13" RYGB" patients" found" a" reduction" in"
resting" metabolic" rate" and" fat" mass" after" surgery" (Liu" et" al." 2012)." Variance" in" negative"
energy"balance"did"not"explain"variance"in"fat"loss,"and"the"authors"suggest"that"the"capacity"
of"diverting"glucose"to"oxidation,"leaving"less"of"it"available"to"make"fat"was"important."They"
found" that" there"was" little" increase" in" physical" activity" in" this" cohort," but" that" even" small"
increases"had"large"effects"fat"loss,"since"even"low)intensity"exercise"is"associated"with"more"
utilization" of" glucose" as" fuel." This" may" be" particularly" relevant" in" this" population," since"








to" play" a" role" in" the" regulation" of" digestion," nutrition," mucosal" function" and" intestinal"









peptide" synthesis" (Osto" et" al." 2013)." Furthermore" caecal" transplant" from" RYGB)mice" to"





Appetite" regulatory" systems" are" often" divided" into" homeostatic" and" non)homeostatic" (or"
hedonic)" control" systems," although" the" divide" can" be" artificial" since" these" are" interlinked."
Homeostatic"control"refers"to"the"control"of"food"intake"and"meal"termination"in"response"to"
physiological"hunger"and"satiety"signaling."These"are"largely"controlled"by"anorexigenic"(e.g."
ghrelin)" and" orexigenic" (e.g." PYY," GLP)1," CCK," oxyntomdulin)" hormones" as" well" as" vagal"
afferent"responses"to"gastric"distension,"the"effects"of"insulin"and"glucose,"and"in"the"longer"
term"adipokines"such"as" leptin" (Saper"et"al."2002;"Flier"2004)."The"main"gateway" for" these"
mechanisms"within" the"central"nervous" system" is" the"hypothalamus" (Schwartz"et"al."2000;"
Sam" et" al." 2012)." Non)homeostatic" mechanisms" include" various" individual" and"
environmental" factors" that" govern" the" intake" of" food" in" addition" to" physiological" hunger."
These" are" primarily" the" individual" hedonic" and" emotional" reactions" to" food" governed" by"





"There" is" increasing" recognition" that" there" are" societal" and" environmental" factors" within"
Westernized"countries,"which"have"contributed" to" the"epidemic" levels"of"obesity" currently"
seen"(de"Castro"2010)."Highly"palatable"highly"calorific"food"is"cheaply"and"easily"accessible"
and" a" high" social" value" is" placed" on" immediate" personal" gratification" and" reward."
Furthermore"an"evolutionary"legacy"of"defense"of"a"higher"rather"than"a"lower"body"weight,"
to"favour"survival"in"periods"of"cyclical"starvation"and"plenty,"makes"humans"ill)suited"suited"
to" an" “obesogenic”" environment" of" continuous" plenty." Homeostatic" and" non)homeostatic"
systems"most"likely"function"in"synergy"with"cross)modulation"between"systems"taking"place"
particularly"during"periods"of" food"deprivation."However," in"an"“obesogenic”"environment,"
the" influence" of" palatable" food" cues" on" brain" food" reward" systems," may" override"




The" hedonic" appeal" of" food" is" used" to" describe" how" rewarding" the" anticipated" or"
experienced"pleasure"of"a"particular"food"is"perceived"to"be."For"instance,"palatable,"or"high)
calorie" foods" are" usually" perceived" to" be" more" hedonically" appealing" and" are" consumed"
more"than"bland"or"unappetizing"foods,"and"may"be"perceived"as"even"more"so"in"obese"and"
dieting" people" (Herman" et" al." 2008)." Food" reward" encompasses" the" concept" of" hedonic"
appeal"but"also" integrates" the" influence"of" learning"and"memory"on"behaviour" that" is"cue)
elicited."In"situations"where"hedonic"appeal"is"high,"approach"and"consummatory"behaviour"










satisfied." " Dopamine" pathways" in" particular" are" thought" to" play" an" important" role" in" the"
processing"of"reward"and"primarily"food"reward"(Martel"et"al."1996;"Schultz"2001;"Kishi"et"al."
2005;"de"Araujo"et"al."2012)."Reward"from"natural" (eg." food"and"sex)"and"non)natural" (e.g."
drugs" of" addiction," which" supplant" natural" rewards" in" valence," and" have" no" beneficial"
evolutionary" purpose)" sources," both" lead" to" increased" dopamine" release" in" the" nucleus"
accumbens" the" ventral" striatum." This" is" an" important" site" for" processing" pleasure" from"
reward" and" crucially" involved" in" the" pathology" of" addiction," particularly" to" certain" drugs,"
considered"stimulants,"such"as"nicotine,"cocaine"and"methamphetamine.""
"
Dopamine" projections" run" from" the" ventral" tegmental" area" (VTA)" of" the" midbrain" to" the"
nucleus"accumbens,"and"to"the"dorsal"striatum"where"consolidation"of"the"efficient"actions"
to" obtain" reward" occur" (eg." learned" behaviour," formation" of" habits," stimulus" response)"
(Hernandez"et"al."1988;"Schultz"2001;"Vanderschuren"et"al."2005)."The"VTA"also"projects"to"
the"amygdala"(governing"emotional"responses),"the"hippocampus"(memory"formation),"the"
OFC" (which" encodes" the" predicted" reward" value" of" a" cue)" and" prefrontal" cortex" (where"
reward" representations" are" consolidated" and" suppression" of" maladaptive" responses" or"
initiation"of"behaviour"to"obtain"a"desired"goal"takes"place)."Dopamine"pathways"appear"to"
be"particularly" important" in"processing" the"hedonic"appeal" rather" than"appetitive"drive" for"
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accumbens." Dopamine" is" fired" in" phasic" bursts" when" reward" exceeds" expectation." If" the"
reward"does"not" reach"expected" levels"of"pleasure," there"are"pauses" in"dopamine" release."
Unpredictable" or" unexpected" rewards" have" a" more" reinforcing" effect" than" predictable"
rewards." " In" addiction" states," dopamine" is" released" regardless" of" actual" reward," but" in"
keeping"with"the"expectation"of"reward."Memory"and"learning"play"a"role"in"this"since"gains"
are"remembered"and"losses"forgotten"(Schultz"2001;"Bellebaum"et"al."2008;"Park"et"al."2010)."
Bello" et" al" in" their" review"of" the" role" of" dopamine" in" binge" eating," suggest" that" sustained"
stimulation"of"the"dopamine"systems"by"bingeing,"promoted"by"pre)existing"conditions"(e.g."
genetic" traits" (D2" receptor" polymorphisms)," dietary" restraint," stress," etc.)" results" in"
progressive" impairments" of" dopamine" signaling" (Bello" et" al." 2010)" which" perpetuate" the"
behaviour."
"
In" addition" to" dopamine," opioid" pathways" have" also" been" shown" to" be" important" in" the"
processing" of" reward" valence"of" food."Mu"opioid" receptors" (MORs)" are" largely" distributed"
within" brain" regions"mediating" food" intake" and" reward" including" nucleus" accumbens" and"
amygdala" (Mansour" et" al." 1995)." Animal" studies" have" shown" MOR" activation" in" VTA"
enhances" hedonic" reaction" to" sweet" and" fatty" foods" (Taber" et" al." 1998;"MacDonald" et" al."
2003;"MacDonald" et" al." 2004;"Olszewski" et" al." 2007)," and" opioid" agonists" and" antagonists"
injected"into"VTA"respectively" increase"or"decrease"food"intake"(Yeomans"et"al."1997;"Echo"
et"al."2002;"Will"et"al."2003;"Smith"et"al."2007)." In"humans,"opioid"antagonists"have"shown"









1996;" Chang" et" al." 2004;" Chang" et" al." 2007;" Barnes" et" al." 2008)," but" there" is" considerable"
variation" in" specific" hypothalamic" and" striatal" region"peptide"expression" following"high" fat"




It" is" generally" accepted" that" dissociation" exists" between" the" hedonic" preference" for" food"
“liking”" and" the" reinforcing" value" of" food" “wanting”." These" appear" to" be" independently"
affected" by" homeostatic" systems," so" that" in" some" studies" hunger" appears" to" increase"
“wanting”" but" not" necessarily" “liking”" (Epstein" et" al." 2003)." In" addition," the" interaction"
between"homeostatic"and"hedonic"systems"in"their"control"of"energy"intake"does"not"appear"
to"be" symmetrical." For"example," increased"palatability"of" food" reduces"hunger"at"a" slower"
rate" and" brings" earlier" satiety" and" a" quicker" return" of" hunger,"whereas" decreased" hunger"
does" not" necessarily" reduce" the" perceived"palatability" of" food," although" increased"hunger"
does"improve"it"(Blundell"et"al."2004).""
"




pathways" have" been" linked" to" “liking”," i.e." a" pleasant" experience," e.g." from" food" intake"
(Davis"et"al."2009)."This" is"probably"an"oversimplification"of" the"matter,"and"an"alternative"




nucleus" accumbens" is" also" associated" with" increased" food" intake" or" “wanting”" of" food."
Conversely" MOR" antagonists’" effects" may" be" mediated" by" inhibiting" MORs" in" the" VTA,"





Studies" have" shown" increased" cue)reactivity" to" drug" cues" in" drug" dependency" in" areas"




dependency" has" been" associated"with" changes" in" neural" circuitry" in" the" VTA" and" nucleus"







other" addictive" behaviours," obese" people" have" been" found" to" have" reduced" striatal"




1.1)," have" resulted" in" a" resurgence" of" interest" in" the" parallels" between" obesity" and" drug"
addiction."""
"
It" has" been" posited" that" certain" foods" may" be" “addictive”," for" example" highly" processed"
sugary" foods" or" fat" (Shriner" 2011)." " In" fact," the" evidence" for" this" in" humans" is" scant." " For"
example," whilst" rodents" will" demonstrate" behaviour" consistent" with" addiction" to" sucrose"
(increased" lever" pressing," withdrawal" symptoms" on" removal" of" the" sucrose," dopamine"
released" in" the" nucleus" accumbens" and" the" induction" of" withdrawal" symptoms" by" opioid"
antagonists)" in" paradigms" designed" to" induce" sucrose" preference" followed" by" periods" of"
food"deprivation,"attempts"to"replicate"this"in"humans"have"failed"(Avena"et"al."2008;"Garber"
et" al." 2011)." " Even" within" animal" models," the" patterns" of" dopamine" release" from" sugar"
differed"significantly"from"those"seen"addictive"drugs"(e.g."reduced"release"upon"satiation"vs."
continued" release)(Corwin" et" al." 2011)." Furthermore" activation" of" reward" circuitry" by"
potentially" “addictive”" foods" may" well" indicate" increase" salience," but" this" does" not"











behavioural"parallels"do"exist" in" this" respect." "The"American"Psychiatric"Association"criteria"
for"the"clinical"diagnosis"of"abuse"and"dependence"is"“maladaptive"pattern"of"substance"use,"
leading" to"clinically" significant" impairment"or"distress,"as"manifested"by" three" (or"more)"of"
the"seven)point"criteria,"occurring"at"any"time"in"the"same"12)month"period"(1)"Tolerance,"as"
demonstrated"by"a"need" for"markedly" increased"amounts"of" the" substance" to"achieve" the"
desired"effect"or"a"markedly"diminished"effect"with" continued"use"of" the" same"amount"of"
the"substance"(2)"Withdrawal,"as"manifested"by"either"a"characteristic"withdrawal"syndrome"
for"the"substance"or"consumption"of"the"same"(or"a"closely"related)"substance"to"relieve"or"
avoid"withdrawal" symptoms" (3)" The" substance" is" often" taken" in" larger" amounts" or" over" a"
longer"period" than"was" intended" (4)"There" is"a"persistent"desire"or"unsuccessful"efforts" to"
cut"down"or"control"substance"use"(5)"A"great"amount"of"time"is"spent"in"activities"necessary"
to" obtain" the" substance" (e.g.," visiting"multiple" doctors" or" driving" long" distances)," use" the"
substance" (e.g.," chain)smoking)," or" recover" from" its" effects" (6)" Important" social,"
occupational,"or"recreational"activities"are"given"up"or"reduced"because"of"substance"use"(7)"
The" substance" use" is" continued" despite" knowledge" of" having" a" persistent" or" recurrent"
physical"or"psychological"problem"that" is" likely"to"have"been"caused"or"exacerbated"by"the"
substance" (e.g.," current" cocaine"use"despite" recognition"of" cocaine)induced"depression,"or"







physical" consequences" from" their" obesity" (Abiles" et" al." 2010)," despite" which" overeating"
persists." The" potential" neurobiological" overlap" in" the" mechanism" of" drug" addiction" and"
obesity," particularly" the" reward" deficiency" hypothesis" (see" Section" 1.7.3.7" (Volkow" et" al."
2011),"provide"a"mechanism"for"the"development"of"tolerance"and"resulting"increased"intake"
to"achieve"the"same"level"of"reward.""In"addition,"psychological"symptoms"of"withdrawal"to"
refined" foods," such" as" sugar," have" been" reported" (Ifland" et" al." 2009)," although" physical"
symptoms" not." Refined" carbohydrates" in" particular" may" sensitise" certain" individuals" to"
increased" use" over" time" (Ifland" et" al." 2009)."Weight" relapse" is" commonly" seen" in" obesity"
after" dieting" (Anderson" et" al." 2001)," and" chronic" dieting" or" restraint" appears" to" induce"
paradoxical" counter)regulatory" (disinhibitory)"eating" "behaviour,"particularly" in" the"context"
of" stress" and" negative" affect" (Herman" et" al." 1984;" Ruderman" 1985;" Haynes" et" al." 2003;"
Chaput"et"al."2009).""Furthermore"the"finding"that"substance"or"alcohol"dependency"seldom"
co)exists"with" obesity" (Kleiner" et" al." 2004;" Sarwer" et" al." 2004)," and" that" after"weight" loss"
through"gastric"bypass"surgery,"the"prevalence"of"alcohol"misuse"increases"(King"et"al."2012)"
suggests"that"food"may"compete"with"drugs"for"addictive"potential"and"salience,"potentially"





















al." 2000)," whereas" food" preference" paradigms" allow" comparison" between" animal" models"
and" humans" (le" Roux" et" al." 2011)." " Dietary" records" and" questionnaires" give" information"






More" objective" measures" of" individual" reward" responsiveness" toward" palatable" food" are"
progressive"ratio"tasks"(which"measure"how"hard"a"participant"is"willing"to"work"to"obtain"a"











Homeostatic" control" is" not" as" reliably" assessed" by" fMRI" due" to" the" small" size" of" the"
hypothalamus,"and"its"anatomical"proximity"to"air"sinuses"in"the"head"which"distort"magnetic"




manganese" enhanced"MRI" (MEMRI)" (which" utilizes" the" calcium" binding" and" paramagnetic"
properties" of" manganese" to" indirectly" measure" calcium" influx" and" therefore" neuronal"





development" of" obesity." These" include" aspects" of" executive" functioning," which" govern"












appetitive" behaviours." The" results" of" the" systematic" search" are" depicted" in" this" Figure." The"major"
domains" are" positioned" in" the" centre" of" the" circle." Some" of" the" domains" are" further" broken" into"
subdomains," when" necessary." Each" rectangle" corresponds" to" a" single" neurobehavioural" task." The"
length"of"the"rectangle"reflects"the"number"of"studies"conducted"with"this"task,"and"the"colour"reflects"
the"overall"outcome."Studies"with" replications"have"a"separate"colour"scheme" from"studies"with"no"
replications." Asterisks" indicate" tasks" that" use" food" stimuli," as" opposed" to" generic" stimuli," and"
rectangles"in"bold"indicate"tasks"that"are"discussed"in"more"detail"in"this"paper."Arrows"indicate"if"task"
has" been" tested" in" a" longitudional" design." *" =" task" uses" food" stimuli;"↑↓" =" Outward" arrow–task"









fMRI" measures" blood" oxygen" level)dependent" (BOLD)" changes" in" contrast" to" map" neural"
activity." The" difference" in" magnetic" properties" of" oxygen)rich" (oxygenated)" and" oxygen"
depleted" (de)oxygenated)" blood" is" exploited" by" fMRI." In" MRI," a" strong" permanent" static"
magnetic" field" (B0)" aligns" hydrogen" nuclei" in" the" brain," and" another" (the" gradient" field" or"
radio" field)" is"applied"at"90"degrees"at" regular" intervals" to"move"the"nuclei" in" its"path" to"a"
higher"magnetization" level."When" the" gradient" field" is" removed," the" nuclei"move" back" to"











are" active," as" a" marker" of" neural" activity." Increased" metabolic" activity" within" an" active"
neuron" results" in" localized" increased" oxygenated" blood" to" that" area," as" a" result" of" local"
vasodilatation"increasing"cerebral"blood"flow"(neurovascular"coupling)."The"oxygenated"non)
paramagnetic" haemoglobin" displaces" magnetically" active" deoxygenated" haemoglobin." In"
areas"where"more"oxygenated"blood"flows,"less"interference"of"the"gradient"field"signal"will"
be" registered"by" the" coil," leading" to" an" increase" in" signal" and" therefore" increase" in" visible"
contrast." This" is" assumed" to" be" an" indirect"measure" of" increased" neuronal" activity" in" that"
area,"and"can"be"linked"a"specific"trigger"event"or"stimulus"being"tested."This"is"termed"the"
BOLD"hemodynamic"response"function"(HRF)."It"lags"the"triggering"event"by"1"to"2"seconds,"
and" takes" about" 5" seconds" to" peak," after"which" a" plateau" is" achieved"whilst" the" neurons"














In" order" to" increase" the" strength" of" signal" obtained," stimuli" are" usually" presented" in"
multiples."For"example,"pictures"are"shown"in"blocks"lasting"18"or"more"seconds."This"results"
in" continued" activation" of" the" same" area" of" the" brain," which" is" assumed" to" increase" the"
signal"strength" in" that"area."By"mapping"the"hemodynamic"response" in" time"against"a" task"
undertaken"whilst"in"the"scanner,"changes"in"BOLD"contrast"during"that"time"period"give"an"
indication" of" how"brain" activation" changes" during" the" task." This" is" then"mapped" against" a"
predicted"response"allowing"statistical"analysis"of"the"change"in"BOLD"signal"in"response"to"a"






Before"changes" in"BOLD"can"be" interpreted," "a"number"of"pre)processing"steps"need"to"be"











The" brain" is" divided" into" hundreds" of" thousands" of" voxels," each" assigned" signal" intensity."
Statistical" analysis" of" each" voxel" or" cluster" of" voxels" can" ascertain" whether" the" signal"
intensity" in" that" particular" voxel" or" cluster" of" voxels" is" greater" than" the" signal" intensity" in"
another"part"the"brain,"in"response"to"a"particular"stimulus."A"statistical"threshold"can"then"
be" applied" to" either" the" whole" brain" or" to" ROIs." " In" analyzing" 100,000" units" of" brain" (or"
voxels)" at" the" same" time" in"whole" brain" analysis," the" problem" of"multiple" comparisons" is"
evident.""Even"small"structures"such"as"the"amygdala"contain"around"50"voxels.""This"can"be"
corrected" for" in" a" number" of" ways." " " For" instance" the" overall" statistical" threshold" can" be"
raised" (e.g." Using" a" P" value" of" <0.001" as" threshold" instead" of" P<0.05)" or" Bonferroni"
correction"can"be"made." "Further"methods" include"using"FDR"(false"discovery"rate)"or"FWE"
(family)wise" error)" corrections," which" are" less" stringent" but" equally" valid" ways" of" making"
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Rest" scans" are" used" to" analyze" functional" connectivity" between" different" brain" regions,"
assuming" that" distinct" neural" networks" function" in" a" coordinated" brain" response" and" that"
these"are"altered"in"various"conditions"(e.g."disease"or"aging"or"even"state)dependent)."Rest"
scans" are" also" used" for" pharmacological" fMRI" studies" in"which" continuous" resting" fMRI" is"
measured" before" and" after" administration" of" a" drug" or" hormone" (Batterham" et" al." 2007;"
Vidarsdottir"et"al."2007;"Jones"et"al."2012).""
"
In" task" related" studies," subjects" are" asked" to" complete" a" task" whilst" in" the" scanner." For"
example," a" common" approach" in" appetite" studies" is" for" subjects" to" be" presented" with"
images," smells" or" tastes" of" food" (with" further" subdivision" into" high)calorie," or" low)calorie"
food," and" anticipation" or" actual" receipt" of" a" tastant)" or" non)food" items." A" subtraction"











Another" popular" imaging" technique" is" positron" emission" tomography" (PET)." PET" involves"
detecting"changes"in"neuronal"activity"from"a"baseline"state,"by"measuring"degeneration"of"
an"unstable"nucleus"radioactive"tracer"injected"intravenously."The"decaying"nucleus"emits"a"
positron" which" collides" with" surrounding" tissue" electron" to" emit" a" ray" which" is" recorded"
using" detectors" around" the" head." Since" the" half" life" of" decay" is" known," within" subject"
differences"can"be"quantified"between"states."The"temporal"resolution"can"be"accurate,"but"
spatially" signal" can" be" up" to" 6mm" from" actual" neuronal" activity." These" differences" in" the"
indirect"measure"of"neuronal"activity"are"then"mapped"onto"standard"space"structural"MRI"
maps," and" statistical" parametric" maps" of" the" average" activation" across" subjects" can" be"
created.""
"
PET" can"measure" state)dependent" differences" but" not" task" related." By" varying" the" tracer,"
different" neuronal" populations" can" be" targeted," offering" the" advantage" of" obtaining"
information" about" neuronal" metabolism" (e.g." 15O)water" for" the" measurement" of" regional"
cerebral"blood"flow"(rCBF)"related"to"neuronal"activity;"18F)fluorodeoxyglucose"(FDG)"for"the"
measurement"of"cerebral"glucose"uptake)"and"neurotransmitters"(e.g."Dopamine"(DRD2/3),"
MOR"or" uptake"of" precursors" e.g." L)DOPA)."Neurotransmitter" function" can"be"deduced"by"
receptor" binding" which" depends" on" the" specificity" of" the" ligand," receptor" availability" and"








temporal" resolution" over" PET," although" temporal" resolution" is" dependent" on" blood" flow"
changes"and"therefore"lags"the"task"by"some"seconds."Spatial"resolution"of"about"8)27"mm3"
(2)3mm"x"2)3mm"x"2)3mm)(approximately" the"size"of"a"peppercorn)" (termed"voxel" size)" is"
possible,"but"still"accounts"for"millions"of"neurons"and"billions"of"synapses.""
"
fMRI’s" limitations"are"due"to"factors"which" limit"the" interpretation"of"data"obtained."These"
are" influenced"by" the" choice" of" experimental" design" and"how" fastidiously" the" paradigm" is"
carried"out."Unwanted"signal"(noise)"from"various"sources"including"from"the"scanner"itself,"
inhomogeneities" in" the"magnetic" field" strength," head"movement," physiological" changes" in"
blood" flow" independent"of" the" task," neuronal" activity" not" related" to" the" task," and" various"
other"sources"corrupts"the"data"obtained."Experimental"designs"therefore"need"to"minimize"
noise" as" far" as" possible," for" instance" by" reducing" head"movement,"making" corrections" for"




It" is"also" important" to"make"sure" that" the"baseline"condition" is" sufficiently"different" to" the"
stimulus"presented"to"obtain"a"meaningful"change"in"signal."Even"rest" involves"activity"that"
may" detract" from" interpretation" of" signal" obtained" during" the" task." A" fundamental"
assumption"of"fMRI"interpretation"is"that"increased"signal"means"increased"activity,"whereas"
increased" signal" may" in" fact" represent" metabolic" activity" in" line" with" deactivation" of" the"
neurons." Neighbouring" neurons" may" be" also" performing" different" tasks" during" the" same"
stimulus" presentation" that" cancel" each" other" out," or" decrease" the" observed" signal." This" is"
particularly"true"of"the"hypothalamus,"where"adjacent"nuclei"perform"opposite"functions."In"









Most" of" these" limitations" can" however" be" overcome" with" good" experimental" design" and"
judicious"and"cautious"interpretation"of"results."fMRI"remains"the"current"mainstay"of"brain"
imaging" particularly" in" the" area" of" cognitive" research." Indeed" functional" neuroimaging"























Several" steps" in" the" analysis" of" MRI" structural" scans" prepare" the" data" for" comparison"
between"subjects."For" instance,"brain"tissue"is"extracted"from"scans"to"exclude"superfluous"
tissue," such" as" skull" tissue," and" the" images" undergo" tissue)type" segmentation" to" separate"
out"grey"matter"from"white"matter"and"cerebrospinal"fluid."Each"individual’s"structural"scan"
is" then" registered" to" a" template" constructed" from" a" standardized" brain" (either" from" a"
reference" brain" e.g." MNI152," or" from" a" study" specific" template" brain)" to" allow" for"
comparison"within"the"same"standard"space."A"technique"called"smoothing"averages"out"the"
concentration" of" each" voxel" and" surrounding" voxels," to" correct" for" registration" errors" and"









Subcortical" areas" of" interest" can" also" be" pre)selected" and" volumetric" differences" between"
groups" in" these" areas" of" interest" calculated" using" T1" images" in" subject" as" opposed" to"
standard"brain"space,"using"FFMRIB’s" Integrated"Registration"&"Segmentation"Tool" (FIRST).""
This"model)based"FSL"tool"uses"a"priori"knowledge"of"the"structure"and"shape"of"previously"
learned" models" of" subcortical" regions" to" calculate" the" most" probable" shape" instance" of"
those" regions" in"study"populations,"given" the"observed" intensities" in"a"T1)weighted" image.""
In" this" way," regions" of" interest" for" specific" conditions," traits" or" functions" can" also" be"
assessed.""
"
There" are" several" methodology" differences" in" VBM" according" to" the" analysis" software"





















However," correlations" of" grey" matter" density" with" clinical" or" psychological" scores," e.g."
dietary" restraint"or"depression"scores,"may"be"particularly"useful" in"making"associations"of"










(Alexander"et"al."2007)."MRI" is"used" to" infer" the"structure"of"white"matter" tracts"based"on"














































For" example," reduced" integrity" in" fibres" connecting" corticolimbic" reward" areas"may" imply"
structural,"connectivity"and"therefore"functional"deficits"in"these"areas"(Delgado"et"al."2012)."""
Reduced"FA"appears"to"be"a"marker"of"reduced"integrity"of"white"matter"tracts"and"is"seen"in"
Parkinson’s" disease" (Cochrane" et" al." 2013)," Alzheimer’s" disease" (Stebbins" et" al." 2009),"
traumatic"brain" injury" (Maller"et"al."2010),"autistic"spectrum"disorder" (Travers"et"al."2012),"
bipolar"disorder"(Vederine"et"al."2011)"and"obsessive"compulsive"disorder"(Peng"et"al."2012)"
amongst" others." " Conversely" increased" FA" or" connectivity" may" be" a" marker" of" improved"

















a" strong" preference" for" high)calorie" foods," which"may" either" predispose" them" to" or" be" a"
learned"behavior"as"a"result"of"overeating,"although"not"all"studies"agree.""
"




people" also" show" greater" anticipatory" orofacial" reactions," galvanic" skin" responses" and"
increases" in" cardiac" rate" toward" palatable" food" cues" such" as" pictures" of" food" or" smell"
compared" to" normal" weight" individuals" (Schachter" 1968;" Soussignan" et" al." 2012)." This"
increased" appeal" of" food" predicts"weight" gain" in" infants" (van" Jaarsveld" et" al." 2011)" and" is"




such" as" smell" or" taste" in" obese" individuals" compared" with" normal" weight" individuals"
(Schachter" 1968;" Rodin" et" al." 1989;" Jansen" et" al." 2003;" Tetley" et" al." 2009;" Ferriday" et" al."
2011)." Several" studies" of" food" biases" have" indicated" that" preference" for" highly" palatable,"










There" are" few" studies" that" examine" the" effect" of" dietary"methods" of"weight" loss" on" food"
preference," and" studies" are" contradictory" in" their" results." Fasting" has" been" shown" to"
increase" the" desire" to" eat" as" measured" by" visual" analogue" scale" and" also" increased" food"
intake" in" adults" (Doucet"et" al." 2000)."Other" studies"using"progressive" ratio" tasks"have"also"
shown"an"increase"in"the"amount"of"work"participants"will"do"for"preferred"foods"after"food"
deprivation" (Epstein"et"al."2003;"Raynor"et"al."2003)." "On"the"other"hand," low"calorie"diets"
have"been"shown"to"reduce"cravings"for"foods"(Lappalainen"et"al."1990;"Harvey"et"al."1993;"
Martin" et" al." 2006)." In" children" at" any" rate," an" observed" shift" in" preference" toward" high)
calorie" foods" is" reversed" following" a" dietary" intervention" (Epstein" et" al." 1989)." " Given" the"




appetite" and" food" craving" is"mediated" by" gut" hormones." " For" example," in" a" recent" study,"
overweight" and" obese" patients" who" underwent" a" 10)week" weight" loss" program" had"
significantly" lower"levels"of" leptin,"PYY,"CCK," insulin,"and"amylin"and"significant" increases" in"
ghrelin"levels"from"baseline"(Sumithran"et"al."2011)."These"differences"persisted"at"one"year"
and"were" accompanied" by" significant" increases" in" appetite" and" pre)occupation"with" food,"
that" may" contribute" to" the" long)term" failure" of" dietary" restriction" for" weight" loss." " In"
addition," taste" acuity" for" sweet" foods" decreases" after" weight" loss," possibly" mediated" by"
reductions"in"plasma"leptin,"so"that"more"sweet"food"may"be"needed"to"satisfy"a"craving"for"




In" gastric" bypass," but" not" gastric" banding," a" shift" in" preference" away" from" high)calorie,"
particularly"sweet"and"fatty,"food"has"been"reported."It"has"been"postulated"to"contribute"to"









rats" and" lean" rats," has" been" reported" (Hajnal" et" al." 2010)." A" similar" effect" was" noted" for"







2011)." In" addition," rats" after" gastric" bypass" show" reduced" acceptance" of" high" fat" liquid" if"
previously"conditioned"to" it,"or"no" intake"of"high"fat"chow"at"all" if"never"exposed"to" it"pre)




and"rats"after"gastric"bypass"performed"similarly" to" lean"rats,"again"suggesting"a"change" in"
hedonics" following" gastric" bypass" surgery," although" these" results" might" also" indicate" an"
improvement" in" concentration" or" cognitive" ability" after" gastric" bypass" surgery" (Shin" et" al."
2011)."
"
In" one" study," a" reduced" preference" for" high" fat" liquids" over" 48" hours,"was" not" replicated"
when" the" test" was" applied" over" a" shorter" period" and" animals" were" water)deprived" to"
eliminate"post)ingestive"effects."An"oral"gavage"of"1"ml"corn"oil"after"saccharin"ingestion"in"
rats"after"gastric"bypass,"but"not"sham)operated"rats,"induced"a"conditioned"taste"aversion,"
suggesting" that" post)ingestive" effects" may" play" a" role" in" the" taste" preference" shifts" seen"






Although" it" has" been" speculated" that" shifts" in" food" preference" may" be" mediated" by"
increased"gut"hormone" levels"operating"through"a"gut)brain"axis," the"only"study"to"date"to"











reduced" reward" responses" to" sweet" and" fatty" food," and" (iv)" altered" taste" acuity" have" all"
been"reported"after"gastric"bypass"surgery."
+













short" term," there" is" a" risk" of" a" confounding" effect" of" post)operative" dietary" advice."Most"
studies" show" no" change" in" the" proportion" of" food" intake" accounted" for" by" protein,"
carbohydrate"or"fats"after"gastric"bypass"surgery"(Coughlin"et"al."1983;"Kruseman"et"al."2010;"
Liu" et" al." 2012)." " There" are" no" studies"which" show" changes" in"macronutrient" composition"
after"BAND"surgery.""
"
One" study" showed" modest" shifts" toward" increased" protein" and" reduced" carbohydrate"
intake," maintained" over" a" 24" month" period" after" gastric" bypass," although" these" patients"















snack"after" surgery"only"occurred" in" those"RYGB"patients"who"had"a"high" index"of" genetic"
susceptibility" to" obesity," suggesting" that" a" shift" in" food" preference" may" involve" an"
interaction"of"RYGB"surgery"on"genetic"factors"(Thirlby"et"al."2006)."
"
There" was" no" difference" in" macronutrient" composition" in" patients" who" had" successful"











in"whom" sweet" food" intake"was"unchanged"and"milk" and" ice" cream" intake" increased" by" a"
third"(Kenler"et"al."1990)."They"found"similar"results"in"a"further"study,"this"time"comparing"
RYGB" and" VBG" patients" (Brolin" et" al." 1994)." Olbers" et" al" similarly" found" that" patients"
randomized" to" RYGB" surgery" had" a" lower" proportional" intake" of" sweet" foods" in" their" diet"
compared" to" VBG" patients" (Olbers" et" al." 2006)." These" results" support" Sugerman’s" earlier"









There" was" no" conclusive" evidence" (most" studies" had" no" control" group" or" comparison" to"
previous"intake)"of"increases"in"fruit"and"vegetable"intake,"with"either"no"change"or"reduced"
intake"reported"(Halmi"et"al."1981;"Brown"et"al."1982;"Trostler"et"al."1995)."Two"studies"did"
find" that" fruit" and" vegetable" intake" was" greater" after" RYGB" compared" to" BAND" or" VBG"
surgery"(Olbers"et"al."2006;"Ernst"et"al."2009).""
"
The"above"studies"on" food"preference"acquired"data"using"dietary" recall"or" the"keeping"of"








Changes" in" taste" acuity" have" been" reported" but" these" are" inconsistent" and" difficult" to"







decreased" for"sweet," salty"and"sour" tastes,"and"was"significantly"decreased" for"bitter" taste"




RYGB"compared" to"46%"of"BAND"patients"answered"yes" to" the"question" “Has" the" taste"of"
food" and" beverages" changed" after" surgery?”" (Tichansky" et" al." 2006)." " There" was" no"
difference" in" reported" loss" of" taste." 92%" of" RYGB" vs." 59%" of" BAND" patients" reported" a"




sweet" foods,"and" increased" intake"of"milk"and" ice"cream"products"at"6,"18"and"24"months"
post)surgery"(Kenler"et"al."1990).""
"
Rodent" studies" have" been" inconclusive" with" regards" to" taste" sensitivity" measures," since"
these" can" be" difficult" to" separate" from" reward)related" behaviour" (Mathes" et" al." 2012)." In"
their" review," the"authors"point" to" the"confounding"effects"of"dietary"advice,"differences" in"
surgical" technique" and" predominance" of" female" patients" but" lack" of" control" of" hormonal"
factors" such" as" stage" of" menstrual" cycle" which" influences" appetite." These" factors" make"
interpretation"of"these"results"difficult."In"addition,"they"suggest"that"there"may"be"different"














snack,"until"a"“breakpoint”" is" reached." In"RYGB"patients," this"“breakpoint”"was" reduced"by"







of" high" calorie" foods," relative" to" low)calorie" foods" following" RYGB" surgery." " Reduction" in"











By" experiencing" unpleasant" symptoms" after" eating," conditioned" taste" aversion" to" these"




of" rapid" gastric" emptying" of" radiographic" contrast" in" patients" who" experienced" typical"
unpleasant"post)prandial"symptoms"after"undergoing"a"gastrectomy"(Wyllys"E)."
"




hyperosmolar" (especially" sugars)" contents" of" the" stomach" entering" the" small" intestine"
resulting"in"fluid"shift"from"the"intravascular"compartment"into"the"intestinal"lumen,"leading"










initial" hyperglycemia" from" rapid" absorption" of" glucose," and" release" of" insulin" takes" place."
Late"dumping"is"characterized"by"systemic"vascular"symptoms,"orthostatic"changes"in"blood"
pressure" and" increased" heart" rate," and" symptoms" include" flushing," dizziness," weakness,"
faintness,"and"palpitations."(Ukleja"2005;"Hejazi"et"al."2010)"
"
Intolerance" to" sweet" foods" (Warde)Kamar" et" al." 2004;" Kruseman" et" al." 2010)" and" milk"
products" (Coughlin" et" al." 1983;" Kenler" et" al." 1990)" and" avoidance" of" fatty" foods" due" to"
unpleasant"effects"(Olbers"et"al."2006)"have"been"all"been"reported"after"RYGB."“Dumping”"
symptoms" have" been" reported" in" up" to" 50%" of" patients" 2)3" years" after" RYGB" surgery"
(Sugerman" et" al." 1987)." However," the" above" observations" of" dumping" symptoms" were"
incidental"or"qualitatively"acquired,"and"had"not"been"formally"measured."In"the"only"study"
that" did" formally" compare" dumping" in" RYGB" and" restrictive" procedures," 75%" of" RYGB"




After" RYGB," symptoms" of" dumping" are" less" clearly" attributable" to" rapid" gastric" emptying"





higher" post)prandial" levels" of" the" gut" hormones" such" as" pancreatic" polypeptide," GLP)1,"
peptide" YY," neurotensin" and" enteroglucagon" as"well" as" noradrenaline" and" serotonin" have"
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"
been" documented" in" the" patients" with" dumping" syndrome" (Gebhard" et" al." 2001)." This" is"
particularly" relevant" in" RYGB" surgery" where" some" of" these" hormones" are" elevated"
postprandially"from"1"week"after"surgery"(le"Roux"et"al."2005),"and"remain"elevated"in"long"
term" studies" (Laferrere" 2011)." In" addition," patients" with" T2DM" have" higher" incidence" of"
dumping"after"bariatric"surgery"(Padoin"et"al."2009).""
"
“Post" bypass" hypoglycaemia”" has" been" described" which" needs" to" be" differentiated" from"
dumping."(Ritz"et"al."2011).""This"is"sometimes"referred"to"as"a"type"of"“nesidioblastosis”"or"
non)insulinoma" pancreatogenous" hypoglycaemic" syndrome" (NIPHS)" (Service" et" al." 2005;"
Deitel" 2008)." Importantly"McLaughlin" showed" that" hyperinsulinaemic" hypoglycaemia" after"
RYGB"is"due"to"the"accelerated"mode"of"nutrient"delivery"to"the"lower"intestine"and"not"β)
cell" dysfunction," as" was" previously" thought" (McLaughlin" et" al." 2010)." In" a" single" patient,"
administering"a" liquid"meal"orally"generated"rapid" release"of"GLP)1"and" insulin" resulting" in"
hypoglycaemia." Administering" the" same"meal" via" a" gastrostomy" into" the" bypassed" gastric"





drastic" solution." High" insulin" secretion" can" be" treated" in" less" severe" cases"with" Verapamil"
and" acarbose" (Moreira" et" al." 2008)," or" diet"modification" (Bantle" et" al." 2007;" Kellogg" et" al."
2008)." Importantly" hypoglycaemia" in"RYGB"patients" needs" to" be"differentiated" from"other"
causes"not"related"to"the"surgery,"such"as"insulinoma"(Zagury"et"al."2004)."
"
Eating" small," dry" protein)rich" low)carbohydrate" meals" more" frequently," results" in"
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"
normalization" of" glucose" levels" and" improved" symptoms" in" at" least" half" of" patients" with"
dumping" symptoms" (Deitel" 2008)." In" severe" cases" treatment" with" a" serotonin" antagonist"
(cyproheptadine)"or"somatostatin"analogue"(Octreotide)"can"be"helpful."Octreotide"reduces"
secretion" of" many" gut" hormones" including" PYY" and" GLP)1" and" reduces" gastrointestinal"
motility.""Interestingly,"administration"of"octreotide"has"been"shown"to"increase"food"intake"
























fMRI" studies" that" use" visual" food" cues"when" subjects" are" hungry" elicit" activation" of" brain"
food" reward" regions" known" to" be" involved" in" the" expectancy," appraisal" and" receipt" of"
reward,"including"the"striatal"nucleus"accumbens"(nucleus"accumbens)"and"caudate"nucleus"
(key" to" dopaminergic" reward" conditioning" and" learning," motivation" and" expectancy),"
amygdala"(emotional"responses"to"rewarding"stimuli),"anterior" insula"(integrating"gustatory"
and" other" sensory" information)" and" orbitofrontal" cortex" (OFC)" (reward" value" appraisal,"
cognitive" control" and" attention)" (Carnell" et" al." 2012;"De" Silva" et" al." 2012;" Ziauddeen"et" al."
2012)." In" normal" weight" subjects," a" fasted" and" therefore" hungry" state" elicits" increased"










regulate" calorie" intake." Restraint" can" be" subdivided" into" rigid" or" flexible" restraint." Rigid"
restraint" refers" to" dichotomous," all)or)nothing" approach" and" a" tendency" to" oscillate"
between" periods" of" strict" dieting" and" periods" of" overeating," particularly" of" high)calorie"










attempt" to" lose" weight" or" maintain" weight" loss," it" can" be" paradoxically" associated" with"
weight"gain."Several"studies"suggest"that"dietary"restraint"predicts"weight"gain,"binge"eating"
and" bulimia" nervosa," particularly" in" women" (Hill" 2004)." Particularly" the" all)or)nothing"
approach" taken" in" restrained" eaters" is" thought" to" lead" to" overeating" of" ‘forbidden’" foods"
under" emotional" distress," commonly" termed"disinhibition." " Repeated"disinhibition)induced"
overeating" appears" to" cause" a" shift" of" the" boundaries" at"which" satiety" is" felt," termed" the"
boundary"model" for" regulation"of"eating"(Herman"et"al."1984;"Polivy"et"al."1999)." " In"other"
words,"once"dietary"restraint"is"overridden,"food"intake"continues"beyond"the"point"at"which"
further"food"intake"would"normally"be"inhibited.""In"these"circumstances,"primed"by"recent"
food" intake," restrained" eaters" may" in" fact" find" food" more" rewarding" and" hence" overeat"
(‘counter)regulatory"eating’)."In"support"of"this,"dietary"restraint"did"not"predict"food"intake"















Colletta" et" al." (2009)" compared" 9" restrained" normal" weight" eaters" and" 10" unrestrained"
eaters"viewing"high)calorie"and"low)calorie"food"pictures."When"fasted,"viewing"high)calorie"
food" pictures" elicited" less" BOLD" activation" in" superior" temporal" gyrus," parahippocampal"
gyrus," dorsolateral" prefrontal" cortex" (DLPFC)," lentiform" nucleus" (putamen)," superior"
temporal"gyrus,"and"parahippocampal"gyrus" in"restrained"eaters"compared"to"unrestrained"
eaters," who" had" more" activation" than" unrestrained" eaters" only" in" the" cerebellum." By"
contrast"when"fed,"high)calorie"food"pictures"elicited"more"activation"in"the"OFC,"DLPFC"and"
insula" in" restrained" eaters" compared" to" unrestrained" eaters,"whereas" unrestrained" eaters"
had"more"activation" in"areas" for"satiation"and"memory" (left"cingulate"gyrus)" (Coletta"et"al."
2009).""
"
Similarly," 50" dieters" (assumed" to" be" exercising" dietary" restraint)" showed" greater" nucleus"
accumbens" BOLD" activation" to" high)calorie" food" pictures" after" a" milkshake" preload" than"
after"water,"compared"to"50"non)dieters"who"had"lower"nucleus"accumbens"activation"after"
a"milkshake"compared"to"water"(Demos"et"al."2011)."Activation"in"the"amygdala"followed"an"
opposite"pattern"however,"such"that"activity" in" the"amygdala"was"greatest" for"dieters"who"
received"water"and"non)dieters"who"received"the"milkshake.""
"




restraint" had" greater" activation" in" the" left" amygdala" and" the" right" thalamus" than"
unrestrained" co)twins" to" fattening" foods" (Schur" et" al." 2012)." Unrestrained" eating" twins"
showed"stronger" responses" to"non)fattening" food" images" in" the"medial"OFC" than"did" their"






responses" in"normal"weight" (n=17)" and"overweight" (n=3)" fasting"men"and"women" to" food"
pictures"when"attempting"to"reduce"the"desire"for"tasty"food"was"increased"in"bilateral"OFC,"
bilateral" inferior" frontal" gyrus" /" anterior" insula," bilateral" DLPFC," pre)supplementary"motor"
area"and"bilateral"temporo)parietal"junction"compared"to"allowing"the"desire"for"tasty"foods."
On"an" individual" level," there"was"a"positive"correlation"between"TFEQ"restraint" scores"and"
activation"in"left"DLPFC"in"cognitive"control"of"tasty"foods."The"study"was"underpowered"to"
detect" differences" between" normal" weight" and" overweight" individuals" (Hollmann" et" al."
2012)." In"another"PET"study," inhibition"of"the"desire"to"eat"when"presented"with"food"cues"
led"to"decreased"activation"in"the"amygdala,"hippocampus,"insula,"orbitofrontal"cortex,"and"
striatum" in" fasting" normal" weight"men," but" not"women" (Wang" et" al." 2009)." " Therefore" it"




In" binge" eating" disorder" (BED)," discrete" episodes" of" dietary" disinhibition" or" loss" of" control"
result" in" the" consumption" of" a" large" amount" of" food" (typically" at" least" ½" of" the" daily"
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recommended" amount" of" calories)," consumed" in" a" short" period" of" time" (½" )1" hour),"
accompanied"by"a"subjective"sense"of"loss"of"control."In"BED,"as"opposed"to"bulimia"nervosa,"
binges" are" not" associated" with" compensatory" purging" techniques," such" as" self)induced"
vomiting" in" an" attempt" to" rid" the" body" of" unwanted" calories." Binge" eating" disorder" is"




patterns" after" surgery," associated" with" poorer" weight" loss" outcomes" (Niego" et" al." 2007)."
Post)operative" binge" eating" in" BAND" surgery" has" been" associated" with" long" term" weight"
regain,"revision"surgery"and"poor"quality"of"life"(Scholtz"et"al."2007)."
"





In"animal"models,"a" chronic"deprivation"model" to"elicit"bingeing" is"used."Using" this"model,"
MOR" antagonists" suppress" food" bingeing" in" a" number" of" studies" (Mathes" et" al." 2009)."




of" the" less" preferred" diet" (i.e." chow)." Using" the" same" model" a" specific" MOR" antagonist"
(GSK1521498)"and"naltrexone" reduced" the"propensity" to" seek" (both"before"and"after" food"
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"
ingestion)," and" binge" eating" of," palatable" chow." " However" only" GSK1521498" reduced" the"
impact"of"high"hedonic"value"on" ingestion"of"chocolate," suggesting" that" the"MOR"pathway"
has"a"specific"role"to"play"in"conditioned"salience"in"binge"eating"(Giuliano"et"al."2012)."
"
Furthermore"direct" stimulation"of"MORs"with"MOR"agonists" such" as"morphine"or"DAMGO"
([D)Ala2," N)Me)Phe4,Gly5)ol5])enkephalin)" within" the" nucleus" accumbens" of" rats"
preferentially"increases"intake"of"energy"rich"foods"such"as"fat"and"sucrose,"as"well"as"tasty"
non)caloric" foods" such" as" saccharin" and" salt" (Will" et" al." 2003;" Mathes" et" al." 2009)" and"
increases" or" amplified" positive" affective" reactions" (i.e." liking" reactions)" to" sucrose" taste"
(Pecina"et"al."2000;"Pecina"et"al."2005)."
"
In" human" fMRI" studies," both" obese" and" lean" binge" eaters" show" increased" activation" in"
frontal"pre)central"area"of"the"brain"(Geliebter"et"al."2006)"and"the"OFC"(Schienle"et"al."2009)"










External" eating" is" a" measure" of" eating" in" response" to" external" cues" (such" as" the" sight" of"
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appetizing" food)," as" opposed" to" internal" cues" (such" as" hunger)." This" is" thought" to" be"
associated" with" overeating" and" obesity," although" it" may" be" the" lack" of" attention" paid" to"
internal"cues"that" is"more"relevant"than"the"attention"paid"to"external"cues"(Herman"et"al."
2008)." Lesion" studies" suggest" that" frontal" lobe" damage"may" increase" external" eating," and"
lead" to" hyperphagia" and" obesity" (Myslobodsky" 2003)." In" fact," relatively" few" studies" have"
actually"confirmed"the"link"between"external"eating"and"obesity"(Nisbett"1968;"Pliner"1973;"
Braet"et"al."1997)"although" it"has"been" linked" to" food"craving" (Burton"et"al."2007)"and" the"
area"remains"under)researched"(Herman"et"al."2008).""
"
Passamonti" et" al." found" correlations" with" external" eating" (measured" with" DEBQ" External"
eating" scale)" and" superior" temporal" lobe" activation" to" food" pictures" in" 21" normal" weight"
male" and" female" volunteers" aged" between" 19" and" 39" years." Increased" functional"
connectivity"between" the"ventral" striatum"and"amygdala"and"prefrontal"motor" cortex,"but"
decreased"connectivity"between"the"ventral"striatum"and"the"dorsal"ACC"was"observed."The"
authors" suggest" that" increased" external" eating"may" therefore" be" underpinned" by" specific"




Emotional" eating," or" eating" in" response" to" emotional" cues" (such" as" sadness," anxiety" or"
anger),"also"known"as"comfort"eating," is"associated"with"depression,"and"a"need"to"escape"
negative" affect." Although" emotional" eating" can" refer" to" eating" in" response" to" positive"
emotions," the"most" common" precipitant" is" negative" emotions," particularly" in" women." " In"
most" studies," emotional" eating" as" measured" by" the" DEBQ" emotional" eating" scale," is"
positively" associated" with" BMI" (Gibson" 2012)." " There" are" also" cross)correlations" and"
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interactions"between"dietary" restraint," external" eating," disinhibition"and"emotional" eating.""
For" example," women" who" scored" highly" on" TFEQ" restraint" and" disinhibition" scores," were"
more" likely" to" eat" in" response" to" negative" affect," whereas" women" who" scored" highly" on"
disinhibition"but"low"on"restraint"were"more"likely"to"overeat"in"response"to"positive"affect"
(Yeomans"et"al."2009)." "Emotional"eaters"and" restrained"eaters"are"more" likely" to"eat"high"
calorie" or" sweet" foods" in" response" to" stress" (Heatherton" et" al." 1991;" Oliver" et" al." 2000)."





Neuroimaging" studies" have" demonstrated" an" interaction" of" emotional" eating" and" neural"
activation" to" food." " In" a" study" of" 12" normal" weight" individuals," negative" emotional" state"
(induced"by"sad"music"and"faces)"was"attenuated"by"intragastric"infusion"of"fatty"acids,"with"
corresponding" reduction" in" BOLD" activation" in" medulla/pons," midbrain," hypothalamus,"
thalamus,"putamen,"cerebellum,"hippocampus"and"cingulated"cortex,"but"not" the" insula"or"
amygdala"(Van"Oudenhove"et"al."2011)."In"another"study,"healthy"weight"women"who"scored"











Depression," and" anxiety" (and" indeed" many" other" mental" disorders)" are" associated" with"





Indeed" common" to" both" obesity" and" depression" are" disruptions" in" immuno)inflammatory"
processes" (e.g." the" kynurenine/tryptophan/serotonin" pathway" (Breum" et" al." 2003;" Myint"
2012)," increased" oxidative" stress," mitochondrial" disturbances," hypothalamic)pituitary" axis"
imbalances" and" neurotransmitter" imbalances," all" of" which" offer" intriguing" possibilities" for"
the"investigation"of"common"mediating"pathways"(Lopresti"et"al."2013)."
"
In" keeping"with" Section"1.7.2.4" depression," premenstrual" low"mood"and"neuroticism"have"
also"been"linked"to"overeating"high"calorie"foods"when"stressed"(Gibson"2006)."""
"
Although" there" have" been" no" studies" which" specifically" examine" the" effect" of" clinical"
depression" on" food" reward" processing" in" the" brain," using" neuroimaging," fMRI" and" PET"
studies" have" demonstrated" altered" neural" activity" in" depressed" subjects" compared" to"









can" lead" to" some" confusion" in" interpreting" study" results." It" is" likely" that" these" systems"
function"in"synergy"to"co)ordinate"behavioural"approach"or"inhibition"toward"food,"and"may"
be" activated" in" both." For" instance," frontal" lobe" regions," including" superior" frontal" gyrus,"
middle" frontal" gyrus," inferior" frontal" gyrus," medial" PFC," DLPFC," VLPFC" and" OFC" all"
consistently"implicated"in"response"inhibition"(Liddle"et"al."2001;"Mostofsky"et"al."2003;"Aron"
et"al."2005;"Buchsbaum"et"al."2005;"Simmonds"et"al."2008),"whereas"the"OFC"has"also"been"
implicated" in" evaluation" of" food" reward" (Small" et" al." 2007)." Poor" response" inhibition"
(impulsivity)"has"been"implicated"in"the"development"of"obesity"(Ryden"et"al."2003;"Braet"et"
al."2007),"and"poor"weight"loss"during"dieting"(Jonsson"et"al."1986;"Nederkoorn"et"al."2006)"
(Weygandt"et"al."2013),"whereas"engagement"of"areas"of" inhibitory" control" in" response" to"
food" cues"may" ensure" successful"weight"maintenance" (Hare" et" al." 2009)." " " Better" impulse"
control" has" been" associated" with" stronger" functional" connectivity" between" VMPFC" and"
DLPFC" at" rest," which" predicted" greater" weight" loss" during" dieting" in" obese" subjects"
(Weygandt"et"al."2013)."
"











with" a" higher" BMI" responded"more" quickly" but" less" accurately" particularly" to" high)calorie"
food"cues"(Batterink"et"al."2010)."They"also"had"less"less"activation"during"response"inhibition"
in"the"frontal"lobes,"including"superior"frontal"gyrus,"middle"frontal"gyrus,"VLPFC,"medial"PFC,"










reduced" subsequent" energy" intake" as" compared" to" men" (Cornier" et" al." 2007)." In" a"




















posterior" cingulate" and" parahippocampal" gyrus," compared" to" women" when" hungry" and"









eating" behaviour." Prader)willi" syndrome" (PWS)" is" a" genetic" obesity" syndrome," associated"
with" neuroendocrine" abnormalities," learning" disability" and" behavioural" problems" with"
marked" hyperphagia" developing" in" childhood," due" to" loss" of" expression" of" paternally"
expressed" imprinted"genes"on"chromosome"15" (15q11–13)," leading" to,"early"onset"morbid"
obesity" (Goldstone" 2006)." Patients" with" PWS" " have" increased" activation" to" food" pictures"




Holsen" et" al." 2009)." Delay" in" response" to" glucose" ingestion" in" reward" areas" of" the" brain"





neural" reactivity" to" food" in" the"nucleus"accumbens," caudate,"putamen"and"globus"pallidus"
(Farooqi"et"al."2007)"with"less"suppression"in"these"areas"after"eating"than"controls"(Aotani"
et" al." 2012)," which" was" reversed" by" leptin" administration" (Aotani" et" al." 2012)." " Leptin"
administration" also" reduces" BOLD" activation" to" food" pictures" the" insula," parietal" and"
temporal"cortex"and"increases"activation"in"prefrontal"cortex"(Baicy"et"al."2007;"Farooqi"et"al."
2007)."""However,"monogenic"disorders"leading"to"obesity"such"as"leptin)deficiency,"(as"well"
as" melanocortin" 4" receptor" (MC4R)," pro)opiomelanocortin" (POMC)" and" prohormone"
convertase"1"(PCSK1))"are"rare"and"probably"account"for"less"than"5%"of"obesity.""
"
The" genetic" influence" on" obesity" is" therefore" mostly" polygenic," and" although" this" may"
contribute" between" 45%" and" 85%" of" the" heritability" in" BMI," the" effect" size" is" likely" to" be"
small.""For"example,"the"FTO"(fat"mass"and"obesity"associated"gene)"allele,"one"of"the"most"
established"common"gene"variants,"results"only"in"approximately"0.4"kg/m2"increase"in"BMI.""
The" mechanism" for" the" effect" of" individual" genetics" on" weight" is" thought" to" be" mostly"
through" increased"appetite" and"eating"behaviour" (Cecil" et" al." 2012)." " Various" studies"have"
therefore" attempted" to" link" emerging" evidence" of" obesity)associated" gene" variants,"





For" instance," the" Taq1A" A1" allele" of" the" DRD2" gene" has" been" associated" not" only" with"
alcoholism,"drug"abuse,"smoking"and"compulsive"gambling,"but"also"with"obesity"(Comings"et"
al." 2000)." Carriers" of" Taq1A" A1" allele" have" increased" impulsivity" (White" et" al." 2008)" and"
increased"body"weight"(Noble"2000)."Behavioural"studies"have"shown"that"especially"obese"
individuals"with"the"allele"will"work"harder"in"a"food"reward"task"for"food"than"those"without"
the" allele" (Epstein" et" al." 2007)." " In" addition," healthy"weight" individuals"with" the" Taq1A"A1"
allele"have"reduced"dopamine"D2"receptors"(Jonsson"et"al."1999)"and"lower"glucose"uptake"
on" FDG" PET" in" prefrontal" and" striatal" (caudate," putamen" and" nucleus" accumbens)" areas"
(Noble" et" al." 1997)," in" keeping" with" the" reward" deficiency" theory" of" obesity" (see" Section"
1.7.5)." " Furthermore," 2" fMRI" studies" of" healthy"weight" participants" has" shown" that" those"
with" the" Taq1A" A1" allele" have" attenuated" activation" of" the" reward" circuitry" (OFC" and"
prefrontal"areas/" thalamus,"midbrain)" in" response" to"receipt"of"appetizing" food" (Felsted"et"
al."2010;"Stice"et"al."2010;"Stice"et"al."2012)"and"that"attenuation"of"BOLD"activation"in"the"





Individuals" positive" for" the" obesity" risk" FTO" (fat"mass" and" obesity" associated" gene)" allele"
have" reduced" brain" volume" (Ho" et" al." 2010;"Melka" et" al." 2013)" and" in" one" recent" study,"
reduced" BOLD" in" response" to" food)related" images" within" the" hypothalamus," left" ventral"
















































































































↓# →# →# Thalamus↓#
Occipital#↓#ACC↓#
HR↑# in# OB# when# showed#
food#pictures;# no#differences#
















































# HvO#↑# ↑# LvO# occipital,# sup#
temporal#




































↑# ↑# ↑# ↑# ventral# pallidum,#
ACC#

































































































for# order# effect.# Fasted#











































































ROI# statistics# invalid,# no#
differences# in#appeal# ratings,#














































































































































































































































# # # insula
↑#
# Insula# higher# with# passive#
viewing,# dlPFC# higher# with#
“cognitive# control”# in# the# OB#
vs.# NW,# no# calorie# subgroups#





































→# ↑# ↑# →# Participants# chose# their#
preferred# cues,# blood# tests#







































in# food# anticipation,↑# insula#
and# FO# and# ↓# caudate# and#
parietal#to#food#receipt##



























































































































→# →# →# →# ↑ROp,#
FO#
# BMI#↑#VLPFC,#DLPFC,#temporal#
in# food# anticipation,# ↑# insula#
and# FO# and# ↓# caudate# and#
parietal#to#food#receipt##

































# # # # TaqA1# allele# amplified# the#
negative# BMI# correlation.#
Activation# in# those# without#
allele# predicted# future# Taq1#
weight# gain# at# 1# yr,# and#




























# # # # Decreased# caudate# activation#
in# women# who# gained# weight#



































































































































































N/A# N/A# N/A# N/A# ↓#ACC# Results# are# correlations# with#
BMI;# no# control# for#
menstrual# periods;# no#





































HvO#↑# # # HvO#↑# HvO# ↑# claustrum,#
globus#pallidus#
Results# are# correlations# with#








































































WC# # # ↑# # # # Results# are# correlations# with#







































Results# are# correlations# with#
BMI#RT#faster#in#the#OB,#weight#






























































































# # # # Results#show#hypoactivation#in#
these# areas# predicting# weight#




























# # # # # ↑#OW#at#1yr##
↓Precuneus#
#
Taq1# allele# had# no#
moderating#effect#on#results.#












































Taq1# allele# had# no#
moderating#effect#on#results.#























































RO# placebo# vs# leptin#
comparison.# Small# n# number,#
too#may#pairwise# comparisons#
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→# →# →# →# Fasted##
EI#↓#ACC#
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N/A# N/A# N/A# N/A# N/A# Slower# and# ↓#
inhibitory# response# in#
the#VMH#and#PVN#
No# correction# for# multiple#
comparisons,# hypothalamus#
too# small# and# close# to#
arteries/sinuses# making#
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thalamus#




































































taste,&NW:# normal#weight,#OB:# obese,#OFC:# orbitofrontal# cortex,#o/n:# overnight,&OW:&overweight,#PANAS:# Positive# and#Negative#Affect# Scale,& PCC:# posterior# cingulate#
cortex,&PET:#positron#emission#tomography,&Pl:#Placebo,&PR:#prospective,#QN:#questionnaire,#rCBF:#regional#cerebral#blood#flow,&RO:&obese#reduced#weight,&ROI:#Region#of#
interest# study,# ROp:# Rolandic# operculum,& RT:# reaction# time,& RYGB:# Roux9en9Y# gastric# bypass,# SFG:& superior# frontal# gyrus,& SPECT:# Single# photon# emission# computer#



































































































































































Age# OB# 33y;# NW#
32y#
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taste,&NW:# normal#weight,#OB:# obese,#o/n:# overnight,&OFC:# orbitofrontal# cortex,#OW:&overweight,#PANAS:# Positive# and#Negative#Affect# Scale,& PCC:# posterior# cingulate#
cortex,&PET:#positron#emission#tomography,&Pl:#Placebo,&PR:#prospective,#QN:#questionnaire,#rCBF:#regional#cerebral#blood#flow,&RO:&obese#reduced#weight,&ROI:#Region#of#
interest# study,# ROp:# Rolandic# operculum,& RT:# reaction# time,& RYGB:# Roux9en9Y# gastric# bypass,# SFG:& superior# frontal# gyrus,& SPECT:# Single# photon# emission# computer#











activation$ to$ food$ cues$ in$many$ areas$ of$ the$ brain$ associated$with$modulating$ dopamine$
release$ (VTA,$ nucleus$ accumbens,$ caudate,$ putamen),$ reward$ or$ saliency$ interpretation$$
(OFC,$ ACC),$ integration$ of$ sensory$ information$ relating$ to$ food$ (insula,$ primary$ gustatory$
cortex),$ motivation$ or$ drive$ to$ seek$ reward$ (OFC),$ emotional$ response$ and$ regulation$






most$ studies$ use$ BMI$ as$ a$ marker$ of$ obesity,$ a$ raised$ BMI$ may$ be$ the$ end$ result$ of$ a$
combination$ of$ any$ number$ of$ etiological$ pathways$ and$ influences,$ all$ of$ which$ may$
differentially$affect$or$be$affected$by$the$neurological$response$to$food$(Berthoud$2012).$In$
other$words,$although$obesity$is$largely$the$end$product$of$eating$in$excess$of$an$individual’s$




traits$ (such$as$ impulsivity$and$reward$responsivity),$different$cognitive$styles$ (such$as$ rigid$
dietary$ restraint$or$selfQcontrol),$and$behaviour$ indicative$of$possible$underlying$deficits$ in$




Section$ 1.7.2).$ Each$ of$ these$ will$ have$ their$ own,$ possibly$ diverse,$ effect$ on$ the$ reward$
response$ to$ food$ cues$ as$ well$ as$ cognitive$ and$ executive$ control$ network$ functioning$ in$
response$ to$ food$ cues$ (Hollmann$ et$ al.$ 2013).$ A$ better$ understanding$ the$ effects$ of$ how$
these$ factors$ affect$ neural$ reactivity$ to$ food$ in$ different$ parts$ of$ the$brain,$ linking$ this$ to$










2008;$Stice$et$al.$2013),$ $was$employed$as$ the$stimulus$ (see$Table$1.1$ for$examples).$Even$
the$type$of$food$pictures$used$may$vary$considerably$across$studies$with$the$use$of$pictures$
of$highQcalorie$foods$(Rothemund$et$al.$2007;$Stoeckel$et$al.$2008;$Dimitropoulos$et$al.$2012;$
Grosshans$ et$ al.$ 2012;$ Ho$ et$ al.$ 2012),$ appetising$ foods$ (Nummenmaa$ et$ al.$ 2012)$ and$
palatable$foods$(Frankort$et$al.$2012)$all$interchangeably$used.$$Some$studies$use$pictures$of$
foods$ that$ subjects$ have$ themselves$ chosen$ as$ palatable,$ introducing$ a$ further$ variability$
factor$(Karhunen$et$al.$2000;$Jastreboff$et$al.$2013).$However,$even$within$studies$that$make$













particularly$when$there$ is$variability$across$study$design.$ $Furthermore,$very$ large$subjects$






(Brooks$et$al.$2013).$ $Of$ the$126$subjects$ included$ in$ the$7$ studies$examining$whole$brain$
response$ to$ food$ images,$ obese$ in$ comparison$ to$ healthy$ weight$ subjects$ had$ increased$











Furthermore$ there$ exists$ variability$ in$ methods$ of$ statistical$ analysis$ of$ neuroimaging$
studies,$with$the$use$of$different$analysis$software$(e.g.$FSL,$SPMQ5,$BrainVoyager),$different$
methods$ of$ determining$ significance$ levels$ (including$ making$ correction$ for$ multiple$
comparisons,$ or$ not),$ and$ different$ methods$ of$ preQprocessing$ and$ processing$ data$ (See$
Chapter$2$for$more$details).$$$$
$
As$ evident$ from$ Table$ 1.1$ and$ Table$ 1.2$ neuroimaging$ techniques$ such$ as$ fMRI$ and$ PET$
although$ both$ used$ to$ investigate$ brain$ responses$ to$ food,$ make$ use$ of$ very$ different$
techniques$to$do$so.$As$such$they$are$measuring$different$biological$aspects$of$this$response,$
e.g$ blood$ flow$ changes$ measured$ by$ changes$ in$ magnetic$ property$ of$ blood$ in$ fMRI$ vs.$
blood$ flow$ changes$ measured$ by$ changes$ in$ the$ degradation$ of$ radioQactively$ tracer$
attached$to$water$molecules$ (15OQwater$PET).$ $Comparison$between$different$modalities$ is$













obese$ and$ lean$ adolescents’$ responses$ to$ food$ pictures.$ $ Increased$ activation$ in$ frontal$
regions$(OFC,$inferior$and$middle$frontal$gyrus)$(Bruce$et$al.$2010)$and$in$the$DLPFC$(Davids$
et$al.$2010)$was$seen$ in$obese$compared$ to$ lean$adolescents$when$viewing$ food$pictures.$$
However$less$activation$in$the$caudate,$hippocampus$and$ACC$was$seen$in$obese$compared$
to$ lean$ adolescents$ in$ the$ latter$ study.$ In$ the$ first$ study,$ obese$ adolescents$ had$ less$
reduction$ in$ frontal$ area$ activation$ than$ lean$ adolescents$ when$ scanned$ again$ after$ a$
500kcal$meal.$$
$
In$ the$ adult$ studies$ employing$ the$ same$ food$ stimulus$ (food$ pictures)$ the$ results$ are$ not$
consistent.$$Even$when$excluding$results$from$those$studies$that$did$not$make$correction$for$
multiple$ comparisons$ (Rothemund$ et$ al.$ 2007;$ Martin$ et$ al.$ 2010;$ Frankort$ et$ al.$ 2012;$
Nummenmaa$et$al.$2012),$ inconsistency$remains.$ $For$ instance,$out$of$the$6$studies$where$
robust$statistical$analysis$was$employed,$greater$BOLD$activation$to$highQcalorie$or$any$food$
pictures$ in$obese$compared$to$normal$weight$ individuals,$was$seen$in$the$OFC$in$2$studies$
(Stoeckel$ et$ al.$ 2008;$ Jastreboff$ et$ al.$ 2013),$ $ the$ DLPFC$ in$ 2$ studies$ (Ho$ et$ al.$ 2012;$
Scharmuller$et$al.$2012),$the$putamen$and$amygdala$in$3$studies$(Stoeckel$et$al.$2008;$Ho$et$
al.$2012;$Jastreboff$et$al.$2013),$and$the$insula$in$3$(Stoeckel$et$al.$2008;$Scharmuller$et$al.$
2012;$ Jastreboff$ et$ al.$ 2013).$ $ Greater$ caudate,$ hippocampus$ and$ ACC$ activation$ to$ food$
pictures$ in$ the$ obese$ compared$ to$ lean$ subjects$was$ also$ observed$ in$ two$ of$ the$ studies$
(Stoeckel$ et$ al.$ 2008;$ Dimitropoulos$ et$ al.$ 2012),$ although$ in$ the$ latter,$ this$ was$ only$
observed$in$the$fed,$not$fasted$state.$$For$the$rest,$obese$people$either$had$no$difference$in$
or$ lower$(Dimitropoulos$et$al.$2012;$Grosshans$et$al.$2012;$Ho$et$al.$2012;$Jastreboff$et$al.$












measuring$ BOLD$ response$ to$ actual$ receipt$ of$ the$milkshake$ (Stice$ et$ al.$ 2008;$ Ng$ et$ al.$
2011).$ $ However,$ later$ studies$ by$ the$ same$ group$ did$ not$ replicate$ these$ findings$ and$
instead$found$reduced$caudate$activation$in$response$to$milkshake$receipt$in$obese$subjects$
compared$ to$ healthy$ weight$ (Stice$ et$ al.$ 2008;$ Stice$ et$ al.$ 2010).$ $ Importantly,$ these$ 2$
studies$also$found$that$the$lower$activation$in$the$caudate$in$response$to$milkshake$receipt$





their$ paradigms.$ $ Subjects$ were$ subjected$ to$ prolonged$ fasting$ of$ 36$ hours$ before$ being$





women$ (Le$ et$ al.$ 2007)$ in$ two$ studies$ using$ this$ paradigm,$ but$ another$ study$ utilizing$ an$
almost$ identical$paradigm$ found$ increased$ activation$of$DLPFC$ in$obese$ compared$ to$ lean$
140$
$
men$ (Gautier$ et$ al.$ 2000).$ $ Similarly$ satiation$ resulted$ in$ greater$ reduction$ of$ rCBF$ in$ the$
ventrolateral$ and$ ventromedial$ prefrontal$ cortex,$ gustatory$ cortex,$ temporal$ and$













fMRI$ studies$ lean$ and$ obese$ adult$ subjects$ using$ food$ pictures,$ BMI$ $ was$ positively$
correlated$ with$ BOLD$ activation$ to$ highQcalorie$ food$ compared$ to$ neutral$ pictures$ in$ the$
caudate,$putamen,$anterior$insula,$PCC,$globus$pallidus$and$OFC$in$one$study$(Rothemund$et$
al.$ 2007)$ and$negatively$with$BOLD$activation$ in$ inferior$ frontal$ gyrus$ and$ACC$ in$ another$








2011).$ $Similarly$BOLD$activation$ in$response$to$exercising$cognitive$control$ in$response$to$
appetizing$ food$pictures,$ correlated$positively$ in$ the$ insula$and$negatively$ in$ the$OFC$with$
BMI$(Batterink$et$al.$2010).$$
$




In$ one$ study$ of$ adolescent$ girls,$ increase$ in$ BMI$ after$ 1$ year$was$ predicted$ by$ increased$
baseline$OFC$activation$to$pictures$of$appetizing$foods$(Yokum$et$al.$2011)$and$in$another$by$
less$ temporal$ activation$when$ exercising$ cognitive$ control$ in$ response$ to$ appetizing$ food$
pictures$ (Batterink$et$al.$2010).$ In$ the$same$portfolio$of$ studies,$utilizing$ taste$ rather$ than$
pictures$as$the$stimulus,$lower$activation$in$the$OFC$and$putamen$in$response$to$imagining$
eating$ palatable$ foods$ also$ predicted$ increased$ BMI$ after$ a$ year$ (Stice$ et$ al.$ 2010),$ and$
lower$ precuneus$ activation$ in$ anticipation$ of$milkshake$ taste$ delivery$ and$ lower$ temporal$
activation$ to$ actual$ delivery$ of$ the$ milkshake$ taste$ predicted$ increase$ in$ progression$ to$
overweight$in$adolescents.$$
$
Increased$ activation$ in$ the$ nucleus$ accumbens$ to$ viewing$ food$ pictures$ also$ predicted$
weight$gain$6$months$later$in$a$study$of$58$normal$weight$college$students.$Unfortunately,$
however$ this$ study$ did$ not$ make$ correction$ for$ multiple$ comparisons$ when$ comparing$







In$ a$ longitudinal$ study$ of$ 6$ obese$ people,$ 10%$ weight$ loss$ has$ been$ associated$ with$
decreased$BOLD$activation$to$food$pictures$in$the$ACC$and$amygdala,$increased$activation$in$
the$brainstem$and$both$increased$and$decreased$activation$in$the$inferior$and$middle$frontal$




BOLD$activation$to$food$pictures$ in$the$ insula$and$visual$cortex$(Cornier$et$al.$2009).$ $They$








may$ ensure$ successful$ weight$maintenance$ (Hare$ et$ al.$ 2009)$ as$well$ as$ reduction$ in$ the$
salience$attributed$to$food$(processed$in$the$OFC).$$$
The$ first$ study$ compared$ obese$ to$ reduced$ obese$ subjects,$ and$ the$ second$
normal/overweight$dieters$to$nonQdieters.$$The$latter$study$also$found$increased$rCBF$in$the$



















Two$ PET$ and$ one$ SPECT$ study$ have$ shown$ that$ obese$ people$ have$ fewer$ D2$ receptors$
availability$ in$ striatal$ areas,$ compared$with$ lean$ people$ (Wang$ et$ al.$ 2001;$ Volkow$ et$ al.$
2008;$de$Weijer$et$al.$2011)$and$that$this$is$correlated$with$BMI,$although$two$other$studies$
have$not$replicated$these$findings$(Haltia$et$al.$2008;$Dunn$et$al.$2012).$$The$findings$of$the$
first$ three$ studies$ support$ a$ dopamine$ hypofunction$ etiological$ theory$ of$ obesity.$ This$








dopamine$ release$ triggered$ by$ food$ anticipation$ or$ receipt$ leading$ to$ eventual$ downQ
regulation$ of$ receptors.$ $ This$ scenario$ would$ be$ more$ in$ keeping$ with$ a$ dopamine$
hyperfunction$theory$of$obesity.$
$
A$unified$ theory$of$ the$above,$ is$ that$ receipt$of$ food$may$ induce$attenuated$activation$of$




low$ risk$ (Stice$ et$ al.$ 2011),$ suggesting$ they$ differ$ in$ this$ respect$ to$ the$ already$ obese.$ A$
potential$mechanism$ is$demonstrated$ in$animal$models$where$a$ repeated$ intake$of$ sweet$












Increased$ connectivity$ (increased$ influence)$ between$OFC$ on$ the$ nucleus$ accumbens$ and$
reduced$ modulation$ of$ the$ amygdala$ on$ both$ the$ $ OFC$ and$ nucleus$ accumbens$ was$
demonstrated$in$one$study$(Stoeckel$et$al.$2009)$whilst$increased$influence$of$the$amygdala$
and$ insula$ on$ caudate$ was$ found$ in$ another$ study$ (Nummenmaa$ et$ al.$ 2012)$ in$ obese$




lobe$ network$ in$ obese$ compared$ to$ lean$ individuals$when$ at$ rest$ (Kullmann$ et$ al.$ 2012).$
Taken$ together,$ these$ studies$ suggest$ a$ dysfunction$ in$ assessing$ and$ adapting$ to$ reward$
value$of$food$cues$in$obese$individuals.$On$the$basis$of$these$findings,$it$has$been$suggested$
that$ an$ imbalance$between$ cognitive$ and$emotional$ processing$of$ food$ cues$ is$ present$ in$






BMI$ with$ grey$ matter$ density/volume$ in$ various$ areas$ of$ the$ brain$ associated$ with$ the$
processing$of$ reward,$ although$ results$ are$ inconsistent$ (see$Table$1.3).$ $However,$ caution$








at$1Qyear$ follow$up,$ as$was$higher$white$matter$ volumes$ in$ the$dorsal$ striatum$ $ (caudate,$
putamen)$and$hippocampus$(Yokum$et$al.$2012).$$Another$adolescent$study$found$increased$
grey$matter$ volume$ in$ the$ hippocampus$ of$ obese$ compared$ to$ normal$ weight$ teenagers$
(MorenoQLopez$et$al.$2012).$$
$
In$ studies$ including$ adults$ <70$ years$ old,$ again$ frontal$ and$ striatal$ regions$ as$ well$ the$
gustatory$cortex$and$amygdala$emerged$as$holding$differences$between$obese$and$normal$
weight$ people,$ although$ the$ direction$ of$ the$ association$ is$ inconsistent$ between$ studies.$$
Increased$grey$matter$volume$ in$ the$OFC$was$associated$with$ increased$BMI$ in$one$study$
(Horstmann$ et$ al.$ 2011),$whereas$ another$ found$ no$ correlation$ (Orsi$ et$ al.$ 2011)$ and$ yet$
another,$ a$ negative$ association$ with$ waist$ circumference,$ although$ not$ BMI$ (Kurth$ et$ al.$
2012).$$Grey$matter$volume$in$the$inferior$frontal$gyrus$has$also$been$shown$to$be$increased$








the$gustatory$cortex$ (frontal$operculum$or$ insula)$has$been$associated$with$ increased$BMI$
(Kurth$et$al.$2012)$and$obesity$(Pannacciulli$et$al.$2006).$$
$
In$ older$ adults$ (>70$ years)$ however,$ obesity$ appears$ more$ clearly$ to$ be$ associated$ with$
147$
$
reduced$ grey$ matter$ volume$ in$ frontal,$ striatal$ (putamen)$ (Raji$ et$ al.$ 2010),$ periQ
hippocampal$(Raji$et$al.$2010),$gustatory$cortex$(Walther$et$al.$2010)and$amygdala$(Ho$et$al.$
2010)$regions.$$However$this$apparent$association$may$be$confounded$by$the$effect$of$age$




white$matter$ volume,$and$ this$may$have$a$ further$ interaction$with$BMI.$ $As$Driscoll$ et$ al.$
point$ out,$ the$ effect$ of$ BMI$ or$ obesity$ may$ be$ overestimated$ in$ studies$ of$ grey$ matter$
volume$ which$ include$ older$ adults,$ even$ if$ nonQdemented$ at$ the$ time,$ since$ a$ subset$ of$
these$will$go$on$to$develop$dementia$and$subQclinical$brain$volume$effects$may$already$be$
present$(Driscoll$et$al.$2012).$ $ In$their$study$of$patients$with$average$age$of$69$years,$they$
found$ an$ association$ of$ age$ with$ reduced$ grey$ matter$ volumes$ over$ one$ year$ in$ frontal,$
cingulate$and$hippocampal$areas.$ $Midlife$obesity$emerged$as$a$modifier$of$brain$atrophy$
associated$with$dementia,$but$not$in$nonQdemented$subjects.$$Therefore,$excluding$patients$




al.$ 2010)$ or$ other$ metabolic$ diseases$ in$ crossQsectional$ studies$ may$ be$ important$
confounders,$which$are$not$always$taken$into$account$or$corrected$for.$$
$
For$ instance,$ in$ a$ their$ study$ of$ women$ of$ average$ age$ 70$ years,$ with$ normal$ cognitive$
functioning,$ correcting$ for$ hypertension$ decreased$ the$ number$ of$ areas$ in$ which$ grey$











The$ FTO$ gene$ has$ also$ shown$ association$ with$ reduced$ total$ brain$ volume$ (Melka$ et$ al.$
2013),$ and$ reduced$ grey$matter$ volume$ in$ frontal$ regions$ (Ho$et$ al.$ 2010).$ObesityQprone$






in$ the$ OFC.$ $ In$ one$ study,$ binge$ eating$ young$ women$ had$ increased$ OFC$ and$ ACC$ grey$
matter$volume$compared$to$nonQeating$disordered$normal$weight$individuals$(Schafer$et$al.$
2010).$ $Although$BMI$was$adjusted$for,$the$groups$were$significantly$different$ in$their$BMI$
which$may$have$confounded$the$ results.$ $Higher$disinhibition$scores$on$ the$TFEQ$has$also$
been$ linked$ to$ increased$ OFC$ grey$ matter$ volume$ in$ adolescents$ (Maayan$ et$ al.$ 2011).$
Another$ study$ linked$ anatomical$ brain$ differences$ in$ obese$ compared$ to$ normal$ weight$






Furthermore$hormones$ that$ control$ appetitive$behaviour$ centrally,$ such$as$ leptin$and$PYY$
have$also$been$shown$to$affect$grey$and$white$matter$volumes.$$In$leptin$deficient$patients,$
leptin$ replacement$ increased$ grey$matter$ volume$ in$ frontal$ regions,$ ACC$ and$ cerebellum$
(Matochik$ et$ al.$ 2005).$ $ Plasma$ leptin$ levels$ in$ a$ group$ of$ obese$ and$ normal$ weight$
individuals$ (average$ age$ 32years)$ were$ associated$ with$ reduced$ frontal$ operculum$ and$
putamen$ grey$matter$ volume$ and$ increased$ cerebellar$ and$ temporal$ grey$matter$ volume$
after$ adjusting$ for$ age,$ body$ fat$ and$ insulin$ levels,$ although$ these$ associations$ did$ not$











































& & $ $ & & & & & & & $
Maayan$$
2011$
CS$ N$ OB45/$ NW$ 36F$ OB$
63%;$NW$56%$
Age$17y$
BMI$ OB$ 40kg/m2;$ NW$
22kg/m2$
USA$












$ $ ↑& n/a& n/a& n/a& n/a& n/a& & Total$ WM:$ OB$ vs.$ NW→,$














$ n/a& →& →& ↑& →& →& & $
OB&vs.&NW&
Adults&<70y$



























































Trend$ for$ lower$ GM$ in$
parietal$ and$ temporal$
lobes$ in$ OB.$ TBV$ lower$ in$















































































































BMI$ & →& →& →$
&
→& →& ↓$ postcentral$
gyrus&



































with$ BMI$ and$ GM.$ BMI$
negatively$ correlated$ with$
TBV.$ Significant$ difference$



































Results$ for$ male$ only,$ no$
correlation$in$female.$$
Main$effect$of$BMI$on$GM,$

































Age,$TBV$ BMI$ $ ↑$ ↑putam
en,$NAcc$$
→$ →$ →$ ↑$hypothalamus$ Significant$ interaction$
between$ BMI,$ gender$ and$
plasma$leptin.$



















ICV$ BMI$ & →OFC$& n/a& n/a& ↑$ (M$
only)&

























































$ $ $ ↓$ ↓temporal$ Fat$mass$index$similar$(OFC$
and$ temporal)$ but$ less$
extensive$correlations$
















BMI$ OB$ 35kg/m2;$ OW$
28kg/m2;$NW$22kg/m2$
USA$
None$ BMI$ →& ↓OFC& ↓$
putamen&
↓& →& →& & Age>70y.$ $ BMI$ correlated$
negatively$ with$ total$ WM$
but$not$GM$
None$ Insulin$ ↓$ ↓OFC$ →$ →$ →& →& ↓$ globus$ pallidus,$
thalamus&
Insulin$ correlated$
negatively$ with$ total$ WM$
and$total$GM.$$$























Age,$ICV$ BMI$ $ ↓$ OFC,$
MFG,$
IFG,$$$





















None$$ BMI$ $ →$ →$ →$ ↓$ →$ $ Alzheimers$ disease$
inclusion$criteria$
















WM:$ ↓$ PHG,$ fusiform$
gyrus,$temporal$
DTI$ results:$ FA$ ↓$
cingulate,$ cerebral$
peduncle,$ temporal.$ ADC$


































BMI$ OB$ 36kg/m2;$ NW$
19kg/m2$
USA$
$ $ →$ →$ →$ →$ →$ →$ $ Small$ study$ early$ onset$
obesity$ vs.$ sibling$ cohorts.$















BMI$ PWS$ 34kg/m2;$ NW$
20kg/m2$$
Japan$
$ $ ↓$ ↓$OFC$$ ↓caudat
e$





Age,$GMV$ $ $ ↓$OFC$ $ $ $ $ $ Adjusting$ for$ GMV,$ or$




















































BMI$ OB$ 37kg/m2;$ DM$
38kg/m2$
USA$
Age$ $ →$ →$ n/a$ n/a$ n/a$ n/a$ n/a$ WM:$↓total,$↓$OFC$$
Correlations&
other&

































































Age$ Δ1y↓$$ Δ1y↓$ n/a$ Δ1y↓$ n/a$ n/a$ Δ1y↓cingulate,$
parietal,$temporal$
Half$ of$ cohort$ had$
dementia,$ results$ shown$




















$Age$ BED$ 26y;$ BN$ 23y;$
NW$22y$















calorie$ vs.$ LowNcalorie,& ICV:& Intracranial$ volume,$ IFG:& inferior$ frontal$ gyrus,& LRVOB:$ LowNrisk$ for$ obesity,$m:$ months,$M:$ male,$MFG:$ middle$ frontal$ gyrus,$ n/a:$ not$
applicable,&NAcc:$Nucleus$Accumbens&N/K:$not$known,&NT:$No$taste,&NW:$normal$weight,$OB:$obese,$OFC:$orbitofrontal$cortex,$o/n:$overnight,&OW:&overweight,$PANAS:$
Positive$ and$Negative$Affect$ Scale,& PCC:$ posterior$ cingulate$ cortex,& PET:$ positron$emission$ tomography,& Pl:$ Placebo,& PR:$ prospective,$PWS:$ PraderNWilli$ Syndrome&QN:$
questionnaire,$rCBF:$regional$cerebral$blood$flow,&RO:&obese$reduced$weight,&ROI:$Region$of$interest$study,$ROp:$Rolandic$operculum,&RT:$reaction$time,&RYGB:$RouxNenNY$
gastric$bypass,$SFG:$superior$frontal$gyrus,$SMA:$Supplementary$Motor$Area,&SPECT:$Single$photon$emission$computer$tomography,&SPM:$Statistical$Parametric$Mapping,$
SSA:$ somatosensory$ area,& SSTAI:$ Spielberger$ State$ and$ Trait$Anxiety$ Inventory,& T:$ Tesla,$TBV:&Total$ brain$ volume,$TFEQ:$ Three$ factor$ Eating$Questionnaire,& TMT:&Trail$










matter$ with$ increased$ body$ weight.$ Whereas$ FA$ appears$ to$ be$ consistently$ negatively$
correlated$with$BMI,$mean$diffusivity$results$are$not$so$straightforward.$Mean$diffusivity$is$
not$easy$to$interpret$since$it$represents$the$average$resistance$to$water$flow$in$all$directions$
within$ a$ voxel.$ Furthermore$both$ intraE$ and$extraEcellular$diffusion$ is$ represented,$ further$
complicating$matters.$However,$ it$ is$generally$accepted$that$ increased$diffusivity$ is$usually$
the$ result$ of$ loss$ of$ cell$membrane$ integrity$ resulting$ in$ increased$ displacement$ of$water$
molecules.$ Chronic$ inflammation$ and$ disease$ leads$ to$ increased$mean$ diffusivity.$ On$ the$




found$ that$ BMI$ negatively$ correlated$with$ FA$ in$ 63%$of$white$matter$ voxels$ in$ the$ brain.$
Clusters$ that$ were$ negatively$ correlated$ with$ BMI$ included$ the$ middle$ and$ superior$
cerebellar$ peduncles,$ areas$ of$ the$ midbrain,$ internal$ capsule,$ cingulum$ and$ periE
hippocampal$ tracts.$Mean$diffusivity$ also$ correlated$negatively$with$BMI,$ and$ the$ authors$










analyses.$ They$ also$ found$ sex$ differences$ in$ white$ matter$ integrity;$ in$ women$ FA$ was$





each$ group).$ Those$with$ T2DM$were$ found$ to$ have$ decreased$ FA$ in$ several$ areas$ of$ the$
brain$including$the$frontal,$temporal$and$cingulate$areas,$indicative$of$reduced$white$matter$
microintegrity$ in$these$areas.$They$also$had$higher$mean$diffusivity$ in$temporal,$prefrontal$
and$ parietal$ cortices$ (Yau$ et$ al.$ 2010).$ In$ a$ second$ study$ comparing$ 49$ adolescents$ with$
metabolic$ syndrome$ (abdominal$ obesity,$ insulin$ resistance,$ low$ high$ density$ lipoprotein$
(HDL)Echolesterol,$ hypertriglyceridaemia$ and$ hypertension)$ with$ 62$ healthy$ controls,$ they$
found$ reduced$ FA$ in$ 14$ clusters$ (including$ corpus$ callosum,$ right$ optic$ radiation,$ left$
parietal,$left$medial$longitudinal$fasciculus,$left$external$capsule,$left$internal$capsule,$medial$
genu,$ left$ cerebral$ peduncle,$ right$ middle$ cerebellar$ peduncle).$ The$ metabolic$ syndrome$
group$ had$ lower$ academic$ achievement$ and$ intelligence$ quotient$ (IQ)$ scores,$ and$ lower$




VBM$ studies$ found$ obesity$ positively$ correlates$ with$ white$ matter$ volume,$ in$ striatal$
(caudate,$ putamen)$ (Pannacciulli$ et$ al.$ 2006;$ Haltia$ et$ al.$ 2007;$ Yokum$ et$ al.$ 2012),$
parahippocampal$ and$ temporal$ regions$ (Haltia$ et$ al.$ 2007).$ $ $ Haltia$ et$ al.$ also$ found$ that$
dieting$ reduced$ white$ matter$ volume$ in$ the$ these$ areas$ in$ obese$ patients$ (Haltia$ et$ al.$
160$
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Several$ key$ peptides$ have$ been$ implicated$ in$ regulating$ food$ intake,$ and$ in$ many$ cases,$








al.$2010).$ In$animal$studies,$ intraEVTA$ injection$of$ghrelin$ increases$ the$ intake$of$palatable$






















Insulin$ also$ normally$ reduces$ appetite$ centrally$ in$ hypothalamic$ centres,$ and$ affects$
dopamine$ release$ in$ the$ rat$ striatum.$ At$ low$ concentrations,$ insulin$ increases$ dopamine$





the$brain,$ and$may$ alter$ reward$processing.$ $ For$ instance,$ exposure$ to$ a$ highEenergy$diet$
increases$ sucrose$ selfEadministration$ and$ prevents$ the$ ability$ of$ centrally$ administered$
insulin$to$reduce$sucrose$intake$(Figlewicz$et$al.$2006;$Cheah$et$al.$2012).$$In$humans,$insulin$





although$ intranasal$ insulin$ augments$ postEprandial$ satiety$ and$ reduces$ food$ intake$ in$










To$ date,$ there$ have$ been$ no$ animal$ studies$ investigating$ PYY$ action$ on$ nonEhomeostatic$
brain$areas.$$Human$subjects$given$a$PYY$infusion$compared$to$saline,$showed$activation$of$










VTA$ and$ nucleus$ accumbens$ core$ resulted$ in$ a$ significant$ increase$ in$ food$ intake.$ FoodE
163$
$
reward$ behaviour$ is$ also$ reduced$ in$ rats$ by$ administration$ of$ a$ GLPE1$ agonist,$ as$ rats$ no$
longer$ prefer$ an$ environment$ previously$ paired$ to$ chocolate$ pellets.$ The$ peripheral$








Currently$ the$only$ successful$ treatment$ for$ obesity$ is$ bariatric$ surgery,$ and$ gastric$ bypass$
surgery$ (RYGB)$ is$ the$ most$ effective$ of$ the$ various$ procedures$ producing$ weight$ loss$ of$
around$ 25%$ and$ significant$ reduction$ of$ obesity$ related$ illness$ (Sjostrom$ et$ al.$ 2007;$
Kashyap$ et$ al.$ 2010;$O'Brien$ 2010;$ Rubino$ et$ al.$ 2010).$ The$ success$ of$ RYGB$ surgery$ over$
other$weight$loss$methods,$including$BAND$surgery,$may$be$at$least$in$part$due$its$ability$to$
influence$hedonic$ food$ responses$ in$ obese$people$ (de$Castro$ 2010;$ Shin$ et$ al.$ 2011),$ and$
preliminary$ longitudinal$ studies$ are$ supportive$ of$ this$ possible$ mechanism$ (Ochner$ et$ al.$




obese$ patients$ were$ scanned$ 1$ month$ before$ and$ 1$ month$ after$ RYGB.$ After$ surgery$
patients$ had$ reduced$ activation$ to$ highEcalorie$ pictures$ and$ words$ (compared$ to$ neutral$




and$ the$ difference$ was$ greatest$ in$ DLPFC,$ precuneus,$ dorsal$ cingulate,$ ventral$ striatum,$
lentiform$ nucleus,$ superior$ temporal$ gyrus,$ inferior$ parietal$ lobule$ and$ precuneus$ (n=10)$
(Ochner$ et$ al.$ 2011).$ A$ greater$ reduction$ in$ the$ desire$ to$ eat$ following$ exposure$ to$ highE
calorie$ food$ cues$ compared$ to$ lowEcalorie$ food$ cues$ and$ “liking”$ of$ highEcalorie$ foods$
compared$ to$ lowEcalorie$ foods,$was$ seen$ after$ RYGB$ compared$ to$before,$mirroring$brain$
activation$patterns.$The$reduction$in$activation$in$DLPFC,$dorsal$striatum,$anterior$cingulate,$
thalamus,$ inferior$parietal$areas$correlated$with$ the$reduction$ in$desire$ to$eat$highEcalorie$
compared$to$lowEcalorie$foods$(n=14)$(Ochner$et$al.$2012).$$$
$
The$ same$ study$was$ repeated$ in$ the$ same$ patients$ in$ the$ fed$ state,$ but$ interestingly,$ no$
differences$were$seen$between$preE$and$postE$operative$neural$responsivity$to$food$cues$in$
these$regions$when$patients$were$fed$(Ochner$et$al.$2012).$$$A$longitudinal$study$of$10$BAND$
patients$ before$ and$ 12$ weeks$ after$ surgery,$ showed$ decreased$ activation$ in$
parahippocampus,$medial$prefrontal$cortex,$insula,$and$inferior$frontal$gyrus$and$increased$
activation$ in$ anterior$ prefrontal$ cortex$ to$ food$ compared$ to$ nonEfood$pictures,$ as$well$ as$
increased$dietary$ restraint$ (Bruce$ et$ al.$ 2011).$ $ Problems$with$ these$ studies$ are$ the$ small$
numbers,$ lack$of$control$group$for$weight$ loss$or$order$effect$of$scanning,$ lack$of$rigorous$
statistical$ thresholding$ (whole$ brain$ data$ uncorrected$ for$ multiple$ comparisons),$ and$ the$
possibility$ that$ scanning$ so$ shortly$ after$ surgery$ in$ the$ RYGB$ patients,$ led$ to$ liquid$ diet$
constraints$and$acute$weight$loss$being$potential$confounders.$$
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should$ be$ corrected$ by$ weight$ loss.$ In$ a$ small$ study$ of$ 5$ obese$ women$ who$ underwent$
RYGB$aged$in$their$30’s,$11CEraclopride$(antagonist$radioligand$of$D2$and$D3$receptors)$PET$
studies$ were$ carried$ out$ 6$ weeks$ preE$ and$ postEoperatively.$ The$ analysis$ was$ limited$ to$
striatum$ (anterior$and$posterior$putamen,$and$anterior$and$posterior$ caudate),$ and$ found$
the$ predicted$ increases$ in$ D2/D3$ receptor$ binding$ after$ RYGB$ (Steele$ et$ al.$ 2010).$ By$
contrast$a$$study$of$5$women$in$their$40’s$with$similar$mean$BMI$to$previous$study,$preE$and$
7$ (6E11)$ weeks$ postE$ RYGB$ and$ VSG$ using$ PET$ 18FEFallypride,$ to$ measure$ D2$ receptor$




The$authors$note$ that$ the$discrepancies$between$the$studies$may$be$related$ to$ lower$age$
and$ changes$ in$ preE$ to$ postEoperative$ depression$ scores,$ in$ the$ subjects$ taking$ part$ in$
Steele’s$ study.$Out$of$ the$5$patients$ scanned$ in$ that$ study,$ 4$had$ reduction$ in$depression$
scores,$which$may$have$been$a$confounder.$In$the$second$study,$there$were$no$differences$
in$depression$scores.$In$the$first$study$one$of$the$patients$had$opposite$results$to$the$rest.$In$
the$ second$ study,$ the$ group$ was$ also$ heterogenous$ as$ one$ patient$ underwent$ VSG,$ not$
RYGB.$ In$ addition,$ in$ both$ studies,$ scanning$ took$ place$ in$ the$ acute$ weight$ loss$ phase$
following$surgery,$which$may$have$independent$effects$on$dopamine$receptor$availability.$In$
the$first$study,$the$authors$begin$with$the$assumption$that$preEoperatively,$obese$patients$
have$ low$ D2/D3$ receptor$ binding,$ but$ in$ fact$ this$ was$ no$ different$ to$ the$ lean$ controls$








similar$ operations,$ the$ mechanisms$ governing$ weight$ loss$ may$ be$ significantly$ different$
between$the$operations.$This$may$be$due$to$their$distinct$physiological$manipulations$of$gut$
anatomy.$ Weight$ loss$ in$ BAND$ surgery$ appears$ to$ be$ primarily$ a$ function$ of$ gastric$
restriction.$ In$RYGB$ surgery$however,$ the$ anatomical$ rearrangement$of$ the$ gut$ as$well$ as$
possibly$accelerated$gastric$emptying,$leads$to$alterations$in$bile$and$nutrient$delivery$to$the$
lower$ gut$ which$ in$ turn$ causes$ profound$ changes$ in$ postEprandial$ release$ of$ specific$ gut$
hormones$known$to$affect$appetite$via$the$gutEbrain$axis.$In$this$respect$particularly$PYY$and$
GLP1$ have$ been$ shown$ to$ significantly$ affect$ eating$ behaviour$ in$ preEclinical$ and$ clinical$
studies$and$ to$have$direct$effects$on$not$only$homeostatic$but$also$brain$ reward$systems.$
The$ role$ of$ other$ hormones$ such$ as$ ghrelin,$ CCK,$ leptin,$ and$ other$ adipokines$ seems$ less$
clear,$and$may$be$a$result$of,$rather$than$cause$of$weight$loss$in$RYGB$surgery.$In$addition,$it$
is$ possible$ that$ some$ weight$ loss$ may$ be$ accounted$ for$ by$ alterations$ in$ resting$ energy$
expenditure$and$malabsorption$in$RYGB$surgery,$but$these$effects$do$not$appear$to$be$large.$
Observed$differences$ in$ food$preference$ and$ dietary$ habits$ between$RYGB$ and$ restrictive$
surgeries$ have$ not$ been$ fully$ explored$ or$ explained$ and$ studies$ in$ this$ area$ suffer$ from$
limitations$of$recall$bias$and$measurement$difficulties.$$
$
Akin$to$addictive$behaviours,$alterations$ in$dopaminergic$and$opioid$pathways,$ involved$ in$
the$ expectancy,$ appraisal$ and$ receipt$ of$ food$ reward$ appear$ to$ be$ important$ in$ the$
development$ and$ maintenance$ of$ obesity.$ Several$ components$ of$ the$ reward$ system,$
including$the$striatal$nucleus$accumbens$and$caudate$nucleus$(key$to$dopaminergic$reward$
conditioning,$ expectancy$ and$ motivation),$ amygdala$ (emotional$ responses$ to$ rewarding$




these$areas$ to$ food$ cues$not$only$predicts$ food$ consumption$and$ choice,$ and$prospective$
weight$ gain,$ but$may$ be$ altered$ in$ obesity,$ predict$ the$ success$ of$ weight$ loss$ strategies,$
changes$with$successful$weight$loss,$including$surgical$treatments,$and$is$altered$in$specific$
eating$ behaviour$ psychopathology$ such$ as$ dietary$ restraint,$ dietary$ disinhibition,$ binge$
eating$ and$ hyperphagia$ in$ genetic$ obesity.$ Interestingly$modulation$ of$ activation$ of$ these$
reward$ systems$ both$ at$ rest$ and$ in$ response$ to$ food$ stimuli$ by$ gut$ hormones$ has$ been$
described.$$
$
Functional$ MRI$ offers$ a$ validated$ method$ of$ testing$ the$ effects$ of$ different$ bariatric$
surgeries$on$brain$reward$and$cognitive$control$systems.$Preliminary$data$from$longitudinal$
fMRI$studies$suggest$that$RYGB$may$have$beneficial$effects$on$food$hedonics$including$brain$
food$ reward$ systems,$ which$ may$ favour$ increased$ weight$ loss$ over$ BAND$ surgery.$ The$
differential$effects$of$RYGB$and$BAND$on$brain$ food$ reward$systems$has$not$been$ tested,$
nor$ the$ relationship$ of$ these$ with$ behavioural$ and$ metabolic$ phenotypes$ (including$
exaggerated$ gut$ hormone$ release$ in$ RYGB)$ found$ in$ these$ two$ surgeries$ for$ obesity.$ The$
differential$ effects$ of$ RYGB$ and$ BAND$ surgery$ on$ brain$ structure$ including$ grey$ matter$
volume$ and$white$matter$ tract$ integrity$ has$ also$ not$ been$ examined.$Understanding$ how$
different$surgeries$differentially$affect$eating$behaviour$and$food$reward$on$a$functional$and$
anatomical$ level$ in$ the$ brain$may$ help$ establish$ the$mechanism$ by$which$ RYGB$ achieves$
greater$success$in$treating$obesity.$$This$not$only$highlights$the$importance$of$gutEbrain$food$








after$ BAND$ procedures,$ and$ hence$ healthier$ eating$ behaviour,$ which$ may$ explain$ the$
greater$ weight$ loss$ seen$ after$ RYGB.$ These$ differences$ in$ food$ hedonics$ will$ not$ be$
explicable$by$differences$in$hunger$levels$or$psychological$traits,$but$will$be$associated$with$
increased$ plasma$ GLPE1,$ PYY,$ bile$ acids$ and$ postEingestive$ dumping$ symptoms,$ indicating$
potential$mediators.$Therefore,$lowering$plasma$anorexigenic$gut$hormones$PYY$and$GLPE1$
in$fed$obese$patients$will$increase$hunger,$reward$system$activation$and$hedonic$responses$
to$ food$ in$ RYGB$ but$ not$ BAND$ patients.$ Differences$ in$ food$ hedonics$ between$ RYGB$ and$










associated$with$ reduced$white$matter$ integrity$ in$ frontostriatal,$ corpus$callosum$and$periE
hippocampal$ tracts.$ It$ is$ therefore$hypothesized$ that$white$matter$ integrity$ in$ these$ tracts$









2.$ To$ compare$ food$ appeal,$ preference$ and$ palatability,$ as$ well$ as$ eating$ behaviour$






4.$ To$ investigate$ the$ role$ of$ exaggerated$ anorexigenic$ postEprandial$ plasma$ gut$ hormone$
(PYY$ and$GLPE1)$ on$ brain$ reward$ systems,$ food$ appeal,$ food$ intake$ and$ palatability$ using$
fMRI,$visual$analogue$scales$and$test$meals,$whilst$suppressing$postEprandial$release$of$PYY$
and$GLPE1$using$subcutaneous$Octreotide$in$BMIEmatched$patients$after$RYGB$and$BAND.$
5.$ To$ compare$grey$matter$density$ and$volume$and$white$matter$ integrity$ in$ areas$of$ the$
brain$ associated$ with$ emotional$ and$ cognitive$ processing$ of$ food$ reward$ and$ eating$
behaviour,$ $ between$ subjects$ who$ underwent$ bariatric$ surgery$ (RYGB$ and$ BAND)$ and$
unoperated$BMIEmatched$controls$and$between$RYGB$compared$to$BAND$surgery$subjects,$
using$VBM,$subcortical$volumetric$analysis$and$DTI.$























Patients$ who$ had$ previously$ undergone$ gastric$ bypass$ (RYGB)$ or$ gastric$ banding$ (BAND)$
surgery$ were$ recruited$ from$ Imperial$Weight$ Centre,$ Charing$ Cross$ Hospital$ at$ follow$ up$
clinics$or$through$invitation$letters.$A$control$BMIEmatched$unoperated$control$group$(BMIE
M)$was$recruited$from$the$clinic$or$by$public$advertisement.$The$study$was$approved$by$the$





Inclusion$ criteria$ for$ the$ study$were$ for$ surgical$ groups$were:$ (i)$ loss$ of$more$ than$ 8%$of$




Exclusion$ criteria$ for$ the$ study$ were:$ (i)$ smoking,$ (ii)$ pregnancy$ or$ breast$ feeding,$ (iii)$
significant$neurological,$psychiatric$or$cardiovascular$disease$including$addiction,$stroke$and$
epilepsy,$other$than$previous$depression,$(iv)$commencement$of$antidepressants$less$than$6$




(ii)$ claustrophobia,$ (iii)$ shoulder$ width$ >58cm$ (inability$ to$ fit$ in$ scanner$ bore),$ (iv)$ metal$
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behavior$ and$ a$ computerEbased$ task$ to$measure$ food$preference$ and$ choice$ (Leeds$ Food$
Preference$Questionnaire,$ LFPQ)$ (Finlayson$ et$ al.$ 2007).$Medical$ notes$were$ examined$ to$
ascertain$preEoperative$clinical$ information$ including$body$weight,$presence$of$T2DM,$and$
binge$ eating$ disorder$ (BED)$ from$ review$ by$ the$ clinic$ psychiatrist$ or$ psychologist,$ and$
calculation$of$obesity$comorbidity$score$using$the$Kings$criteria$(Aylwin$et$al.$2008).$$
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RYGB% 30% 21% 10% 19% 17%
BAND% 28% 20% 9% 19% 12%
BMIWM% 25% 20% n/a% 20% 17%
$
In$line$with$standard$policy$of$the$obesity$clinic,$patients$in$this$study$had$chosen$themselves$
which$ surgical$ procedure$ to$ undergo$ and$were$ not$ guided$ by$medical$ professionals$ as$ to$
which$ patients$ had$which$ surgery,$ as$ there$were$ no$ evidence$ based$ guidelines$ to$ inform$
bariatric$ procedure$ selection.$However,$ in$practice,$ patients$with$ T2DM$ tended$ to$ choose$
206 subjects agreed to 
take part but did not meet 
inclusion criteria 
86 subjects attended 
initial assessment visit 
83 subjects’ data included 




RYGB$ more$ often$ due$ to$ its$ more$ beneficial$ effects$ on$ glycaemic$ control$ and$ T2DM$
resolution$ (Kashyap$et$al.$2010;$Pournaras$et$al.$2012).$There$was$ therefore$a$significantly$
greater$ prevalence$ of$ T2DM$ and$ thus$ obesity$ coEmorbidity$ score$ in$ the$ RYGB$ group$ preE





1. Dutch$ Eating$Behaviour$Questionnaire$ (DEBQ)$ to$measure$ dietary$ restraint,$ emotional$
(e.g.$ stressEinduced$ eating)$ and$ external$ (e.g.$ food$ palatability)$ influences$ on$ eating$
behavior$(Wardle$1987).$These$factors$have$been$shown$to$influence$fMRI$responses$to$
food$ cues.$ $ For$ instance,$ increased$ DEBQ$ restraint$ scores$ have$ been$ associated$ with$
increased$activation$ in$nucleus$ accumbens$ and$amygdala$ in$ response$ to$ food$pictures$
(Demos$et$al.$2011;$Schur$et$al.$2012);$increased$DEBQ$external$eating$scores$have$been$
associated$with$ increased$superior$temporal$activation$to$food$pictures$ (Passamonti$et$
al.$ 2009)$ and$ increased$ DEBQ$ emotional$ eating$ scores$ with$ increased$ activation$ in$
parahippocampal$ gyrus$ and$ACC$ in$ response$ to$milkshake$ anticipation$ and$ in$ caudate$
and$pallidum$in$response$to$milkshake$receipt$(Bohon$et$al.$2012).$$
2. Eating$ Disorder$ Examination$ Questionnaire$ (EDEEQ)$ to$ measure$ dietary$ restraint,$
preoccupation$ with$ weight$ and$ shape$ and$ binge$ eating$ (Fairburn$ et$ al.$ 1994).$ Binge$
eating$has$been$associated$with$increased$striatal$dopamine$release$in$response$to$food$
presentation,$ smell$ and$ taste(Wang$et$ al.$ 2011),$ and$with$ increased$OFC$activation$ to$
food$pictures$(Schienle$et$al.$2009).$$






Although$ there$ have$ been$ no$ studies$ which$ specifically$ examine$ the$ effect$ of$ clinical$
depression$on$ food$ reward$processing$ in$ the$brain,$using$neuroimaging,$ fMRI$and$PET$
studies$ have$ demonstrated$ altered$ neural$ activity$ in$ depressed$ subjects$ compared$ to$
controls$ both$ at$ rest$ and$ in$ nonEfood$ taskErelated$ activity$ in$ various$ areas$ including$
frontal$gyri,$ the$DLPFC,$cingulated$cortex$and$amygdala$ (Mitterschiffthaler$et$al.$2006)$
(Fitzgerald$et$al.$2006).$$$
5. Barratt$ Impulsivity$ Scale$ to$measure$ impulsivity,$ which$ has$ been$ linked$ to$ overeating$
(Patton$ et$ al.$ 1995;$ Yeomans$ et$ al.$ 2008).$ Impulsivity$ has$ also$ been$ linked$ to$ DLPFC$
functioning$ (Hare$ et$ al.$ 2009)$ and$ better$ impulse$ control$ has$ been$ associated$ with$
stronger$ functional$ connectivity$ between$ VMPFC$ and$ DLPFC$ at$ rest$ (Weygandt$ et$ al.$
2013).$
6. Eysenck$ Personality$ Questionnaire$ (EPQER)$ to$ measure$ extraversion,$ psychoticism,$
neuroticism$and$ tendency$ to$ lying$ (Eysenck$ 1985).$ Extraversion$ includes$ traits$ such$ as$
sociability,$ dominance$ and$ sensation$ seeking;$ neuroticism$ includes$ anxiety,$
obsessiveness,$ tension,$ guilt$ and$ low$ selfEesteem;$ psychoticism$ includes$ aggression,$
egocentricity$and$being$toughEminded.$$
7. Behavioural$Activation$/$Behavioural$Inhibition$Scales$(BAS/BIS)$to$measure$punishment$










explicit$ and$ implicit$ components$ of$ food$ choices$ and$ ratings.$ Subjects$ are$ presented$with$
food$pictures$and$asked$to$rate$their$'explicit$liking'$(“How$pleasant$would$you$find$the$taste$
of$ this$ food$ right$now?”)$ and$ 'explicit$wanting'$ (“How$much$do$ you$want$ to$ eat$ this$ food$
right$ now?”)$ on$ a$ visual$ analog$ scale$ (100$ mm).$ In$ addition$ foods$ are$ presented$ in$
randomized$pairs$and$subjects$are$asked$to$choose$a$food$(“select$the$food$that$you$most$
want$ to$ eat$ right$ now”)$ as$ quickly$ and$ accurately$ as$ possible.$ During$ the$ latter,$ both$
frequency$of$preferred$choice$(relative$food$preference)$and$reaction$time$were$measured.$
Because$participants$were$not$ informed$about$the$measurement$of$their$reaction$time$for$
each$ choice$ and$ were$ unable$ to$ monitor$ their$ responses,$ this$ measure$ provided$ a$
nonverbal,$ implicit$ assay$ of$ their$ motivation$ (implicit$ wanting).$ Food$ pictures$ contained$
foods$that$varied$in$fat$(high$or$low)$and$taste$(savoury$or$sweet).$These$4$categories$were$
matched$on$ energy$ density,$ fat$ content,$ and$ type$ of$ food.$ There$were$ 8$ pictures$ of$ each$
category;$“high$fat$sweet”$(HFSW)$e.g.$cream$éclair,$ice$cream,$“high$fat$savoury”$(HFSA)$e.g.$






bias$ toward$high$ fat$ foods$and$ ‘wanting’$HFSA$but$ ‘liking’$HFSW,$whereas$ satiation$with$a$
bland$savoury$meal$ is$associated$with$a$ reduction$ in$explicit$wanting$and$ liking$of$all$ food$
categories,$ and$ increased$ implicit$ wanting$ and$ relative$ preference$ of$ sweet$ foods,$
demonstrating$ a$ dissociation$ between$ liking$ and$ implicit$ wanting$ following$ satiation$
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(Finlayson$ et$ al.$ 2008).$ In$ binge$ eating,$ dietary$ disinhibition$ on$ TFEQ$ and$ compensatory$
eating$after$exercise$greater$implicit$wanting$of$HFSW$foods$is$observed$and$in$binge$eaters,$


















For$ Study$ 1$ (Chapter$ 3),$ 61$ (21$ RYGB,$ 20$ BAND$ patients$ and$ 20$ BMIEM$ controls)$ of$ the$
screened$ subjects$ attended$ a$ study$ visit,$ which$ included$ fMRI$ scanning,$ metabolic$ and$









further$ study$ visits$ identical$ to$ the$ first$ visit$ except$ that$ they$ received$ a$ standardized$
milkshake$breakfast$(1$sachet$Complan®$plus$200ml$whole$milk$giving$385kCal)$at$t$=$0$mins,$
60$mins$prior$to$scanning.$They$were$randomized$to$receive,$15$min$before$breakfast$(t$=$E15$
mins),$either$a$ subcutaneous$ injection$of$ saline$ (FedESaline)$or$Octreotide$ (100$mcg)$ (FedE
Octreotide)$plus$weight$adjusted$dosage$of$shortEacting$ insulin$ to$correct$ for$somatostatin$
analogueEinduced$suppression$of$insulin$which$would$otherwise$lead$to$hyperglycaemia$(see$
Section$2.7).$Of$these,$2$RYGB$subjects$did$not$undergo$scanning,$but$completed$the$rest$of$
the$ protocol,$ and$ a$ further$ 3$ subjects’$ visits$ had$ to$ be$ excluded$ from$ analysis$ due$ to$
insufficient$ sleep$ the$ night$ before$ scanning,$ feeling$ unwell$ on$ the$ study$ visit$ day$ and$
excessive$head$motion$(Subject$1:$RYGB,$33years,$female,$BMI$23.19kg/m2,$Subject$2:$RYGB,$





tensor$ imaging$ (DTI)$ data$ of$ 17$ RYGB,$ 12$ BAND$ and$ 17$ BMIEM$ subjects$ acquired$ during$
Study$1$and$2$were$analyzed.$Due$to$poor$ image$quality,$scans$ from$2$patients$ from$VBM$











Clinical$ Investigation$Unit$ in$ the$morning$ having$ eaten$ or$ drunk$ nothing$ since$ supper$ the$
evening$before$other$than$water.$Subjects$had$measurements$of$height,$weight,$%$body$fat$


























of$ the$ study$ visits.$ Patients$ were$ scanned$ for$ 1$ hour$ starting$ between$ 11am$ and$ noon$










therefore$ mimics$ its$ action.$ $ Somatostatin$ suppresses$ the$ release$ of$ a$ number$ of$
gastrointestinal$ hormones$ including$ GLPE1,$ PYY,$ gastrin,$ cholecystokinin$ (CCK),$ secretin,$
motilin,$ vasoactive$ intestinal$ peptide$ (VIP),$ gastric$ inhibitory$ polypeptide$ (GIP)$ and$
enteroglucagon.$ $ It$ also$ has$ various$ other$ effects$ within$ the$ gastroEintestinal$ system$
including$decreasing$the$rate$of$gastric$emptying,$reducing$smooth$muscle$contractions$and$
blood$ flow$ within$ the$ intestine,$ suppression$ of$ the$ release$ of$ pancreatic$ hormones,$
including$ insulin,$ and$ inhibiting$ the$ release$ of$ glucagon.$ $ Octreotide$ is$ a$ more$ potent$
inhibitor$ of$ growth$ hormone,$ glucagon$ and$ insulin$ than$ naturally$ occurring$ somatostatin,$
and$has$a$longer$halfElife$(90$minutes).$$It$is$poorly$absorbed$from$the$gut$and$so$is$usually$
administered$ subcutaneously.$ Octreotide$ is$ safely$ used$ to$ treat$ disorders$ associated$with$
high$ levels$ of$ gut$ hormones$ such$ as$ tumours$ of$ the$pancreas$ and$ intestine$ (Modlin$ et$ al.$
2010).$Octreotide$is$an$ideal$compound$to$use$to$lower$gut$hormones$after$obesity$surgery$




administered$ subcutaneously$ in$ a$ randomized$ doubleEblinded$ manner,$ together$ with$
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Actrapid$ (shortEacting$ insulin,$ Novo$ Nordisk,$ 0.075E0.10$ units/kg)$ to$ prevent$
hyperglycaemia,$or$placebo$saline$injections$(which$were$also$given$at$FastedESaline$visits$in$






































related$household$objects$ (e.g.$ furniture,$clothing)$and$ (4)$180$Gaussian$blurred$ images$of$
the$other$pictures$(as$a$lowElevel$baseline),$similar$to$those$used$previously$(Goldstone$et$al.$
2009).$Food$images$were$selected$to$represent$familiar$foods$that$are$typical$to$the$modern$
Western$diet.$ Pictures$were$obtained$ from$ freely$ available$websites$ and$ the$ International$
Affective$ Picture$ System$ (IAPS,$ NIMH$ Center$ for$ the$ Study$ of$ Emotion$ and$ Attention,$






of$ four$ pseudorandom$ block$ orders$ with$ a$ randomized$ picture$ order$ within$ each$ block.$




The$ total$ caloric$ load,$ caloric$ density$ and$macronutrient$ composition$ of$ the$ food$pictures$
used$in$the$fMRI$task$were$assessed$using$Dietplan6$(Foresfield$Software$Ltd,$West$Sussex,$






images$ from$ a$ projector$ using$ the$ IFIS$ image$ presentation$ system$ (In$ Vivo,$ Wurzburg,$
Germany)$ and$ ePrime$ 2$ software$ (Psychology$ Software$ Tools$ Inc.,$ Pittsburgh,$ PA,$ USA).$
Whilst$ each$ image$ was$ on$ display$ to$ subjects$ in$ the$ scanner,$ they$ were$ asked$ to$
immediately$ and$ simultaneously$ rate$ how$ ‘appealing’$ each$picture$was$ to$ them$using$ a$ 5$
button$handEheld$keypad$(1=not$at$all,$2=not$really,$3=neutral,$4=a$little,$5=a$lot)$(Goldstone$








second$ blocks,$ subjects$ performed$ two$ of$ each$ of$ the$ following$ tasks$ simultaneously:$ (i)$
listening$to$a$story,$(ii)$tapping$their$right$index$finger$once$every$second,$or$(iii)$watching$a$






The$ first$ 6$ scans$ were$ discarded$ to$ allow$ for$ the$ BOLD$ signal$ to$ stabilize.$ The$ following$
preprocessing$ was$ applied:$ motion$ correction$ using$ MCFLIRT;$ field$ mapEbased$ EPI$
unwarping$using$PRELUDE+FUGUE$nonEbrain$ removal$using$BET;$ spatial$ smoothing$using$a$
Gaussian$ kernel$ of$ FWHM$ 6.0mm;$ grandEmean$ intensity$ normalization$ of$ the$ entire$ 4D$
dataset$by$a$single$multiplicative$factor$and$high$pass$temporal$filtering$(GaussianEweighted$
leastEsquares$ straight$ line$ fitting,$ with$ sigma=100.0s).$ TimeEseries$ statistical$ analysis$ was$
carried$ out$ using$ FILM$ with$ local$ autocorrelation$ correction$ including$ picture$ onsets,$
temporal$derivative$and$motion$parameters$as$covariates.$Two$subjects$(1$gastric$bypass,$1$













In$ study$ 1,$ whole$ brain$ mixed$ effects$ analysis$ compared$ BOLD$ signal$ between$ surgical$
groups$and$then$between$each$surgical$group$and$the$BMIEmatched$controls,$using$unpaired$
tEtests$ with$ cluster$ threshold$ Z>2.1,$ corrected$ P<0.05$ including$ age,$ gender$ and$ BMI$ as$
covariates.$$
$
For$ the$ food$ pictures,$ higher$ level$ analysis$ was$ carried$ out$ using$ a$ fixed$ effect$model$ to$











Functional$ regions$ of$ interest$ (fROIs)$ for$ the$ following$ areas:$ bilateral$ OFC,$ amygdala,$
nucleus$accumbens,$anterior$ insula$and$caudate$nucleus$were$determined$from$a$separate$





























Higher$ level$ whole$ brain$ analysis$ was$ carried$ out$ with$ mixed$ effects$ analysis$ to$ identify$
those$ voxels$which$were$ significantly$more$ activated$ at$ the$ group$ level,$with$ voxelEbased$
correction$for$multiple$comparisons$made$using$false$discovery$rate$(FDR)$at$P<0.05$for$the$
food>objects$ contrast$ (highEcalorie$or$ lowEcalorie$ food$minus$objects)$ (Fig.$2.3,$ Table$2.2).$
Similar$ functional$ localizers$were$made$ from$this$ separate$cohort$ for$ the$control$auditory,$
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170$ 3.81$ 18$ 36$ E18$
$ Left$ 63$ 3.60$ E20$ 38$ E14$
Amygdala$ Right$ 110$ 3.85$ 18$ 0$ E26$
$ Left$ 16$ 3.99$ E18$ 0$ E26$
Nucleus$Accumbens$ Right$ 62$ 3.45$ 8$ 14$ E4$
$ Left$ 91$ 4.11$ E6$ 10$ E2$
Anterior$Insula$ Right$ 188$ 5.08$ 40$ 8$ E14$
$ Left$ 116$ 4.43$ E38$ 8$ E12$
Caudate$ Right$ 129$ 3.88$ 8$ 6$ 2$
$ Left$ 74$ 4.18$ E6$ E6$ 0$




1109$ 5.56$ 64$ E14$ 4$
$ Left$ 1108$ 5.39$ E62$ E22$ 2$
Motor%task% $ $ $ $ $ $
Precentral$gyrus$ Left$ 873$ 5.78$ E36$ E24$ 56$
% $ $ $ $ $ $
Visual%task% $ $ $ $ $ $












Group$activation$ in$separate$cohort$of$obese/overweight$patients$ for$any$food$(highEcalorie$or$ lowE
calorie)$vs.$object$picture$contrast.$Activation$is$thresholded$at$voxelEcorrected$FDR$P<0.05,$overlaid$
onto$ the$ average$ T1$ scan$ for$ all$ subjects$ (n=24).$A" priori$ functional$ regions$ of$ interest$ (ROIs)$ are$
indicated:$ nucleus$ accumbens$ (nucleus$ accumbens,$ yellow),$ orbitofrontal$ cortex$ (OFC,$ light$ blue),$











Figure% 2.4% A" priori% functional% regions% of% interest% for% auditory,% motor% and% visual% cortex%
activation%during%control%task%
$
(A)$ Group$ activation$ maps$ of$ separate$ cohort$ of$ overweight/obese$ subjects$ overlaid$ with$ a" priori$
anatomical$regions$of$interest$for$control$auditoryEmotorEvisual$task:$auditory$(red:$listening$to$story)$
with$ bilateral$ posterior$ division$ of$ superior$ temporal$ gyrus$ (overlaid$ in$ yellow),$motor$ task$ (green:$
button$ press)$ with$ left$ preEcentral$ gyrus$ (overlaid$ in$ magenta),$ and$ visual$ (dark$ blue:$ flashing$
checkerboard)$with$lingual$gyrus$(overlaid$in$light$blue).$Activation$is$thresholded$at$voxelEcorrected$
FDR$ P<0.05,$ overlaid$ onto$ the$ average$ T1$ scan$ for$ all$ subjects$ (n=24).$ CoEordinates$ are$ given$ in$
standard$MNI$space.$$
(B)$Comparison$of$BOLD$signal$for$auditory,$motor$and$visual$control$task$in$a"priori"functional$regions$









The$ functional$ anatomically$ constrained$ ROIs$ were$ obtained$ by$ masking$ these$ group$
activation$ maps$ with$ the$ a$ priori$ anatomical$ ROI.$ These$ were$ defined$ by$ the$ relevant$
bilateral$ROIs$from$the$cortical$and$subcortical$structural$Harvard$FSL$atlases$thresholded$at$
10%$probability.$The$OFC$fROI$included$regions$in$the$OFC$and$frontal$pole$with$y$>$22$and$z$












for$ the$ food$ evaluation$ task,$ as$ well$ as$ the$ average$ BOLD$ activation$ in$ all$ 5$ fROIs$
representing$brain$food$reward$systems$(De$Silva$et$al.$2011).$$
$
Similar$ timeEseries$ statistical$ analysis$ was$ performed$ for$ the$ single$ run$ AMV$ paradigm$
including$the$onsets$of$each$task$(auditory,$motor$and$visual),$with$temporal$derivative$and$








Structural$ changes$ in$grey$matter$volume$were$analysed$using$FSLEVBM$v3.1.8$ to$perform$
voxelEbased$ morphometry$ (Good$ et$ al.$ 2001).$ InterEsubject$ spatial$ normalisation$ was$
achieved$ through$ brain$ extraction$ of$ each$ T1$ image$ using$ BET$ (Smith,$ 2002a),$ which$
segmented$the$brain$from$nonEbrain$tissue.$The$next$step$involved$tissueEtype$segmentation$
using$ FAST4$ (Zhang$ et$ al.$ 2001)$ in$ order$ to$ separate$ grey$ matter,$ white$ matter$ and$
cerebrospinal$fluid$to$enable$individual$analyses.$The$next$process$required$the$construction$
of$ a$ template$ on$ which$ all$ images$ would$ be$ nonElinearly$ registered.$ Using$ the$ FLIRT$
(Jenkinson$ et$ al.$ 2001;$ Jenkinson$ et$ al.$ 2002)$ and$ FNIRT$ tools$ (Anderson$ et$ al.$ 2007;$
Anderson$et$al.$2007)$the$template$was$created$from$the$subject$list$using$equal$numbers$of$
RYGB,$ BAND$ and$ BMIEM$ participants$ (n=19$ in$ each$ group$ to$ avoid$ bias$ in$ template$
construction$ towards$a$group)$ to$produce$a$custom$template.$The$ final$ stage$of$preparing$
the$ T1$ images$ involved$ nonElinear$ reEregistration$ onto$ the$ template,$ which$ was$ then$
modulated$in$order$to$correct$for$regional$ increases$and$decreases$through$dividing$by$the$









VBM$ structural$ data$ were$ analysed$ using$ a$ GLM$which$ included$ age,$ gender$ and$ BMI$ as$
covariates$ in$order$ to$determine$ the$potential$differences$ in$grey$matter$density$between$
the$ three$ groups$ (RYGB,$ BAND,$ BMIEM).$ Subsequent$ VBM$ anatomical$ ROIs$were$ selected$
based$ on$ the$ examination$ of$ previous$ research$ including$ nucleus$ accumbens,$ amygdala,$
caudate$nucleus,$hippocampus,$insula,$pallidum$and$the$putamen,$as$well$as$the$precentral$
gyrus$as$a$control$region.$$




In$ order$ to$ determine$ subcortical$ volumes$ of$ the$ amygdala,$ nucleus$ accumbens,$ caudate$
nucleus,$hippocampus,$pallidum,$putamen$and$thalamus$the$FSL$tool$FIRST$was$used$on$the$
T1$ images$ (Patenaude$et$al.$2011).$FIRST$ is$a$modelEbased$segmentation/registration$ tool.$
3D$T1$ images$were$transformed$into$standard$space$(MNI152)$and$a$subcortical$mask$was$
used$with$a$threshold$set$at$10%$applied$to$identify$the$subcortical$regions$of$interest.$The$
shape/appearance$ models$ used$ in$ FIRST$ were$ constructed$ from$ manually$ segmented$
images$provided$by$ the$Center$ for$Morphometric$Analysis$ (CMA),$MGH,$Boston.$Based$on$
learned$ models,$ using$ voxel$ boundary$ correction$ to$ ensure$ correct$ identification$ of$ each$
subcortical$region,$FIRST$searched$through$linear$combinations$of$shape$modes$of$variation$
for$ the$ most$ probable$ shape$ instance$ given$ the$ observed$ intensities$ in$ the$ T1$ image.$
Volumetric$analysis$was$then$carried$out$by$determining$the$label$number$of$the$structure$







starts$ by$ extracting$brain$ and$ skull$ images$ from$ the$ single$wholeEhead$3D$T1$ image$ input$
data$(Smith$et$al.$2002)[Smith$2002b].$The$brain$image$is$then$affineEregistered$to$MNI152$
space$(Jenkinson$et$al.$2001;$Jenkinson$et$al.$2002)(using$the$skull$ image$to$determine$the$
registration$scaling);$ this$ is$primarily$ in$order$to$obtain$the$volumetric$scaling$ factor,$ to$be$
used$as$ a$normalisation$ for$head$ size.$Next,$ tissueEtype$ segmentation$with$partial$ volume$
estimation$ was$ carried$ out$ in$ order$ to$ calculate$ total$ volume$ of$ brain$ tissue$ (including$






Voxelwise$ statistical$ analysis$ of$ the$ FA$ and$ MD$ data$ was$ carried$ out$ using$ TractEBased$
Spatial$ Statistics$ (TBSS)$ (Smith$ et$ al.$ 2006),$ part$ of$ FSL.$ First,$ FA$ and$ MD$ images$ were$
created$ by$ fitting$ a$ tensor$ model$ to$ the$ raw$ diffusion$ data$ using$ FDT,$ and$ then$ brainE
extracted$using$Brain$Extraction$technique$(BET)$(Smith$2002).$All$subjects'$FA$and$MD$data$
were$ then$ aligned$ into$ a$ common$ space$ using$ the$ nonlinear$ registration$ tool$ FNIRT$
(Anderson$ et$ al.$ 2007;$ Anderson$ et$ al.$ 2007),$which$ uses$ a$ bEspline$ representation$ of$ the$
registration$warp$field.$Next,$the$group$mean$FA$image$was$created$and$thinned$to$create$a$
mean$ FA$ skeleton$which$ represents$ the$ centres$ of$ all$ tracts$ common$ to$ the$ group.$ Each$





A$ voxel$ wise$ general$ linear$ model$ analyses$ evaluated$ the$ between$ group$ differences$ of$
measured$ FA$ and$ MD$ across$ the$ whole$ FA$ skeleton,$ including$ age,$ gender$ and$ BMI$ as$
covariates.$Three$methods$of$permutationEbased$nonEparametric$testing$(randomise),$were$
employed$ to$ detect$ differences$ between$ the$ groups:$ threshold$ free$ cluster$ enhancement$
(TFCE)$at$corrected$P<0.05,$voxelEbased$thresholding$at$FDR$corrected$P<0.05,$and$clusterE
based$ thresholding$ (cluster$ size$>1.5mm)$FDR$corrected$P<0.05$ to$calculate$ the$ tEstatistics$
maps$between$the$three$groups$(RYGB,$BAND$and$BMIEM)$(Nichols$et$al.$2002).$
$
Subsequent$ white$ matter$ tract$ regions$ of$ interest$ (ROI)$ were$ selected$ based$ on$ the$
examination$of$previous$research$(Hellyer$et$al.$2012)$and$included$anterior$thalamic$tract,$
cingulate$ cingulum,$ cingulate$ hippocampus,$ corticospinal$ tract,$ inferior$ frontoEoccipital$
tract,$ inferior$ longitudinal$ fasciculus,$ superior$ longitudinal$ fasciculus,$ superior$ longitudinal$
frontal$ tract,$ uncinate$ fasciculus,$ body,$ genu$ and$ splenium$ of$ corpus$ callosum,$ forceps$
major$ and$ forceps$minor.$ The$ ROIs$ were$ created$ by$masking$ the$mean$ FA$ skeleton$with$
individual$tracts$from$the$JHU$white$matter$tract$atlas$thresholded$at$10%.$
$





Visual$ analogue$ scale$ (VAS)$ ratings$ (0E10$ cm)$ of$ appetite$ and$ other$ symptoms$ were$











ice$ cream$meal,$ ,$ given$ to$ subjects$ in$ the$operated$groups$ in$50ml$ (43g)$portions$every$5$
minutes,$ starting$ at$ t$ =$ +150$mins$ as$ per$ previous$ experiments$ (le$ Roux$ et$ al.$ 2007).$ $ Ice$
cream$was$chosen$as$both$BAND$and$RYGB$subjects$were$able$to$consume$without$difficulty$
Subjects$were$asked$to$eat$until$comfortably$full.$Upon$completion,$they$were$asked$to$rate$














Blood$ samples$ for$ gut$ hormone$ analysis$ were$ collected$ into$ chilled$ lithium$ heparin$
polypropylene$ tubes,$ containing$ 4E(2EAminoethyl)$ benzenesulfonyl$ fluoride$ hydrochloride$
(AEBSF)$ (A8456$SigmaEAldrich)$and$aprotinin$ (Nordic$Phama$UK)$protease$ inhibitor$ to$give$
final$ concentration$ of$ 1$mg/mL$ and$ 200$ kIU/mL$whole$ blood$ respectively.$ Blood$ samples$
were$ centrifuged$ at$ 4ºC,$ 4000$ rpm$ for$ 10$ min.$ Aliquots$ of$ separated$ plasma$ were$
immediately$ mixed$ with$ HCl$ (final$ concentration$ of$ 0.05M)$ for$ subsequent$ assay$ of$ acyl$
ghrelin,$and$separate$unacidified$aliquots$for$assay$of$other$gut$hormones$(GLPE1$and$PYY).$
All$plasma$samples$were$stored$at$E80°C$until$assay.$Other$metabolic$and$hormonal$assays$
were$ done$ on$ plain$ serum$ or$ fluoride$ oxalate$ plasma$ samples$ sent$ immediately$ to$ the$
routine$clinical$laboratory.$
$
Plasma$ glucose$ and$ serum$ insulin$ were$ measured$ in$ the$ Department$ of$ Clinical$
Biochemistry,$Imperial$College$Healthcare$NHS$Trust$using$either$an$Abbott$Architect$ci8200$









et$ al.$ 2003).$ BA$ fractions$ were$ analysed$ using$ highEperformance$ liquid$ chromatography$
198$
$




Area$ under$ the$ curve$ (AUC)$ for$ metabolites$ and$ hormones$ were$ calculated$ from$ +40$ to$
+150$mins,$and$for$bile$acids$from$+70$to$+150$mins,$to$cover$the$period$before$and$during$





The$presence$of$ symptoms$of$ possible$ ‘dumping$ syndrome’$was$ assessed$using$ change$ in$
nausea$and$sleepiness$from$before$lunch$to$1.5$hours$after$lunch$(ΔAUC$+150$to$+240$mins),$
and$ change$ in$ physiological$ markers$ indicative$ of$ dumping$ syndrome,$ pulse$ and$ blood$














test$ or$ Friedman$ ANOVA$ on$ Ranks$ with$ post/hoc$ Dunn’s$ test.$ Comparison$ of$ prevalence$
between$ groups$ used$ chiEsquared$ test.$ Comparisons$ between$ groups$ for$ fMRI$ activation$
and$ eating$ behavior$ and$ psychological$ questionnaires$ were$ adjusted$ for$ age,$ gender$ and$
BMI.$ To$ further$ investigate$ the$ link$ between$brain$ responses$ to$ food$ cues,$ food$hedonics$




Comparison$ of$ ROI$ VBM$ and$ FIRST$ volumetric$ results$ between$ groups$ were$ analysed$
adjusting$for$age,$gender,$BMI$and$unEnormalised$ICV.$Multiple$linear$regression$was$used$to$
analyse$ the$ potential$ relationship$ between$ grey$matter$ density$ corrected$ for$ age,$ gender$
and$ICV$and$the$effect$of$group*BMI,$and$if$this$was$nonEsignificant,$group$and$BMI.$$







































































































































(BMIEM),$ gastric$ bypass$ (RYGB),$ gastric$ banding$ (BAND)]$ in$ age,$ gender$ ratio,$ ethnic$
background$ distribution,$ current$ BMI,$ percentage$ body$ fat,$ prevalence$ of$ type$ 2$ diabetes$
mellitus$(T2DM)$or$binge$eating$disorder$(BED),$for$both$the$scanned$participants$only$(Table$
3.1)$and$the$whole$cohort$(Appendix$13).$The$two$surgical$groups$had$similar$preEoperative$
BMI$ and$ prevalence$ of$ BED.$ The$ RYGB$ group$ had$more$ obesityEassociated$ coEmorbidities$
preEoperatively,$ including$T2DM,$and$a$higher$obesity$coEmorbidity$compared$to$the$BAND$
group$but$were$not$different$in$postEoperative$obesity$coEmorbidity$scores$or$prevalence$of$
T2DM.$ RYGB$ patients$ had$ also$ lost$ significantly$ more$ weight$ than$ the$ BAND$ patients,$
although$their$BMI$at$the$time$of$scanning$was$similar$to$BAND$patients.$In$the$whole$cohort$













$ BMIWM% BAND% RYGB% P%values%a%






Gender%(Male%:%Female)% 3:17$ 1:19$ 2:19$ 0.57$
Ethnicity:%European%


























































PreWoperative%BED,%n%(%)% n/a$ 4$(25%)$ 4$(19%)$ 1.00$














There$ were$ no$ differences$ between$ the$ three$ groups$ in$ any$ psychological$ questionnaire$
measures$ (Table$ 3.3).$ Specifically$ there$ was$ no$ difference$ in$ depression$ or$ mood$ as$
measured$by$the$Beck$Depression$ Inventory$(BDIEII)$and$Positive$and$Negative$Affect$Scale$
(PANAS).$There$was$no$difference$ in$ impulsivity$as$measured$by$Barratt’s$ Impulsivity$Scale$
between$the$three$groups,$nor$ in$ reward$sensitivity$ (reward$responsiveness,$ reward$drive,$
funEseeking,$ behavioural$ inhibition)$ as$ measured$ by$ the$ Behavioural$ activation$ and$
inhibition$scale$ (BIS/BAS).$There$was$also$no$difference$between$ the$groups$ in$personality$






% BMIWM$ BAND$ RYGB$ Pa$










(>15),$n$(%)% 5$(20%)$ 7$(25%)$ 7$(23%)$ 0.22$
On%antidepressants%
treatment,%n%(%)% 3$(12%)$ 5$(18%)$ 8$(27%)$ 0.38$




























































































cortex,$ putamen,$ caudate,$ nucleus$ accumbens,$ hippocampus,$ cingulate$ and$ paracingulate$
gyri$ (Fig.3.1,$Table$3.3).$BOLD$activation$when$viewing$ low/calorie" foods$was$also$ lower$ in$
the$OFC$and$subcallosal$cortex$ in$RYGB$than$BAND$(Table$3.4).$By$contrast,$ there$were$no$




































was$ lower$ in$ the$RYGB$ compared$with$ the$BAND$when$ viewing$ highEcalorie,$ but$ not$ lowE
calorie,$foods.$
$
When$ examining$ individual$ fROIs,$ BOLD$ activation$ in$ the$ OFC$ was$ lower$ in$ the$ RYGB$
compared$ with$ the$ BAND$ and/or$ control$ groups$ when$ viewing$ any$ food$ or$ lowEcalorie$
foods,$with$ a$ trend$ for$ highEcalorie$ food$ (Fig.$ 3.2$ B,$ C,$ Table$ 3.4).$ BOLD$ activation$ in$ the$




















Comparison$of$BOLD$signal$ to$any$ food,$only$highEcalorie$or$only$ lowEcalorie$ food$ (vs.$objects)$ in$a"
priori" functional$ regions$ of$ interest$ (fROI)$ between$ body$mass$ indexEmatched$ unoperated$ controls$
(BMIEM,$white),$ and$obese$patients$after$gastric$banding$ (BAND,$dotted)$and$gastric$bypass$ (RYGB,$
striped)$ surgery,$ adjusting$ for$ age,$ gender$ and$ BMI.$ (A)$ Average$ in$ all$ five$ fROIs,$ (B)$ orbitofrontal$








Contrast& Number&of&voxels& Z&statistic& x& y& z& Brain&region&
GASTRIC&BANDING&>&GASTRIC&BYPASS& & & & & & $
Any&food&(highJcalorie&or&lowJcalorie)$ Cluster$1$,$1470$ 4.12$ 16$ 30$ ,12$ Right$orbitofrontal$cortex$
& $ 3.69$ ,18$ 44$ ,8$ Left$orbitofrontal$cortex$
& $ 3.61$ ,6$ 8$ ,20$ Left$orbitofrontal$cortex$
& $ 3.45$ ,16$ 40$ ,14$ Left$orbitofrontal$cortex$
& $ 3.42$ 16$ 16$ ,18$ Right$orbitofrontal$cortex$
& $ 3.20$ 0$ 22$ ,8$ Right$orbitofrontal$cortex$
& $ 3.18$ 4$ 10$ ,14$ Right$subcallosal$cortex$
& $ 2.93$ 38$ 34$ ,16$ Right$orbitofrontal$cortex$/$subcallosal$cortex$
& $ 2.89$ ,8$ 18$ ,20$ Left$orbitofrontal$cortex$/$subcallosal$cortex$
& $ 2.83$ ,16$ 18$ ,8$ Left$putamen$/$caudate$/$nucleus$accumbens$
& $ $ $ $ $ $
HighJcalorie&food$ Cluster$1$,$980$ 4.05$ ,38$ 18$ ,30$ Left$$temporal$cortex$
& $ 3.55$ ,18$ 44$ ,10$ Left$orbitofrontal$cortex$
& $ 3.51$ 16$ 30$ ,10$ Right$orbitofrontal$cortex$
& $ 3.21$ ,42$ 26$ ,14$ Left$orbitofrontal$cortex$
& $ 3.17$ 40$ 34$ ,14$ Right$$orbitofrontal$cortex$
& $ 3.12$ ,36$ 38$ ,12$ Right$orbitofrontal$cortex$
& $ 3.04$ 32$ 42$ ,8$ Right$orbitofrontal$cortex$/$frontal$pole$
& $ 3.03$ ,42$ 30$ ,16$ Left$orbitofrontal$cortex$/$frontal$pole$
& $ 3.00$ 10$ 46$ ,8$ Right$cingulate/paracingulate$gyrus$
& $ 2.92$ ,34$ 44$ ,8$ Left$frontal$pole$
$ Cluster$2$,$1232$ 3.54$ ,6$ 6$ ,18$ Left$subcallosal$cortex$
& $ 3.28$ 10$ ,32$ ,18$ Right$brainstem$
& $ 3.22$ 4$ 10$ ,14$ Right$subcallosal$cortex$
214$
$
& $ 3.21$ 32$ ,32$ ,18$ Right$hippocampus$
& $ 3.05$ 10$ ,22$ ,24$ Right$brainstem$
& $ 3.04$ 2$ ,22$ ,22$ Right$brainstem$
& $ 2.89$ ,16$ 18$ ,8$ Left$putamen$/$caudate$/$nucleus$accumbens$
& $ 2.88$ 12$ ,40$ ,22$ Left$brainstem$
& $ $ $ $ $ $
LowJcalorie&food& Cluster$1$,$1041$ 3.95$ 14$ 30$ ,12$ Right$orbitofrontal$cortex$
& $ 3.46$ ,16$ 40$ ,14$ Left$orbitofrontal$cortex$
& $ 3.43$ 4$ 22$ ,8$ Right$subcallosal$cortex$
& $ 3.32$ ,4$ 8$ ,18$ Left$subcallosal$cortex$
& $ 3.25$ 16$ 16$ ,18$ Left$orbitofrontal$cortex$
& $ 3.20$ ,16$ 46$ ,6$ Left$orbitofrontal$cortex$
& $ 3.17$ 12$ 8$ ,18$ Right$orbitofrontal$cortex$/$subcallosal$cortex$
$ $ 3.02$ ,6$ 18$ ,18$ Left$subcallosal$cortex$
$ $ 3.01$ ,18$ 42$ ,20$ Left$orbitofrontal$cortex$/$frontal$pole$
$ $ 2.94$ ,8$ 12$ ,22$ Left$orbitofrontal$cortex$/$subcallosal$cortex$
$ $ $ $ $ $ $
GASTRIC&BYPASS&>&GASTRIC&BANDING$ $ $ $ $ $ $
Any&food&(highJcalorie&or&lowJcalorie)$ $ $ $ $ $ Nil$significant$
HighJcalorie&food$ $ $ $ $ $ Nil$significant$











Region&of&interest& Contrast& BMI–M& BAND& RYGB& P&value&a&
n& & 19$ 20$ 20$ $
























































































































































Over$ the$ scanning$ period$ both$ the$ RYGB$ and$ BAND$ groups$ rated$ their$ ‘hunger’,$
‘pleasantness$to$eat’$and$ ‘volume$of$ food$they$could$eat’$as$ lower$than$the$control$group,$











$ BAND$ RYGB$ P$value$
n$ 20$ 21$ $



















































n$ 18$ 15$ $








































fat$ and$ low$ fat$ savoury$ categories.$ There$ were$ no$ significant$ or$ trends$ for$ significant$


























































































































































psychopathology,$ compared$ with$ the$ BAND$ and/or$ control$ groups.$ The$ RYGB$ group$ had$




the$ DEBQ$ (External$ Eating$ Scale)$ than$ the$ BMI8matched$ controls$ and$ a$ trend$ for$ lower$
scores$ than$ the$ BAND$ patients.$ RYGB$ patients$ had$ less$ symptoms$ of$ eating$ disorder$










# BMI>M& BAND& RYGB& P&value&a&
n& 25# 28# 30# #


































































dotted)# and# gastric# bypass# (RYGB,# striped)# surgery.# Data# are# presented# as# (A,G)# median# and#
interquartile# range,#or# (B,C,D,E,F,H)#mean#±#SEM.# #P<0.05,# ###P<0.005#vs.#BMI)M;#*P<0.05,#**P<0.01##







levels#during#scanning#were#higher# in# the#RYGB#than#control#group,#and# increased#more# in#













































Both# the# retrospective# dumping# symptom# questionnaire# (Arts’# and# Sigstad’s)# scores# were#
significantly# higher# for# the# RYGB# than# BAND# patients# (Fig.# 3.8# A,# B,# Table# 3.9).# The# RYGB#
group#had#a#greater#increase#in#symptom#of#`feeling#sick’,#but#not#‘sleepiness’#than#the#BAND#
group#after#the#meal#(Figs.#3.4#D#and#Table#3.9).#However#there#were#no#differences#in#the#












' BAND' RYGB' P'value'






























































BOLD# activation# to# high)calorie# food# pictures# in# the# whole# reward# system# was# positively#






However# within# the# RYGB# group,# there# was# no# significant# correlation# between# BOLD#
activation# to# any# food,# or# high)calorie# or# low)calorie# food# pictures# in# the# whole# reward#
system,#OFC# or# amygdala#with# any# of# the# following# secondary# outcome#measures:# GLP)1,#
PYY#or#total#bile#acids#area#under#curve#(AUC)#during#fMRI#scan#(correlation#coefficient#)0.35#
to#+0.31,#P=0.13)0.92);#absolute#GLP)1,#PYY#or# total#bile#acids#AUC#after# ice)cream#meal# ()














# BMI;M& BAND& RYGB& P&value&a&



















































The# results# of# this# study# show# that# obese# patients# after# RYGB# surgery# have# markedly#















cues# (visual# and# auditory)# post>operatively# in# the# dorsal# striatum# (lentiform# nucleus# and#
putamen),#middle#and#superior#frontal#gyrus.##These#reductions#were#significantly#greater#for#









in# high># to# low># food# calorie# cues# were# most# pronounced# in# DLPFC,# precuneus,# dorsal#
cingulate,#lentiform#nucleus,#and#ventral#striatum#(Ochner#et#al.#2011).###
#
The# areas# in#Ochner’s# studies# that# changed# after# RYGB# surgery# differed# from# those# areas#
observed#to#differ#in#activation#between#RYGB#and#BAND#surgery#in#my#study,#except#for#the#
caudate.#One#possible# explanation# for# this#may#be# that# activation# in# the# areas# affected# in#
Ochner’s# study# are# similarly# reduced# in# both# types# of# surgery,# and# that# there# are# other#




There# were# several# other# differences# in# study# paradigm,# which# may# account# for# the#
differences#seen.##For#instance,#although#Ochner’s#subjects#had#been#fasted#overnight,#they#
were#also#given#a#250kCal#meal#60#minutes#before#scanning,#reducing#the#effect#of#fasting,#
but# also#not# rendering# them# satiated,#whereas# in# the# current# study,# subjects#were# fasted.##














objects,#although# these#differences#did#not# reach#statistical# significance.#The#current# study#





There# has# been# one# longitudinal# study# investigating# fMRI# responses# to# food# after# BAND#
surgery.# # In# this# study,# 10# obese# subjects#were# scanned# before# and# 3#months# after# BAND#
surgery.##The#authors#found#increased#BOLD#signal#after#surgery#for#food#compared#to#non>
food#pictures#in#the#fasted#state#in#the#middle#frontal#and#superior#frontal#gyrus,#whereas#in#
the# post>prandial# state,# BOLD# activation# in# the# parahippocampus,# medial# PFC,# insula# and#
inferior# frontal# gyrus# was# lower# and# in# the# anterior# prefrontal# cortex# higher# for# food#
compared# to# non>food# pictures# (Bruce# et# al.# 2011).# In# this# study# there# was# no# statistical#
correction#made#for#multiple#comparisons#and#no#control#group#for#the#effect#of#weight#loss#
was# used.# # In# addition,# the# study# suffers# from# the# confounding# order# effect,# in# which#
familiarity# with# the# cues# may# lead# to# reduced# salience# and# therefore# BOLD# signal# in#


































The# observed# differences# in# brain# reward# responses# to# food# were# not# explicable# by#
differences#in#underlying#psychological#traits#or#current#mood.#There#were#no#differences#in#




instance# negative# affect# (measured# by# PANAS)# has# been# associated# with# greater# BOLD#
activation# in# the#OFC,#ACC# and# insula# on# viewing#high>calorie# food#pictures# (Killgore# et# al.#






several# eating# behaviours,# but# also# notes# that# most# personality# questionnaires# share# the#
same# underlying# structure.# A# general# model# of# high# neuroticism,# high#
assertiveness/extraversion# (also# interpreted# in# some# studies# as# ‘wanting’# or# reward#









the#PANAS#has#been#shown# to#be#associated#with#obesity# (Pasco#et#al.#2013),# to# correlate#





Differences# in# brain# reward# responses# to# food# were# accompanied# by# differences# in# food#
appeal,#food#preference#and#actual#eating#behaviour#between#the#groups.#This#is#important,#
since# neuroimaging# studies# are# improved# in# validity# if# concurrent# behavioural# measures#
support#the#assumptions#made#on#the#basis#of#the#fMRI#findings#(Poldrack#2006).#Not#only#
was#the#appeal#of#high>calorie#foods# lower# in#RYGB#than#BAND#and#BMI>matched#controls,#
liking#and#wanting#of#high# fat# and# low# fat# savoury# foods#was# significantly# lower#and# there#
was# a# trend# for# high# and# low# fat# sweet# foods# to# be# lower# in# RYGB# compared# to# BAND#
patients,#using#the#LFPQ.#Furthermore,#palatability#of#ice#cream,#measured#by#VAS#ratings#of#
pleasantness# to# eat,# was# also# lower# in# the# RYGB# group# compared# to# the# BAND# group.#
Furthermore# the# VAS# palatability# of# ice# cream# correlated# with# whole# reward# system#
activation#to#food#pictures.##
#
It#was# suprising#not# to#observe# lower#consumption#of# ice#cream# in# the#RYGB#compared# to#
BAND#group.#A# possible# explanation# is# that# the# test#meal#was# not# specifically# designed# to#
examine# food#preference,#as# subjects#were#not#given#a#choice#of# foods#of#different#caloric#





RYGB#patients#had# lower#average#calorie# intake# (corrected# for# lean#body#mass),#and# lower#
proportional# fat# intake# in# obese# patients# who# had# undergone# RYGB# compared# to# BAND#
surgery.##Dietary#records#and#questionnaires#give#information#about#food#choice#and#actual#
dietary#behaviour#but#suffer#from#the#vagaries#of#being#subjective# in#nature,#and#therefore#








be#at#higher# risk#of#disordered#eating#and#potentially#weight# regain# in# the# future# than# the#
RYGB# patients.# Conversely,# low# dietary# restraint# and# external# eating# in# RYGB# patients#
compared# to# BMI>matched# controls# suggests# that# their# eating# behaviour# may# have# been#
significantly#changed#from#those#patterns#potentially#present#prior#to#surgery.#In#effect,#the#
loss# of# reward# attached# to# food#may# result# in# the# possibility# of# liberation# from# constantly#
having# to# monitor# and# exercise# restraint# over# food# intake.# Interestingly,# there# were# no#
differences# in# emotional# eating# between# the# groups,# suggesting# that# despite# the# loss# of#
hedonic#reward#from#food,#RYGB#and#BAND#patients#may#continue#to#use#food#for#emotional#
regulation.#Another#study#has,#however#found#lower#emotional#eating#after#RYGB#(Laurenius#





The# findings# in# the# current# study# of# higher# weight# and# shape# concerns# amongst# BAND#
patients# compared# to# RYGB# patients,# despite# similar# BMI# may# also# relate# to# unresolved#
emotional#conflict#over#eating,#and#therefore#weight,#in#BAND#patients,#epitomised#by#high#





It# could# be# argued# that# the# Food# Addiction# Scale# would# have# been# a# useful# addition# to#
measures# of# eating# behaviour,# given# the# similarities# neural# substrates# involved# in# drug#
addiction#and#obesity#(Volkow#et#al.#2008),#and#similarities#in#BOLD#response#to#drug#cues#in#
drug# addiction# and# food# cues# in# obesity,# although# there# is# some# controversy# surrounding#
this#(Ziauddeen#et#al.#2012).#Also#food#addiction#scores#have#been#shown#to#correlate#with#
BOLD#activation# in# the#ACC,#OFC# and# amygdala# in# response# to# anticipated# receipt# of# food#
(Gearhardt#et#al.#2011).##However,#this#scale#measures#symptoms#of#addiction#to#food#over#
the#past#12#months#(Gearhardt#et#al.#2009),#and#would#therefore#not#have#been#suitable#in#
this# study# where# at# the# time# of# questionnaire# completion,# the# time# period# from# surgery#
varied#from#less#than#3#months#to#more#than#3#years#after#surgery,#although# it#could#have#
been#shortened#for#the#purpose#of#the#study.##A#similar#scale,#the#Power#of#Food#Scale#(PFS),#













Interestingly,# although# RYGB# patients# reported# less# hedonic# appeal# of# particularly# high>
calorie# food,#ate# less#proportional#dietary# fat,#had#healthier#eating#behaviour#and#had# less#
brain#reward#system#activation#to#food#compared#to#BAND#patients,#there#was#no#difference#
in#reported#hunger#or#fullness#levels#using#VAS#between#the#groups.#This#suggests#that#it#may#
be# differences# in# hedonic# responses# and# reward# based# eating,# rather# than# homeostatic#






differences# in# post>prandial# anorexigenic# gut# hormones# and# bile# acid# responses# between#
groups#in#this#study#sample,#in#agreement#with#previous#studies#(Borg#et#al.#2006;#Korner#et#
al.# 2006;# le# Roux# et# al.# 2007;# Korner# et# al.# 2009;# Nakatani# et# al.# 2009;# Patti# et# al.# 2009;#
Chandarana#et# al.# 2011;# Laferrere#2011;#Pournaras#et# al.# 2012).#Differences# in# acute#post>
prandial#gut#hormone#responses#are#unlikely#to#have#had#an#effect#on#fMRI#findings# in#this#











In# this# study,# plasma# levels# of# bile# acids#were# also# higher# in# the# RYGB# than# BAND# group.#
RYGB#modifies#the#anatomical#location#at#which#bile#enters#the#upper#gastrointestinal#tract#









acids# also# stimulate# small# bowel# production# of# fibroblast# growth# factor# 19# (FGF19)# and#
FGF19#receptors#have#been#found#in#the#rat#hypothalamus#and#their#expression#is#reduced#in#







Symptoms# of# dumping# syndrome# were# higher# in# RYGB# compared# to# BAND# patients,#
suggesting#a#further#possible#mechanism#underlying#differences#in#BOLD#signal#to#food#cues,#
mediated#by#conditioned#taste#aversion.#The#mechanisms#underlying#dumping#syndrome#are#
poorly# understood,# but# symptoms#have#been#associated#with# elevations# in# PYY# and#GLP>1#
(Gebhard# et# al.# 2001)# and#may# also# be# related# to# increased# bile# acids.# Patients# who# had#
undergone# RYGB# reported# increased# symptoms# of# dumping# in# the# first# 3# months# after#
surgery,#such#as#post>prandial#nausea,#pain,#tiredness,#diarrhoea,#sweating#and#feeling#faint,#
compared#to#those#that#had#undergone#BAND#surgery.#Dumping#symptoms#are#precipitated#






avoidance# of# foods# that# precipitate# it,# and# that# over# time,# through# learning,# these# foods#
therefore#are#associated#with#less#hedonic#appeal.##
#
Although# the#stomach>derived#orexigenic#hormone#ghrelin#has# stimulatory#effects#on# food#
hedonics# and# reward# system# activation# to# food# cues# (Malik# et# al.# 2008;# Goldstone# et# al.#
2010;#Skibicka#et#al.#2011)#there#was#no#difference# in#plasma#acyl#ghrelin#between#surgical#
groups.# Some# studies#have# found# reduced# fasting# and/or#post>prandial# ghrelin# levels# after#
RYGB# compared# to# before# surgery# or# to# unoperated# controls# (Cummings# et# al.# 2004;#
Pournaras#et#al.#2009;#Stefater#et#al.#2012).#This#finding#is#however#not#universal,#related#to#






Patients# in# this# study# were# not# randomized# as# to# which# surgery# they# receive,# as# it# is# the#
policy#of#the#unit#to#allow#patients#choice#of#surgery.#This# introduced#a#potential#source#of#
bias#since# it# is#possible#that#patients#choosing#RYGB#surgery#differed# in#some#way#to#those#
choosing# BAND# surgery# even# pre>operatively# in# a# way# that# would# affect# their# hedonic#
responses#to#food#post>operatively.#The#groups#were#however#similar#in#many#respects#with#
regard# to# pre>operative# and# post>operative# demographics# and# obesity# related# co>
morbidities,# but# did# differ# in# the# amount# of# weight# they# had# lost,# the# prevalence# of# pre>
operative#(but#not#post>operative)#T2DM#and,#probably#as#a#result#of#this#difference#in#T2DM#
prevalence,# their# pre>operative# obesity# related# co>morbidity# score.# # However,# the# RYGB#




and#hedonic#responses#to#food.# If#anything,# it# is# likely#that#high>calorie#sweet#foods#should#
have#held#more#hedonic#appeal#to#patients#who#had#been#denied#them#by#dietary#restriction#
in# the# past.# # On# the# other# hand,# T2DM# patients# may# have# received# different# or# more#
consistent# dietary# advice# prior# to# bariatric# surgery# compared# to# non>T2DM# patients,# and#







in# the#OFC# and# insula,#whereas# emotional# eating# positively# correlated#with# activity# in# the#
amygdala,#putamen#and#nucleus#accumbens#(Chechlacz#et#al.#2009).#The#possibility#of#long>
standing#effects#of# insulin#resistance#on#brain#reward#area#activation#cannot#be#completely#
ruled,# but# the# above# study# suggests# that# if# anything# this# would# have# minimized# the#
difference#between#BOLD#activation#in#the#RYGB#and#BAND#groups.##Furthermore,#evidence#










not#possible# to#match# the#groups# for#both#weight# loss#and#BMI.# It# is#possible,#but#unlikely#
that#the#results#of#the#study#could#be#explained#by#this#6%#difference# in#weight# loss#alone,#
when#both#groups#had#lost#more#than#20%#of#their#body#weight.#If#anything,#greater#weight#
loss# per# se# is# likely# to# lead# to# greater,# rather# than# less# brain# reward# response# to# food,#
mediated#by#falls#in#plasma#leptin#(Rosenbaum#et#al.#2008).##
#
Although# effort# was# made# to# record# and# where# possible,# reduce# differences# in# potential#




in# potential# mechanisms# identified# in# the# phenotyping# part# of# the# study.# The# number# of#
participants# in# the# study,# although#comparable#with# similar# studies#using# fMRI# to#examine#
food# reward# (Fletcher# et# al.# 2010;# De# Silva# et# al.# 2011),# and# with# those# examining# gut#
hormone#and#bile#acid#responses#(le#Roux#et#al.#2006;#Laferrere#2011),#is#small.#Some#aspects#
of# the# study# may# be# therefore# be# underpowered# to# detect# differences# between# groups,#





(Carnell# et# al.# 2012).# Additionally# fMRI# responses# to# food# pictures,# anticipation# of# food#
receipt#and#actual#food#receipt#all#increase#during#food#restriction#(Stice#et#al.#2013).#The#use#
of#food#pictures#also#allows#exposure,#albeit#visual,#of#the#subjects#to#more#complex,#real>life#









that# there#exists#dissociation#between#perceived# liking#of#particular# foods,#as#measured#by#
subjective#ratings,#and#unconscious#attraction#to#these,#measured#by#BOLD#signal#in#selected#
areas# of# the# brain.# # However# another# more# likely# explanation# is# that# fMRI# lacks# the#
247#
#
sensitivity# to#make# this# kind# of# distinction# in# cross>sectional# studies,#whereas# longitudinal#




different# areas# within# the# reward# system# act# in# synergy# with# each# other,# but# may# have#
distinct# roles# in# the# processing# of# food# reward.# For# instance,# the# OFC,# which# did# differ#
between#groups# is#known#to#encode#the#reward#value#of# food,# in#anticipation#of# food#and#
other#salient#cues,#whereas#the#striatal#structure,#the#nucleus#accumbens#and#caudate#may#
be# more# directly# involved# in# dopamine# release# in# response# to# receipt# of# reward.# The#
amygdala#in#turn#is#involved#in#emotional#processing#of#reward.###
#
It#was#not#possible# to# further# clarify#which#of# the#potential#mediators#might# contribute# to#
the# reduced# brain# hedonic# response# to# food# after# RYGB,# as#within# the# RYGB# group,# none#
were#correlated#with#BOLD#activation#to#food#cues#(in#those#ROIs#that#displayed#differences#
between#surgical#groups).#The#ability#to#detect#such#an#association#may#have#been#hindered#











response# to# food,# on# a# behavioural# and# neurological# level,# between# patients# who# have#
undergone#RYGB#surgery# for#obesity#compared#to#BAND#surgery.#RYGB#patients#had# lower#
BOLD#activation#to#high>calorie#food#pictures#in#the#OFC,#amygdala,#caudate#nucleus,#nucleus#
accumbens# and# hippocampus# and# rated# high# calorie# food# pictures# as# less# appealing# than#
BAND# patients# did.# They# also# rated# an# ice# cream# test# meal# as# less# palatable,# showed#
preferential# eating# behaviour# patterns# and# reported# lower# calorie# intake,# including#
proportionally# less# dietary# fat# intake# than# BAND# patients.# These# differences# were# not#
associated#with#differences# in#hunger#or#psychological# traits#or# states,# such#as# impulsivity,#
mood# or# depression.# Further# hormonal# and# metabolic# phenotyping# suggested# possible#
underlying#mechanisms# for# the# healthier# eating# behaviour# and# hedonic# response# to# food#
seen#in#RYGB.#RYGB#patients#had#increased#PYY#and#bile#acid#levels#at#the#time#of#scanning,#
and#elevated#post>prandial#PYY,#GLP>1#and#plasma#bile#acid#levels,#but#no#difference#in#acyl#





These# results# have# revealed# novel# differences# in# food# reward# and# hedonics# between# two#
successful# surgical# treatments# of# obesity.# This# may# prompt# the# development# of# more#
personalized# approaches# to# surgical# choices# that# incorporate# pre>operative# assessment# of#









In# conclusion,# RYGB# and# BAND# surgical# treatments# for# obesity# are# distinct# in# their#
mechanisms# of# weight# loss.# Post>operatively# patients# have# reduced# hunger# after# both#
procedures,#but#there#are#lower#brain#hedonic#and#exaggerated#gut#hormone#and#bile#acid#
responses# to# food# after# RYGB,# that#would# explain# its# greater# efficacy# for#weight# loss.# This#
implicates# the# gut>brain# axis# in# regulating# reward>driven# eating# behaviour,# as# well# as#
homeostatic#appetite,#and#hence#body#weight.#Further# in#depth#interrogation#of#these#gut>














































Campbell# et# al.# 2013).# In# addition# emerging# evidence# suggests# that# not# only# homeostatic#





brain#axis#controlling#food# intake.# It#has# long#been#established#through#animal#studies#that#
PYY#and#GLP>1#have#direct#effects#on#hypothalamic#and#brainstem#appetite#centres#(Field#et#
al.# 2009;# Parkinson# et# al.# 2009;# Field# et# al.# 2010).# PYY# acts# on# the# hypothalamic# arcuate#
nucleus# to# inhibit# neuropeptide# Y# (NPY)# neurons# to# reduce# appetite# and# food# intake#




2003).# Peripheral# GLP>1# crosses# the# blood# brain# barrier# (Kastin# et# al.# 2002)# and# GLP>1#
receptors#are#located#in#the#paraventricular#(PVN),#dorsomedian#(DMN),#and#arcuate#(ARC)#
hypothalamic# nuclei.# Infusion# of# GLP>1# peripherally# and# directly# into# the# brain# ventricles#
reduces#food#intake#in#rats#(Hayes#et#al.#2010;#Baldassano#et#al.#2012).##
#
However# it#has#become# increasingly#apparent#that# these#hormones#and#other#may#act#not#
only# on# hypothalamic# appetite# centres,# but# also# hedonic# and# reward>based# eating# as# is#
evidenced#by#both#animal#and#human#studies#(Egecioglu#et#al.#2011).##
#
To# date,# there# have# been# no# animal# studies# investigating# PYY# action# on# non>homeostatic#
brain#areas.#Human#subjects#given#a#PYY#infusion#compared#to#saline,#showed#activation#of#
the# parabrachial# nucleus,# the# VTA,# limbic# regions,# ventral# striatum# and# certain# frontal#
cortical#regions#as#assessed#by#BOLD#imaging#(Batterham#et#al.#2007).#The#substantia#nigra,#
parabrachial#nucleus#and#hypothalamic#BOLD#response#correlated#with#PYY#levels,#while#OFC#








reward# behaviour# is# also# reduced# in# rats# by# administration# of# a# GLP>1# agonist,# as# rats# no#
253#
#
longer# prefer# an# environment# previously# paired# to# chocolate# pellets.# The# peripheral#




in# combined# reward# regions# (amygdala,# caudate,# insula,# nucleus# accumbens,# OFC,# and#
putamen)# compared# to# saline# and# to# GLP>1# infusion# alone# in# healthy# non>obese#men# (De#
Silva#et#al.#2011).#
#
PYY# also# reduces# gastrointestinal# motility# and# increases# water# absorption# in# the# gut,# and#
GLP>1# inhibits#gastric#secretion#and#also#reduces#motility,#which#means#that#macronutrient#
absorption# is# protracted# and# delayed,# leading# to# satiety# and# a# reduction# in# food# intake.#
(Wang#et#al.#2010).#GLP>1# is#also#a#potent#anti>hyperglycaemic#hormone,#which# stimulates#




GLP>1# is# also#expressed# in# taste# receptors,# and#GLP1>receptor#knock#out# (KO)#mice#exhibit#

















Following# RYGB# surgery,# but# not# BAND# surgery,# post>prandial# secretion# of# PYY# is# also#
increased# (Bose#et#al.#2010;# Jacobsen#et#al.#2012).#PYY# is# secreted#earlier#and# to#a#greater#
level# than# that# seen# in# lean# people# (Korner# et# al.# 2006;# le# Roux# et# al.# 2006),# and# remains#




Administration#of# exogenous#PYY# to#RYGB# rats# causes# increased#weight# loss# (Fenske#et# al.#
2012).#RYGB# in#PYY#KO#mice# induces# less#weight# loss# than# in#wild# type#mice.#Furthermore,#
gastric#bypass#PYY#KO#mice#have#no#difference# in#weight# loss#compared#to#sham>operated#
and,#suggesting#that#PYY#is#an#important#mediator#of#weight#loss#after#RYGB#(Chandarana#et#






Reduction# of# PYY# and# GLP>1# secretion# by# administration# of# somatostatin# or# an# analogue,#
increases# food# intake# in#rats# (le#Roux#et#al.#2006),#and#humans#that#have#undergone#RYGB#
surgery# (le# Roux# et# al.# 2007;# Fenske# et# al.# 2012),# although# somatostatin# also# suppresses#
secretion#of#many#other#gut#hormones#including#orexigenic#ghrelin#(see#section#4.1.5).#Direct#




Although# PYY# and# GLP>1# have# been# shown# to# acutely# influence# food# intake,# the# chronic#
effects#of#PYY#and#GLP>1#may#also#be# important.#For# instance,#sustained# increased#salivary#
PYY# resulted# in# a# significant# long>term# reduction# in# food# intake# and# body# weight# in#mice#





independent# of# the# effect# of# weight# loss# and# potentially# mediated# by# increased# incretin#





(Sjostrom#et#al.#2004).#Reduction# in#peripheral# insulin#resistance#occurs# in#accordance#with#
weight#loss,#but#hepatic#insulin#resistance#can#change#earlier#(Lim#et#al.#2011).#A#recent#study#
has#also#shown#using#PET#2>deoxy>2>[18F]fluoro>D>glucose#that#due#to#early#exposure#of#the#





on# food# hedonics.# Insulin# reduces# appetite# centrally# in# hypothalamic# centres,# and# affects#
dopamine# release# in# the# rat# striatum.# At# low# concentrations,# insulin# increases# dopamine#





the# brain,# and#may# alter# reward# processing.# For# instance,# exposure# to# a# high>energy# diet#
increases# sucrose# self>administration# and# prevents# the# ability# of# centrally# administered#
insulin#to#reduce#sucrose#intake#(Figlewicz#et#al.#2006;#Cheah#et#al.#2012).#In#humans,#insulin#
resistance# is# associated# with# attenuated# striatal# and# prefrontal# brain# glucose# metabolism#
following#insulin#infusion#(Anthony#et#al.#2006).#Altered#resting#state#functional#connectivity#
in#the#OFC#and#putamen#is#influenced#by#insulin#resistance#(Kullmann#et#al.#2012).#Moreover,#
although# intranasal# insulin# augments# post>prandial# satiety# and# reduces# food# intake# in#




Insulin# levels# correlate# with# BOLD# signal# response# to# food# imagery# in# the# putamen# and#
thalamus# (Jastreboff#et#al.#2013),#and#with# reduced#activation# in# the#OFC#and# thalamus# to#
high>calorie# food# pictures# in# obese# subjects# (Wallner>Liebmann# et# al.# 2010).# # Significant#
associations#have#also#been#found#between#postprandial#changes#in#insulin,#glucose#and#FFA#
and#postprandial# changes# in#neuronal# activity# in# the#precuneus#as#measured#by# rCBF#with#
PET# in# response# to# a# satiating# liquid# meal,# which# suggests# that# both# insulin# and# these#
metabolites#might#act#as#modulators#of#postprandial#neuronal#events#(Del#Parigi#et#al.#2002).##
#
Evidence# from# a# recent# study# suggests# that# RYGB# reverses# insulin# resistance# induced#





resulted# in# greater# release# of# GLP>1# and# PYY,# reduced# food# intake# and# body# weight#
(Pournaras#et#al.#2012).#This#study#suggested#that#the#delivery#of#undiluted#bile#(not#bound#
up# in# micelles# created# by# progressing# through# the# stomach# and# proximal# intestine# and#
combining#with#food)#to#the#terminal#ileum#stimulates#bile#acids#to#produce#PYY#and#GLP>1#









therefore# mimics# its# action.# Somatostatin# suppresses# the# release# of# a# number# of#
gastrointestinal#hormones#including#GLP>1,#PYY,#PP,#gastrin,#cholecystokinin#(CCK),#secretin,#
motilin,# vasoactive# intestinal# peptide# (VIP),# gastric# inhibitory# polypeptide# (GIP)# and#
enteroglucagon.# It# also# has# various# other# effects# within# the# gastro>intestinal# system#
including#decreasing#the#rate#of#gastric#emptying,#reducing#smooth#muscle#contractions#and#
blood# flow# within# the# intestine,# suppression# of# the# release# of# pancreatic# hormones,#
including# insulin#and#glucagon.#Octreotide# is# safely#used# to# treat#disorders#associated#with#





approximately# 60%# (Haqq# et# al.# 2003),# similar# to# the# reduction# observed# by# acute#
administration#of#somatostatin#infusion#in#another#study#(Tan#et#al.#2004).##
#
Octreotide# is#a#more#potent# inhibitor#of# insulin# than#naturally#occurring#somatostatin,#and#
has# a# longer# half>life# (90# minutes).# It# is# poorly# absorbed# from# the# gut# and# so# is# usually#
administered#subcutaneously.#It#increases#fasting#glucose#levels#and#lowers#fasting#insulin#in#
healthy# individuals# (Parkinson#et#al.#2002),#and# its# insulin# lowering#effect#promotes#weight#
loss# in# some# but# not# all# obese# adults# (Velasquez>Mieyer# et# al.# 2003).# In# normal# weight#




meal# fullness,# without# altering# food# intake# (Foxx>Orenstein# et# al.# 2003;# Cremonini# et# al.#
2005).# Peripheral# somatostatin# infusion# also# increases# satiety# and# reduces# food# intake# in#
humans#over#a#1#hour#period,#but#when#intraduodenal#fat#is#introduced,#food#intake#actually#
increases# following# somatostatin# compared# to# saline# infusion# (Lieverse# et# al.# 1995).#
Intracerebral# Octreotide# increases# food# intake# in# chicks# (Tachibana# et# al.# 2011),# mice#
(Stengel# et# al.# 2010)# and# rats# (Danguir# 1988)# through# its# action# on# hypothalamic#
somatostatin# receptors# but# potentially# also# through# amygdala,# hippocampal# and# striatal#
pathways# in# the# brain,# which# also# express# somatostatin# receptors# (Viollet# et# al.# 2008).#
Octreotide#has#been#successfully#used#in#the#treatment#of#hyperinsulinaemic#hypoglycaemia#




hormones# after# obesity# surgery# because# its# properties,# dosage# and# side# effect# profile# are#


















in# the# fasted# state# in# obese# patients# who# had# undergone# RYGB# compared# to# patients# of#
similar# BMI#who#had# undergone#BAND# surgery# and/or# BMI>matched#unoperated# controls.#
These# differences# were# accompanied# by# reduced# appeal# and# palatability# of# high>calorie#
foods,#and#healthier#eating#behaviour#including#less#proportional#fat#intake#in#RYGB#patients.#
Furthermore# fasting# PYY# and# post>prandial# PYY# and# GLP>1# were# higher# in# RYGB,# but# not#
BAND,#compared#to#BMI>matched#unoperated#patients,#while#fasting#and#post>prandial#bile#




1.# Lowering#plasma#anorexigenic# gut#hormones#PYY#and#GLP>1# in# fed#obese#patients# after#
RYGB#surgery#will#increase#hunger,#brain#reward#system#and#hedonic#responses#to#food.#
#
2.# By# contrast# lowering# plasma# anorexigenic# gut# hormones# PYY# and# GLP>1# in# fed# obese#




























Attended$$ 9$ 9$ 9$ 9$
Scan$excluded$/$
contraUindicated$
2$ 2$ 1$ 1$
Behavioural$data$
included$
9$ 9$ 8$ 8$
BOLD$within$subject$
comparison$included$
6U7$ 6U7$ 8$ 8$
#
A# subset# of# operated# subjects# from#Chapter# 3# attended# further# visits# for# scanning# and/or#















no# significant# differences# between# the# groups# in# age,# gender# ratio,# ethnic# background#
distribution,#current#or#pre>operative#BMI,#percentage#body#fat,#current#prevalence#of#type#2#
diabetes#mellitus#(T2DM)#or#current#or#pre>operative#binge#eating#disorder#(BED)#(Table#4.2).#
The# RYGB# group# had# more# obesity>associated# co>morbidities# pre>operatively# including#





# BAND$$ RYGB$ Pa$




Gender$(Male$:$Female)$ 1:8# 1:8# 1.00#

























PreUoperative$DM,$n$(%)$ 0#(0%)# 5#(56%)# 0.03$










PreUoperative$BED,$n$(%)$ 2#(22%)# 2#(22%)# 1.00#
Current$BED,$n$(%)$ 0#(0%)# 1#(11%)# 1.00#
Data#presented#as#mean#±#SEM,#and# (range).# a#P#value# for# comparison#of#averages#between#groups#






$ BAND$ RYGB$ Pa$




Moderate>severe#depression#(>15),#n#(%)$ 1#(11%)# 0#(0%)# 0.30#
On$antidepressants$treatment,$n$(%)$ 2#(22%)# 3#(33%)# 0.60#







































































trend# (P=0.09)# for# BOLD# signal# in# the# average# reward# system# ROIs# (average# of# OFC,#



















BOLD# activation,# or# for# difference# in# effects# between# the# groups# in# the# change# in# BOLD#
activation# between# Fed>Saline# and# Fed>Octreotide# visits,# in# the# posterior# division# superior#
temporal# gyrus,# left# precentral# gyrus# or# lingual# gyrus# respectively# during# the# control#


































Comparison#of#BOLD#activation# to#any# food,#only#high>calorie#or#only# low>calorie# food# (vs.#objects),#
after# consuming# milkshake# breakfast# of# 385kCal,# in# obese# patients# after# gastric# banding# (BAND)#
surgery# in#a.priori. functional# regions#of# interest# (fROI)# adjusting# for# age,# gender#and#BMI,#between#











Comparison#of#difference# in#BOLD#signal# to#any# food,#only#high>calorie#or#only# low>calorie# food# (vs.#
objects),# after# consuming# milkshake# breakfast# of# 385kCal,# and# administration# of# subcutaneous#
Octreotide# vs.# saline# in# a. priori. functional# regions# of# interest# (fROI)# between# obese# patients# after#
gastric# banding# (BAND,# red,# n=8)# and# gastric# bypass# (RYGB,# green,# n=7# except# OFC# n=6)# surgery,#







interest& Contrast& RYGB&& BAND&& FED&OCTREOTIDE&–&FED&SALINE&
& & Fed7Saline& Fed7Octreotide& P&& Fed7Saline& Fed7Octreotide& P&& BAND& RYGB& P&a&












































































































































































































































































































cortex$during$ control$ task.$Data$ adjusted$ for$ age,$ gender$ and$BMI$ in$ the$between$group$difference$of$ effect$of$Octreotide.$Data$presented$as$mean$±$ SEM$or$median$
[interquartile$range]$for$data$that$is$not$normally$distributed$and$(range).$$
a$P$value$ for$overall$ comparison$of$averages$between$visits$or$groups$using$paired$or$ independent$ t,test$ for$normally$distributed$data$or$Mann,Whitney$U$or$Wilcoxon$
Signed$test$where$not$normally$distributed.$$
*OFC:$1$subject$data$excluded$in$RYGB$group$for$both$visits$due$to$signal$dropout$















more$ appealing$ in$ the$ Fed@Octreotide$ compared$ with$ the$ Fed@Saline$ visit$ (Table$ 4.5,$ Fig.$
4.4A).$ There$were$ no$ significant$ differences$ in$ ratings$ of$ individual$ subcategories$ of$ high@








There$was$no$ significant$difference$between$ the$RYGB$and$BAND$groups$ in$ the$ change$ in$









Figure$ 4.4$ Effect$ of$ Octreotide$ on$ food$ hedonics$ and$ meal$ palatability$ in$ fed$ obese$
patients$after$gastric$bypass$surgery$
$
Comparison$of$ (A)$ appeal$ of$ any$ food,$ only$ high@calorie$ or$ low@calorie$ food,$ or$ object$ pictures;$ (B)$
appeal$ of$ sub@categories$ of$ high@calorie$ food$pictures;$ (C)$ ice$ cream$ lunch$ intake$ adjusted$ for$ lean$
body$ mass$ (D)$ VAS$ of$ ice$ cream$ lunch$ palatability,$ in$ obese$ patients$ after$ gastric$ bypass$ surgery$












Comparison$of$ (A)$ appeal$ of$ any$ food,$ only$ high@calorie$ or$ low@calorie$ food,$ or$ object$ pictures;$ (B)$
appeal$ of$ sub@categories$ of$ high@calorie$ food$pictures;$ (C)$ ice$ cream$ lunch$ intake$ adjusted$ for$ lean$











Figure$ 4.6$ Difference$ in$ effect$ of$ Octreotide$ on$ food$ hedonics,$ meal$ palatability$ in$ fed$
obese$patients$after$gastric$bypass$and$gastric$banding$surgery$$
$
Comparison$ of$ difference$ between$ fed@saline$ and$ fed@Octreotide$ visits$ in$ (AA)$ appeal$ of$ any$ food,$
only$high@calorie$or$ low@calorie$ food,$or$object$pictures;$ (B)$appeal$of$sub@categories$of$high@calorie$
food$ pictures;$ (C)$ ice$ cream$ lunch$ intake$ adjusted$ for$ lean$ body$mass,$ (D)$ VAS$ of$ ice$ cream$ lunch$






APPEAL&SCORES&b& RYGB&& BAND&& FED&OCTREOTIDE&–&FED&SALINE&
& Fed@Saline& Fed@Octreotide& Pa& Fed@Saline& Fed@Octreotide& Pa& BAND& RYGB& Pa&









































































































& RYGB& BAND&& FED&OCTREOTIDE&@&FED&SALINE&&
& Fed@Saline& Fed@Octreotide& Pa& Fed@Saline& Fed@Octreotide& Pa& BAND& RYGB& Pa&
n& 9c# 9c# # 8# 8# # 8# 9c# #







































































































There$was$ no$ significant$ difference$ in$ ice4cream$ test$meal$ intake$ between$ the$ Fed4Saline$
and$Fed4Octreotide$visits$in$the$RYGB$or$the$BAND$group$(Table$4.6,$Fig.$4.4$C,$D$and$Fig.$4.5$





















the$ ice$ cream$ lunch$meal$ between$ the$ Fed4Saline$ and$ Fed4Octreotide$ visits$ in$ either$ the$
RYGB$or$BAND$group$(Table$4.7,$Fig.$4.7$and$4.8).$$
##
4.4.5.2# Difference# in# effect# of# Octreotide# on# visual# analogue# scales# between# surgical#
groups#
There$were$no$significant$differences$between$the$RYGB$and$BAND$groups$in$the$change$in$






& RYGB& BAND&& FED&OCTREOTIDE&–&FED&SALINE&
& FedESaline& FedEOctreotide& Pa& FedESaline& FedEOctreotide& Pa& BAND& RYGB& Pa&
n& 9c$ 9c$ $ 8$ 8$ $ 8$ 9c$ $










































































































































































pleasantness# to#eat,# (G,#H)# volume#of# food# that# could#be#eaten,# and# (I,# J)# fullness,# (A,C,E,G,I)# levels#
during#fMRI#scanning#(area#under#curve#(AUC)#+40#to#+150#mins)#and#(B,#D,#F,#H,# J)#change# in# levels#
after# ice#cream#lunch#meal#(ΔAUC#+150#to#+210#mins)#between#obese#patients#after#gastric#banding#
(BAND,# red)# and# gastric# bypass# (RYGB,# green)# surgery# between# FedSOctreotide# and# FedSSaline#






In#RYGB#patients,# plasma#glucose# levels# increased#more# after# the# iceScream# lunch#meal# at#
the#FedSSaline#visit#than#the#FedSOctreotide#condition#(Table#4.8,#Fig.#4.10B).#There#were#no#
significant#differences#between#visits# in#preSlunch#plasma#glucose#or# insulin# levels#or#postS
prandial#changes#in#plasma#insulin#levels#(Table#4.8,#Fig.#4.10A,#C,#D)#in#the#RYGB#group.#Due#




In#BAND#patients,#preSlunch# insulin# levels#were#higher#at# the#FedSSaline#visit# than#the#FedS
Octreotide#visit# (Table#4.8,#Fig.#4.11C).#PreSlunch#triglyceride# levels#were#also#higher#at# the#
FedSSaline# than# the# FedSOctreotide# visit# (Table# 4.8,# Fig.# 4.11E).# There# were# no# significant#
differences# in#BAND#patients#between#visits# in#the#preSmeal#plasma#glucose# levels#or#postS




The# increase# in#glucose# levels#preSlunch#between#FedSSaline#and#FedSOctreotide#visits,#and#
decrease# in# postSlunch# glucose# levels# between# FedSSaline# and# FedSOctreotide# visits,# were#
both#greater# for# the#RYGB#compared#with# the#BAND#group# (Table#4.8,#Fig.#4.12A,B).#There#
were#no#significant#differences#between#the#RYGB#and#BAND#groups#in#the#change#in#insulin#
levels#between#the#FedSSaline#and#FedSOctreotide#visits#(Table#4.8,#Fig.#4.12C,D).#Again#this#
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to$ +150$mins)$ and$ (B,D,F)$ change$ in$ glucose,$ insulin$ and$ triglycerides$ after$ iceGcream$meal$ (ΔAUC$



















Comparison$ of$ difference$ between$ FedGSaline$ and$ FedGOcteotide$ visits$ in$ (A,C,E)$ plasma$ levels$ of$
glucose,$ insulin$ and$ triglycerides,$ area$ under$ curve$ (AUC)$ +40$ to$ +150$mins)$ and$ (B,D,F)$ change$ in$













smaller$ breakfast$ than$ the$ standard$ (251$ kCal$ compared$ to$ 385$ kCal)$ due$ to$ adjustments$
being$made$in$the$protocol$at$that$time,$but$otherwise$both$subjects$followed$the$standard$
protocol$ in$ every$ other$ way,$ except$ that$ they$ did$ not$ undergo$ fMRI$ scanning.$ The$
participants$ate$563$kCal$(9.9$kCal/kg$lean$body$mass$[LBM])$and$338$kCal$(8.3$kCal/kg$LBM)$































There$was$no$difference$ in$physiological$markers$of$dumping$ syndrome$ (heart$ rate,$blood$
pressure)$ or$ VAS$ ratings$ of$ ‘sleepiness’$ or$ ‘nausea’$ between$ visits$ in$ either$ the$ RYGB$ or$
BAND$group$(Table$4.9).$There$was$also$no$difference$between$the$RYGB$and$BAND$groups$
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GLP81$ in$ RYGB$ on$ food$ hedonics$ was$ made$ by$ administration$ of$ Octreotide$ to$ suppress$
plasma$GLP81$and$PYY$levels.$Acute$Octreotide$administration$increased$BOLD$activation$in$
the$nucleus$accumbens$to$any$food$or$just$low8calorie$food$in$the$picture$evaluation$task$in$
fed$ obese$ patients$ after$ RYGB$ surgery.$Octreotide$ also$ increased$ the$ subjective$ appeal$ of$
any$ food$pictures$ in$ the$RYGB$ group,$ but$ did$ not$ significantly$ alter$ ice$ cream$palatability.$





Octreotide$ lowered$satiety$ (measured$by$ ‘volume$able$to$eat’$VAS)$ following$an$ ice$cream$
test$meal$in$obese$patients$after$RYGB,$but$had$no$effect$on$reported$hunger$or$the$amount$
of$ice$cream$consumed$in$either$RYGB$or$BAND$patients.$Octreotide$had$no$effect$on$satiety$
measures$ in$ the$ BAND$ group,$ but$ again$ there$ were$ no$ significant$ differences$ between$
groups.$Octreotide$had$no$effect$in$either$group$on$dumping$symptoms.$Preliminary$analysis$










response$on$BOLD$signal$ to$ food$cues.$ In$a$ longitudinal$study,$5$RYGB$patients$were$ fed$a$
small$ liquid$ meal$ (250$ml,$ 250$ kCal)$ or$ 250$ ml$ water,$ 45$min$ prior$ to$ scanning,$ after$ an$
overnight$ fast.$No$difference$ in$BOLD$activation$ to$ food$cues$ (pictures$and$spoken$words)$
was$seen$in$the$fed$state$one$month$after$surgery$compared$to$one$month$before$surgery,$
even$though$the$same$patients$had$a$reduction$in$BOLD$activation$to$food$cues$after$surgery$









Although$ cross8sectional$ in$ nature,$ this$ study$ revealed$ increased$ activation$ in$ the$ nucleus$
accumbens$ to$ food$ cues$ (hypothesised$ to$ be$ associated$ with$ dopaminergic$ release$ in$
response$ to$ reward$ anticipation)$ in$ the$ fed$ state$ in$ RYGB$ patients$ when$ gut$ hormone$




post8prandial$ state.$Another$possibility$ is$ that$ the$ relatively$ small$ size$of$meal$ in$Ochner’s$
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lower$ activation$ in$ the$ RYGB$ than$ BAND$ groups$ in$ the$ response$ to$ food$ pictures$ when$
fasted,$the$latter$study$did$not$show$any$change$in$the$nucleus$accumbens$in$fROI$analysis$
(Chapter$ 3).$Meanwhile$ the$ lower$ OFC$ and$ amygdala$ activation$ to$ food$ pictures$ in$ RYGB$





Roux$ et$ al.$ have$ previously$ shown$ after$ RYGB$ (2007).$ In$ their$ study,$ which$ measured$
appetitive$ but$ not$ hedonic$ response$ to$ food,$ the$ same$ dose$ of$ Octreotide$ (100mcg)$was$
administered$to$6$RYGB$and$7$BAND$patients$after$a$12$hour$fast,$and$a$subsequent$increase$
of$nearly$50%$was$seen$in$ice$cream$intake$in$the$RYGB$but$not$BAND$patients.$This$increase$
in$ food$ intake$was$associated$with$a$ reduction$ in$ fullness$on$VAS$ in$ the$RYGB$group$only,$
and$ reduction$ in$ post8prandial$ PYY$ and$GLP81$ secretion$ in$ both$ groups.$ The$ post8prandial$
PYY$levels$were$lower$at$30$minutes,$were$most$reduced$at$60min,$and$remained$reduced$at$





The$ two$ paradigms$made$ use$ of$ the$ same$ dosage$ of$ Octreotide$ to$ reverse$ gut$ hormone$
responses,$ and$ identical$ test$ meals$ were$ given.$ The$ most$ notable$ difference$ in$ the$ two$
paradigms$was$the$fact$the$patients$were$fasted$for$12$hours$in$le$Roux’s$study$and$that$the$
test$ meal$ was$ given$ 60$ minutes$ after$ the$ injection$ in$ the$ fasted$ state,$ whereas$ in$ my$
paradigm,$patients$were$fed$a$385kCal$milkshake$breakfast$after$an$overnight$fast,$and$the$














be$that$ the$milkshake$breakfast$was$ too$similar$ to$ the$ ice$cream$ lunch$and$therefore$may$








and$GLP81$on$ food$hedonic$ responses,$appetite$measures$and$ food$ intake.$To$counter$ the$
suppression$of$insulin$levels$by$Octreotide,$Actrapid$was$co8administered$with$Octreotide$to$
all$patients$ (see$Section$2.7).$ In$RYGB$patients,$administration$of$Actrapid$appears$to$have$
attenuated$ the$ expected$ post8prandial$ increase$ in$ glucose,$ but$ only$ after$ the$ ice$ cream$
lunch$meal,$and$not$after$breakfast$(Fig.$4.10A,B).$Although$Actrapid$is$a$short8acting$insulin,$




there$were$many$missing$ insulin$ samples$ for$ the$ RYGB$ group.$ In$ addition$ it$ is$ difficult$ to$




In$ addition,$ high$ pre8operative$ (but$ not$ post8operative)$ rates$ of$ T2DM$ in$ the$RYGB$ group$
may$mean$that$this$group$has$persistently$impaired$β8cell$function$which$is$influencing$the$
results,$ particularly$ in$ the$ comparison$ between$ the$ effects$ of$ Octreotide$ on$ glucose$ and$







somatostatin$ (Tan$ et$ al.$ 2004).$ Since$ ghrelin$ is$ known$ to$ increase$ appetite,$ food$ intake$
(Druce$et$al.$2005;$Neary$et$al.$2006),$appeal$of$food$and$OFC,$amygdala,$hippocampal$and$
striatal$ BOLD$ activation$ to$ food$ pictures$ (Malik$ et$ al.$ 2008;$ Goldstone$ et$ al.$ 2010),$









In$ those$ studies$ that$ did$measure$ acyl$ ghrelin,$ two$ showed$ reduced$ fasting$ acyl$ ghrelin$ 2$

























Octreotide$on$BOLD$signal$e.g.$on$neurovascular$ coupling.$ $However$Octreotide$ itself$may$
have$effects$on$appetite$and$food$ intake$and$potentially$BOLD$signal$ to$ food$cues.$Animal$
studies$have$shown$increased$food$intake$after$Octreotide$in$mice,$rats$and$chicks$(Danguir$
1988;$ Stengel$ et$ al.$ 2010;$ Tachibana$ et$ al.$ 2011).$ By$ contrast$ human$ studies$ have$ shown$
increased$satiety$but$no$change$in$food$intake$following$Octreotide$administration$in$normal$
weight$ and$ obese$ subjects$ (Foxx8Orenstein$ et$ al.$ 2003;$ Cremonini$ et$ al.$ 2005).$ Another$
study$ found$ somatostatin$ infusion$ increased$ satiety$ and$ reduced$ food$ intake$ in$ healthy$
volunteers,$ but$ this$ was$ reversed$ after$ infusion$ of$ fat$ into$ the$ duodenum,$ resulting$ in$
increased$food$ intake$after$somatostatin.$Somatostatin$receptors$are$ located$widely$ in$the$
brain,$ not$ only$ in$ the$ hypothalamus$ but$ also$ the$ amygdala,$ hippocampal$ and$ striatal$
pathways$ in$ the$brain$ (Viollet$ et$ al.$ 2008).$Octreotide$ is$ believed$ to$ cross$ the$blood8brain$
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barrier$ (Fricker$ et$ al.$ 2002)$ supported$ by$ its$ use$ in$ treating$ neuroendocrine$ tumours.$
Therefore$it$is$conceivable$that$Octreotide$may$have$intra8cerebral$effects$of$its$own,$which$







to$delineate$a$specific$ role$ for$ these$hormones$ in$altering$hedonic$responses$to$food$after$
bariatric$ surgery.$ Indeed$ counter$ to$ the$ expected$ hypothesis,$ KO$mice$ lacking$ the$ GLP81$
receptor$did$not$differ$in$weight$loss$or$food$choices$after$VSG$compared$to$wild8type$mice$
(Wilson8Perez$et$al.$2013).$The$GLP81$antagonist,$Exendin(9839),$has$been$shown$to$reverse$
the$glycaemic$ improvements$ seen$ in$RYGB$and$VSG$surgery$ in$animal$and$human$studies,$












These$ methods$ carry$ their$ own$ problems$ however.$ For$ example,$ the$ degree$ of$ receptor$
blockade$ by$ GLP81$ antagonist$ Exendin(9839)$ is$ uncertain,$ and$ it$ may$ have$ partial$ agonist$
effects$which$lead$to$a$reduction$in$the$overall$antagonist$effect.$Genetic$approaches$have$
the$advantage$of$unequivocal$long8term$disruption$of$the$GLP81$pathway,$but$could$result$in$








likely$ not$ to$ have$ yielded$ the$ expected$ results$ due$ to$ insufficient$ power$ to$ detect$
differences$ between$ visits$ and$ groups.$ These$ pilot$ results$ provide$ a$ basis$ for$ planning$
extension$of$this$study$with$larger$numbers$(see$Chapter$6).$$
$
As$ in$ Chapter$ 3,$ the$ groups$ were$ not$ different$ in$ psychological$ traits$ that$ could$ have$
affected$ BOLD$ activation$ to$ food$ pictures.$ BAND$ subjects$ did$ differ$ between$ visits$ in$ the$
number$of$hours$of$sleep$the$night$before$the$visit.$They$had$approximately$1.5$hours$ less$
sleep$on$ the$Fed8Saline$ than$ the$Fed8Octreotide$visit.$Since$sleep$deprivation$can$ increase$
the$ neural$ responsivity$ to$ food$ (St8Onge$ et$ al.$ 2012),$ it$ is$ possible$ that$ this$ chance$
occurrence$ has$ partially$ masked$ some$ of$ the$ potential$ difference$ between$ groups$ in$




Unfortunately$the$gut$hormone$analyses$are$not$available$ for$this$part$of$ the$study$at$ this$
time,$as$ further$study$visits$are$planned$and$ the$hormone$assays$are$best$carried$out$ in$a$
single$run$to$improve$accuracy.$However,$the$test$sample$results$suggest$that$Octreotide$is$






















their$ associated$ appeal$ in$ RYGB$ but$ not$ BAND$ patients$ when$ given$ the$ somatostatin$




The$preliminary$ nature$of$ this$ small$ study$precludes$ extensive$ interpretation$ especially$ of$
the$ difference$ between$ surgical$ groups.$ In$ addition$ the$ lack$ of$ specificity$ of$ Octreotide$






Nonetheless,$ the$ results$ would$ be$ in$ agreement$ with$ the$ hypothesis$ that$ acute$ post8
prandial$ anorexigenic$ gut$ hormone$ responses$may$ indeed$ influence$ hedonic$ responses$ to$






























Brain$ structural$ changes$ or$ abnormalities$ within$ normal$ or$ disease$ populations$ can$ be$
visualized$ in$ a$ number$ of$ ways,$ but$ voxel8based$morphology$ (VBM,$ for$ grey$matter)$ and$
diffusion$ tensor$ imaging$ (DTI,$ for$ white$ matter)$ have$ emerged$ as$ effective$ ways$ of$
measuring$ subtle$ effects$ of$ disease$ and$ age8related$ neurodegeneration$ on$ specific$
structures$and$tissue$types$at$a$group$level.$$
$
VBM$ is$ a$ neuroimaging$ analysis$ technique$ that$ measures$ voxel8wise$ grey$ matter$ (grey$
matter)$ volume$ and$ topographical$ differences$ in$ brain$ structures$ across$ populations$ or$
across$ time,$ using$ high8resolution$ structural$ MRI$ T1$ scans$ (Ashburner$ et$ al.$ 2003).$ Brain$
tissue$ is$ extracted$ from$ scans$ to$ exclude$ superfluous$ tissue,$ such$ as$ skull$ tissue,$ and$ the$
images$ undergo$ tissue8type$ segmentation$ to$ separate$ out$ grey$matter$ from$white$matter$
and$ cerebrospinal$ fluid.$ Each$ individual’s$ structural$ scan$ is$ then$ registered$ to$ a$ template$
constructed$from$a$standardized$brain$(the$average$of$a$large$number$of$control$brains)$by$
spatial$warping.$ The$grey$matter$density$ in$each$voxel$ across$ the$brain$ is$ then$ calculated.$






VBM$ has$ been$ a$ particularly$ useful$ tool$ in$ detecting$ early$ signs$ of$ neurodegeneration$ in$
conditions$such$as$Alzheimer’s$disease$and$cerebrovascular$disease$(Ferreira$et$al.$2011;$Pan$
et$ al.$ 2012)$ and$ as$ a$measure$ of$ response$ to$ treatment$ (Bottini$ et$ al.$ 2012).$ Its$ use$ has$









FIRST$ (FMRIB’s$ Integrated$ Registration$ and$ Segmentation$ Tool)$ is$ a$ newer,$ model8based$
segmentation$tool,$which,$using$Bayesian$principles$and$a$library$of$training$data,$to$model$
the$most$probable$ average$ shape$and$ likely$ variations$of$ a$ given$brain$ structure,$ across$ a$
population.$ An$ average$ volume$ measurement$ of$ the$ particular$ anatomical$ structure$ in$
question$ across$ the$ population$ can$ then$ be$ calculated.$ This$ technique$ aims$ to$ replace$
previous$ volumetric$ analyses$ that$ made$ use$ of$ manual$ tracing$ around$ structures,$ which$




A$ number$ of$ VBM$ cohort$ studies$ of$ adults$ younger$ than$ 70$ years$ have$ found$ that$ grey$
matter$ (and$ white$ matter)$ volume$ may$ be$ increased$ in$ the$ OFC,$ dorsal$ striatum,$ peri8
hippocampal$ areas$ and$ amygdala$ in$ obesity$ or$ positively$ associated$ with$ increased$ BMI$
(Pannacciulli$et$al.$2006;$Haltia$et$al.$2007;$Horstmann$et$al.$2011;$Orsi$et$al.$2011;$Taki$et$al.$













TFEQ$ (Maayan$ et$ al.$ 2011)$ and$ food$ preference$ (Cohen$ et$ al.$ 2011)$ have$ also$ been$




of$ BMIs,$ our$Group$ (Natalie$White,$MSc$ Clinical$Neuroscience$ project)$ has$ recently$ found$
obese$ subjects$ to$ have$ increased$ grey$ matter$ volume$ in! the$ caudate,$ putamen,$ nucleus$
accumbens,$ amygdala,$ precentral$ gyrus,$ middle$ temporal$ gyrus,$ parahippocampal$ gyrus,$
and$ the$ left$ middle$ frontal$ gyrus$ on$ whole$ brain$ analysis$ (adjusting$ for$ age$ and$ gender,$






volume$ compared$ to$ the$ obese$ subjects$ in$ the$ bilateral$ nucleus$ accumbens$ (P<0.001),$
amygdala$ (P<$ 0.03),$ caudate$ nucleus$ (P<0.001),$ pallidum,$ (P<$ 0.001),$ and$ putamen$ (P<$














overlaid$ onto$ GM$ template$ for$ lean$ and$ obese$ groups.$ Co8ordinates$ given$ in$ MNI$ space.$
Abbreviations:$PCG,$Precentral$gyrus;$Put,$Putamen;$CBM,$Cerebellum;$PHG,$Parahippocampal$gyrus;$
Ins,$ Insula;$Caud,$Caudate;$MFC,$Middle$ frontal$ gyrus;$COC,$Central$Opercular$ cortex;$NAc,$Nucleus$





white$ matter$ based$ on$ the$ pattern$ of$ diffusion$ of$ water$ molecules$ within$ these$ tracts.$






the$ structural$ integrity$ of$ the$ white$ matter$ tracts.$ Fractional$ anisotropy$ refers$ to$ how$
parallel$ the$ flow$ of$ water$ is$ compared$ to$ the$ main$ direction$ of$ the$ tract,$ and$ mean$
diffusivity,$the$average$rate$of$diffusion$of$water$in$all$directions$within$a$voxel.$$
$DTI$ has$ been$widely$ used$ to$ investigate$white$matter$ tract$ integrity$ in$ psychiatric$ illness,$
including$schizophrenia,$depression,$obsessive$compulsive$disorder$and$autism$(White$et$al.$
2008),$as$well$as$anorexia$nervosa$(Frieling$et$al.$2012).$Brain$ insult$ resulting$ from$trauma$




Several$ DTI$ studies$ have$ demonstrated$ an$ association$ of$ reduced$ FA$with$ increased$ BMI,$
indicative$ of$ reduced$ white$ matter$ tract$ integrity,$ in$ the$ middle$ and$ superior$ cerebellar$
peduncles,$parts$of$the$midbrain,$the$internal$capsule,$cingulum$and$peri8hippocampal$tracts$




matter$ structure$ in$ different$ parts$ of$ the$ brain$ compared$ to$ normal$ weight$ individuals.$
Obesity$ itself$may$ lead$ to$ atrophy$ or$ damage$ in$ brain$ structure,$ through$ cerebrovascular$
disease,$inflammation$or$lack$of$micronutrients$due$to$poor$diet$(e.g.$diet$low$in$fish$oils$or$
high$in$saturated$fat).$For$instance,$high$fat$and$sugar$diets$can$directly$damage$the$brain$in$
animal$ studies$ by$ reducing$ hippocampal$ brain8derived$ neurotrophic$ factor$ (Molteni$ et$ al.$
2002),$whereas$omega83$fish$oils$may$have$a$protective$role$in$brain$function$and$structure$
(Luchtman$ et$ al.$ 2013).$ Obesity,$ and$ particularly$ associated$ metabolic$ syndrome,$ is$
increasingly$seen$as$a$chronic$inflammatory$condition,$leading$to$activation$of$astroglia$and$
microglia$ and$ high$ levels$ of$ pro8inflammatory$ cytokines$ in$ the$ hippocampus$ in$ animal$
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studies$ (Thirumangalakudi$ et$ al.$ 2008).$ This$ inflammation$ leads$ to$ cognitive$ deficits$ and$
associated$ structural$ brain$ damage$ (Fung$ et$ al.$ 2012;$ Yates$ et$ al.$ 2012).$ One$ VBM$ study$
found$ the$ inflammatory$ marker,$ fibrinogen,$ to$ be$ associated$ with$ increased$ grey$ matter$
volume$in$the$OFC$(Cazettes$et$al.$2011).$Obesity$related$atrophy$might$therefore$result$ in$






Brain$ structural$ changes$ associated$ with$ behaviour$ related$ to$ obesity$ may$ also$ be$
important.$ For$ instance,$ impulsivity$ was$ negatively$ correlated$with$ ACC$ (Lee$ et$ al.$ 2013),$
OFC$(Hesslinger$et$al.$2002)$and$VMPFC$volumes$(Matsuo$et$al.$2009),$and$with$reduced$FA$
in$ the$ frontostriatal$white$matter$ tracts$ (Gruber$ et$ al.$ 2011;$ Peper$ et$ al.$ 2013).$ Increased$
reward$ sensitivity$ positively$ correlated$ with$ grey$ matter$ volume$ in$ the$ somatosensory$
cortex$(Moreno8Lopez$et$al.$2012;$Weng$et$al.$2013)$and$OFC$(Tanabe$et$al.$2009;$Weng$et$
al.$ 2013),$ and$ reduced$ FA$ in$ frontal,$ corpus$ callosum$ tracts$ (Weng$ et$ al.$ 2013)$ and$ para8
hippocampal$ gyrus$ (Yuan$ et$ al.$ 2011).$ On$ the$ other$ hand$ addiction$ (non8alcohol)$ is$
associated$ with$ reduced$ ACC,$ DLPFC,$ amygdala$ and$ hippocampus$ volumes$ (Cousijn$ et$ al.$
2012).$ Therefore$ there$ may$ be$ structural$ alterations$ within$ the$ brains$ of$ obese$ people$
which$ are$ unrelated$ to$ obesity$ itself,$ but$ are$ related$ to$ behavioural$ correlates$ of$ obesity,$
either$predisposing$to,$or$caused$by$obesity.$$
$
As$ evidenced$ from$ Chapter$ 3,$ there$ were$ significant$ differences$ in$ hedonic$ responses$ to$





and$ white$ matter$ structure$ in$ areas$ involved$ in$ encoding$ reward$ value$ and$ sensitivity$
(nucleus$accumbens,$caudate,$putamen),$emotional$processing$(amygdala)$and$behavioural$
conditioning$ to$ food$ (hippocampus,$ OFC,$ DLPFC)$ between$ these$ groups$ if$ making$ the$
assumption$ that$ neural$ pathways$ that$ are$ used$ more$ frequently$ increase$ in$ volume$ or$
density$ over$ time.$ RYGB$ surgery$ also$ results$ in$ eating$ behaviour$ that$ differs$ significantly$




Possible$mechanisms$ underlying$ the$ lower$ hedonic$ response$ in$ obese$ people$ after$ RYGB$
compared$ to$ BAND,$ were$ further$ explored$ in$ Chapter$ 4.$ Administration$ of$ Octreotide,$ a$
somatostatin$ analogue,$ to$ both$ RYGB$ and$ BAND$ subjects,$ reversed$ exaggerated$
anorexigenic$ gut$ hormone$ responses$ in$ RYGB$ patients.$ This$ resulted$ in$ increased$ NAcc$




with$ caudate$ grey$ matter$ volume$ in$ normal$ weight$ adults$ (Weise$ et$ al.$ 2012),$ providing$
another$possible$link$between$changes$after$RYGB$and$brain$structure.$$
$
Weight$ loss$ itself,$through$either$RYGB$or$BAND$surgery$may$also$result$ in$changes$in$grey$
and$ white$ matter$ in$ obesity.$ Longitudinal$ studies$ have$ shown$ that$ weight$ loss$ through$





In$ this$ third$part$of$ the$cross8sectional$ study$ I$ therefore$explored,$using$VBM,$ sub8cortical$
volume$ analysis$ (FIRST)$ and$ DTI,$ whether$ grey$ or$ white$ matter$ structural$ differences,$
particularly$ in$brain$reward$systems,$exist$between$patients$who$have$undergone$RYGB$or$
BAND$surgery$for$obesity.$Furthermore,$comparison$with$BMI8matched$unoperated$controls$
gives$ an$ indication$ as$ to$ whether$ weight$ loss$ itself,$ independent$ of$ BMI,$ may$ result$ in$
structural$ changes$ to$ the$ brain,$ for$ example,$ repair$ of$ potential$ obesity8related$





had$ undergone$ RYGB,$ compared$ to$ BAND$ surgery,$ associated$ with$ healthier$ eating$
behaviour$ in$ RYGB$ patients,$ whereas$ unhealthy$ eating$ behaviour$ such$ as$ binge$ eating,$ is$




2.$ Increased$ grey$ matter$ volume$ in$ the$ OFC,$ striatum$ (nucleus$ accumbens,$ caudate$ and$
putamen),$peri8hippocampal$areas$and$amygdala$has$been$reported$ in$obese$adults$under$





3.$ Increased$ BMI$ and$ behavioural$ traits$ linked$ to$ obesity$ such$ as$ reward$ sensitivity,$ have$
been$associated$with$reduced$white$matter$ integrity$ in$ frontostriatal,$corpus$callosum$and$
316$
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peri8hippocampal$ tracts.$ It$ is$ therefore$ hypothesized$ that$ white$ matter$ integrity$ in$ these$





The$ aims$ of$ this$ cross8sectional$ study$ were$ to$ determine$ using$ VBM,$ volumetric$ and$ DTI$



























background$ distribution,$ current$ BMI,$ percentage$ body$ fat$ or$ prevalence$ of$ binge$ eating$
disorder$ (BED)$ at$ the$ time$ of$ scanning.$ The$ two$ surgical$ groups$ had$ similar$ pre8operative$
BMI$and$pre8operative$prevalence$of$BED.$The$RYGB$group$had$more$obesity8associated$co8






$ BMIKM$ BAND$ RYGB$ P$a$







(Male$:$Female)$ 3:17$ 1:17$ 2:18$ 0.86$
Ethnicity:$ European$















































PreKoperative$BED$ 2$(10%)$ 4$(22%)$ 4$(22%)$ 0.57$






on$ Ranks$ with$ post2 hoc$ Dunn’s$ test.$ Below$ statistically$ significant$ P$ values$ (<0.05)$ for$ the$ overall$












































































Data$ are$ presented$ as$ mean$ ±$ SEM$ cm3,$ and$ range$ in$ brackets.$ Normality$ was$ assessed$ using$
Kolmogarov8Smirnov$test$and$variance$with$Levene’s$test.$Data$are$corrected$for$age$and$gender,$and$
normalized$ for$ skull$ size,$ except$ for$ ICV.$ Comparisons$used$one8way$ANOVA$with$post2 hoc$ Fisher’s$
LSD$test.$$
$





ROIs$were$ obtained$ using$ Harvard$ anatomical$masks$ for$ 8$a2 priori$ defined$ ROIs:$ bilateral$
nucleus$ accumbens,$ amygdala,$ caudate,$ hippocampus,$ insula,$ pallidum,$ putamen$ and$
precentral$ gyrus$ (as$ a$ control$ area).$ After$ adjusting$ for$ age,$ gender$ and$BMI,$ grey$matter$
volume$was$significantly$ lower$ in$obese$patients$who$had$undergone$bariatric$surgery$(i.e.$
RYGB$and$BAND$patients$combined)$compared$to$BMI8matched$unoperated$controls$in$the$
amygdala,$ nucleus$ accumbens$ and$ hippocampus$ (Table,$ 5.3,$ Fig$ 5.2).$ In$ comparison$
between$ all$ 3$ groups,$ amygdala$ grey$ matter$ volume$ was$ also$ significantly$ lower$ in$ both$




























Figure' 5.3' Comparison' of' GM'density' (adjusted' for' age,' gender' and' BMI)' between' obese' patients' after' gastric' bypass,' gastric' banding' surgery' and'
controls$
$







































































































cluster$ in$the$ left$temporal$region$for$which$grey$matter$volume$was$ lower$ in$the$patients$
who$ had$ undergone$ BAND$ surgery$ compared$ to$ BMIBmatched$ unoperated$ controls,$ after$
adjusting$for$age,$gender$and$BMI$(Table$5.4).$There$were$2$clusters$in$left$middle$temporal$





grey$matter$ volume$ than$BMIBmatched$ controls,$where$ grey$matter$ volume$BMIBmatched$








value&& x& y& z& Brain&region&
& & & & & & $
BMIJM&>&BAND$ 98$ 0.028$ B70$ B44$ B8$ Left$middle$
temporal$




485$ 0.004$ B64$ B42$ B6$ Left$middle$
temporal$










When$ comparing$ operated$ with$ unoperated$ groups$ in$ the$ VBM$ analysis$ using$ multiple$







matter$ volume$ in$ the$ caudate$ (mean$ ±$ SEM$β$ B0.0010$ ±$ 0.0005,$ P=0.03),$with$ a$ trend$ to$
increase$grey$matter$volume$ in$ the$nucleus$accumbens$and$reduce$grey$matter$volume$ in$
the$ hippocampus$ (Table$ 5.$ 5,$ Fig$ 5.6$ ABC).$ As$ reported$ in$ the$ ANCOVA,$ there$ was$ a$
significant$ effect$ of$ group,$ independent$ of$ BMI,$ such$ that$ the$ operated$ group$ had$ lower$
grey$matter$volume$in$the$caudate$than$the$unoperated$group$(Table$5.5).$
&





















Relationship$between$BMI$ and$GM$density$ in$ (A)$ nucleus$ accumbens,$ (B)$ amygdala,$ (C)$ caudate$ in$




















# BMI*group& BMI*group& BMI& BAND&–&RYGB&Group& BMI& Operated&–&Unopterated&Group&
# P& P& β&±&SEM& P& β&±&SEM& P& β&±&SEM& P& β&±&SEM& P&
N.&Accumbens& 0.23# 0.35# 0.0011#±#0.0008# 0.19# +0.012#±#0.012# 0.36# 0.0014#±#0.0008# 0.08# 0.025#±#0.013# 0.06#
Amygdala& 0.15# 0.24# +0.0013#±#0.0006# 0.04& 0.008#±#0.009# 0.40# +0.0010#±#0.0005# 0.03& +0.019#±#0.007# 0.01&
Caudate& 0.61# 0.09# 0.0006#±#0.0006# 0.29# 0.011#±#0.009# 0.21# 0.0010#±#0.0005# 0.03& +0.001#±#0.008# 0.89#
Hippocampus& 0.24# 0.50# +0.0013#±#0.0007# 0.06# 0.004#±#0.010# 0.67# +0.0011#±#0.0005# 0.06# +0.013#±#0.009# 0.16#
Insula& 0.19# 0.40# 0.0001#±#0.0009# 0.87# 0.001#±#0.013# 0.96# +0.0000#±#0.0006# 0.95# +0.003#±#0.010# 0.75#
Pallidum& 0.32# 0.13# +0.0001#±#
0.0002#
0.70# 0.004#±#0.003# 0.15# 0.0000#±#0.0001# 0.95# +0.002#±#0.002# 0.32#
Precentral&
Gyrus& 0.80# 0.41# 0.0004#±#0.0006# 0.58# 0.003#±#0.009# 0.78# 0.0007#±#0.0005# 0.13# +0.004#±#0.008# 0.59#










out# using# FIRST.# Using# this# measurement# technique,# the# volume# of# the# bilateral# nucleus#
accumbens# was" higher# in# the# operated# group# (RYGB# and# BAND# combined)# compared# to#
unoperated#BMIJmatched#controls,#after#adjusting#for#age,#gender,#BMI#and#ICV#(Table#5.6,#
Fig.# 5.7).# There# were# no# significant# differences# between# the# 3# groups# in# the# subcortical#
volumetric#analysis#of#any#of#the#aforementioned#structures#(Table#5.6,#Fig.#5.8).##
%




controls# (BMIJM)# (n=20,# white)# and# obese# patients# who# have# undergone# gastric# bypass# (RYGB)# or#



















































































background#distribution,# current#BMI,# percentage#body# fat# or#prevalence#of#BED.# The# two#
surgical# groups# had# similar# preBoperative# BMI# and# preBoperative# prevalence# of# BED.# The#
RYGB# group# had# more# obesityBassociated# coBmorbidities# preBoperatively,# but# not# postB
operatively,#compared#to#the#BAND#group#(Table#5.7).##
Table%5.7%Participant%demographics%at%time%of%DTI%scans%%
# BMI@M% BAND% RYGB% P%a%






Gender%(Male%:%Female)% 3:14# 1:11# 2:15# 0.87#
Ethnicity:%
















































Pre@operative%BED% 2#(12%)# 4#(33%)# 3#(18%)# 0.33#
Post@operative%BED% # 2#(17%)# 1#(6%)# 0.37#
Data#are#presented#as#mean#±#standard#error#of# the#mean#±#SEM,#and#range# in#brackets.#Normality#
was#assessed#using#KolmogarovBSmirnov#test#and#variance#with#Levene’s#test.#Comparisons#between#
2# groups# used# Student’s# unpaired# tBtests# or,# if# not# normally# disturbed,#Mann#Whitney# U# test# and#
between#3#groups#used#oneBway#ANOVA#with#post%hoc#Fisher’s#LSD#test#or,#if#not#normally#distributed,#









compared# to# BAND# surgery,# or# between# operated# patients# (RYGB# and# BAND# combined)#











undergone#gastric#banding# (BAND,#dotted)#and#gastric#bypass# (RYGB,# striped)# surgery,# adjusting# for#

















Comparison#of#mean#diffusivity# (MD),# in#a%priori#white#matter# tracts#and#average#of#whole#
white#matter#skeleton,#between#BMIBmatched#controls#(BMIBM,#white),#obese#patients#who#
have#undergone#gastric#banding#(BAND,#dotted)#and#gastric#bypass#(RYGB,#striped)#surgery,#














































































































































































































































































































for# nucleus# accumbens# and# caudate.# However# that# analysis# had# shown# opposite# positive#
associations# of# obesity# and/or# BMI#with# amygdala# and# hippocampus# grey#matter# volume,#
which#are#difficult#to#interpret.#
#
There#were# also# no# significant# differences# between# operated# and# unoperated# subjects# or#




The# amygdala# is# known# to# be# involved# in# the# processing# of# emotional# responses# to#




reward,# by# incorporating# the# affective# associations# of# the# stimuli# in# a# Pavlovian# manner.#
Both# positive# and# negative# affective# associations# are# processed# in# the# amygdala.# For#
instance,# the# amygdala# plays# an# important# role# in# the# development# of# conditioned# taste#
aversion# (Yamamoto# 1993),# but# also# plays# a# role# in# positive# reinforcement# (Paton# et# al.#
2006).###
#
Early# life# emotional# deprivation# leads# to# increased# amygdala# volume# (Mehta# et# al.# 2009),#
and#dysfunction# in# the# amygdala# has# been# implicated# in# illnesses# of# emotional# regulation,#
such#as#depression#(Kennedy#et#al.#1997).#For#instance,#in#depression,#amygdala#metabolism#
is# positively# associated# with# the# severity# of# illness# and# reduces# in# response# to# treatment#
(Drevets#1999).#A#recent#study#found#that#mindfulness#is#associated#with#reduced#amygdala#
volume#(Taren#et#al.#2013).#Mindfulness#is#a#psychological#attribute,#which#can#be#innate#or#
acquired,# which# leads# to# increased# awareness# of# thoughts,# emotions# and# surroundings,#
whilst# maintaining# an# attitude# of# curiosity,# openness,# and# acceptance.# Treatments#
incorporating# mindfulness# training# have# been# shown# to# reduce# stress# reactivity,# anxiety#
(Roemer#et#al.#2007)#and#disordered#eating#(Kristeller#et#al.#2011).##
#
As# seen# in# Figure# 5.1# (and# Table# 5.10)# and# in# one#other# study# (Orsi# et# al.# 2011)# amygdala#
volume# is# increased# in# obesity# or# with# raised# BMI.# The# finding# of# reduced# amygdala# grey#
matter# volume# in# the#bariatric# surgery# groups,# compared# to# the#unoperated#obese# in# this#
study#therefore#suggests#that#bariatric#surgery#may#have#a#restorative#role#in#this#area#of#the#






or# structure# in# this#area.# #However# the#crossAsectional#analysis#of# this# study#makes# further#
interpretation#of# these# findings#difficult.# # In#addition,# the# lack#of#difference#between#RYGB#
and#BAND#in#grey#matter#volume#of#the#amygdala,#suggests#that#the#finding#of#lower#BOLD#
response# to# food#pictures# in#RYGB#compared# to#BAND#patients# in#Chapter#3# is# not#due# to#
structural#differences#between#the#groups.##
#
In# contradiction# to# the# conclusion# from# the# larger# cohort# analysis# that# raised# BMI# is#
associated# with# increased# amygdala# volume,# BMI# negatively# correlated# with# amygdala#
volume#independent#of#group#(unoperated#or#operated)#(See#Figure#5.4B).#This#may#reflect#
the#smaller#sample#number#in#this#analysis#compared#to#the#larger#unoperated#cohort,#or#a#































































































group.# BMIAM:# body# mass# index# matched,# BAND:# gastric# banding,# EDEAQ:# Eating# Disorders#









The#nucleus#accumbens# is#known#to#be# important# in# the#processing#of# reward,#particularly#






mediates# sensationAseeking# in# those# with# a# high# risk# of# addiction# (family# history# of#
alcoholism)# (Weiland# et# al.# 2013).# In# obesity,# the# nucleus# accumbens# has# increased#
connectivity#with#the#OFC#(Stoeckel#et#al.#2009)#and#nucleus#accumbens#activation#to#highA











In# the#study# referred# to# in#Section#5.1,#conducted#within#our#Group# (unpublished),#obesity#
(see# Figure# 5.1# and# Table# 5.10)# was# associated# with# increased# nucleus# accumbens#
volume/density#using#VBM#in#a#larger#cohort,#for#which#a#trend#was#also#found#in#this#study#
using# the# combined# unoperated# and# operated# cohort.# The# larger# cohort# study# study# also#
349#
#
found# reduced#nucleus# accumbens# size#using# the# FIRST# technique.#Another# study#has# also#




in# obese# patients# who# had# undergone# bariatric# surgery# compared# to# BMIAmatched#
unoperated# patients.# This# suggests,# similarly# to# the# amygdala# results,# that# obesity# related#
changes#have#been#reversed#by#bariatric#surgery.##However#again#the#crossAsectional#analysis#
of#this#study#makes#further#interpretation#of#these#findings#difficult.#This#may#be#related#to#






introducing# a# fourth# covariate.# Although#many# studies#make# adjustment# for# ICV# or# global#
grey# matter# volumes,# some# authors# suggest# that# the# sensitivity# of# detecting# regional#
differences# in# grey# matter# volume# may# be# reduced# by# adjusting# for# ICV,# rather# than#
increased#(Ridgway#et#al.#2008).##
#
FIRST# results# of# subcortical# volume,# showed# reduced# nucleus# accumbens# size# in# obese#
patients#compared#to#normal#weight#controls#in#the#unpublished#cohort#study#by#our#Group.#
The#current#analysis#found#increased#nucleus#accumbens#size# in#the#operated#compared#to#





possibly# relates# to# methodological# differences,# perhaps# with# issues# concerning#
segmentation,# # and# the# balance# between# increased# cell# number,# synaptic# density# and#




The#hippocampus# is#particularly# important# in# learning#and# the#consolidation#of#memory.# It#
has# been# implicated# as# part# of# the# system# involved# in# rewardAbased# learning.# Alzheimer’s#
disease# has# been# consistently# linked# with# reduced# hippocampal# volume# as# a# result# of#
atrophy# (Ferreira#et#al.#2011).# LongAstanding#depression# (McKinnon#et#al.#2009),# childhood#
maltreatment#(Chaney#et#al.#2013)#and#diabetes#(McIntyre#et#al.#2010;#Cherbuin#et#al.#2012;#




to# low#risk#of#addiction# (Clinton#et#al.#2011),#and# in#adolescents#performance#on#the#delay#




In# our# Group’s# large# cohort# analysis# of# unoperated# subjects,# hippocampal# volumes# were#
increased#in#obese#compared#to#normal#weight#subjects,#but#the#literature#is#contradictory#in#






(see#Table#1.3),#and#one#study# found# reduced#hippocampal#volume# in#obesity# (Kurth#et#al.#
2012).##
#
Fitness#was# associated#with# increased# hippocampal# volumes# in# children,# which# correlated#
with#better#cognitive#performance#(Chaddock#et#al.#2010).#The#same#was#true#for#adults#with#




to# unoperated# obese# patients.# Given# the# crossAsectional# nature# of# this# study# and# the#
contradictory#findings#of#the#influence#of#obesity#on#hippocampus#grey#matter#volume#from#
previous#studies#(as#discussed#above),#it#is#difficult#to#clarify#whether#these#findings#are#as#a#
result# of# weight# loss# or# a# persistent# effect# of# the# preAoperative# higher# BMI# and# higher#
prevalence# of# diabetes.# In# keeping# with# the# potential# effect# of# weight# loss# per# se# on#





matter# integrity# in# normal#weight# or# obese# individuals.# One# study,# using# an# older,# cruder#
method#of#brain#volume#calculation#than#VBM,#found#that#weight#loss#did#not#result#in#brain#
mass# loss# in# obese# or# lean#women# (Peters# et# al.# 2011).#On# the# other# hand# one# study# has#







The# literature# is# more# consistent# when# it# comes# to# DTI# studies# of# white# matter# tract#
integrity.#These#indicate#that#there#tends#to#be#reduced#white#matter#integrity#as#evidenced#
by# reduced#FA#and# increased#MD# in#obesity.#Again#a# link#between#microstructural#damage#





correlated#with#greater# ventral# striatum#activation# to#monetary# loss# (compared# to#gain)# in#
healthy#subjects#(Camara#et#al.#2010).#This#tract#is#involved#in#cognition#and#emotion#linking#
the#OFC,#PFC,#striatum#and#amygdala#(Hasan#et#al.#2009).#Increased#integrity#of#white#matter#
tracts# in# reward# areas# has# also# been# positively# correlated# with# monetary# reward# cue#
reactivity# of# the# ventral# striatum#during# fMRI# tasks# (Koch# et# al.# 2013).# # This# suggests# that#
white# matter# structure# may# be# altered# by# psychological# correlates# of# rewardArelated#






#The# crossAsectional# nature#of# the# study# limits# interpretation,#whereas# longitudinal# studies#










with# caution,# due# to# low# numbers,# particularly# in# the# BAND# group.# The# lack# of# significant#
differences# in#white#matter# integrity#between#the#RYGB#and#BAND#groups#does#agree#with#





surgery# for#obesity# is#novel.#However,# the# lack#of#consistency# in# the#previous#studies#as# to#
the#effect#of#obesity#on#grey#matter#volumes# in# the#hippocampus,#nucleus#accumbens#and#
amygdala#amongst#others,#makes# these# results#difficult# to# interpret.#The# lack#of#difference#
between#the#two#types#of#surgery#(RYGB#vs.#BAND)#implies#that#the#effects#seen#may#be#due#
to# weight# loss# per# se,# rather# than# any# specific# effects# of# each# type# of# surgery.# It# does#










VBM#and# FIRST# have# the# advantage# over# older#methods# of# volumetric# assessment# in# that#
they#are#not#operator#dependent#for#accuracy#and#VBM#can#also#be#carried#out#on#a#voxelA
wide# basis.# Interpretation# of# VBM# findings# is# however# limited# by# the# fact# that# not# only#
atrophy#or#thickening#of#the#grey#matter,#but#also#differences#in#the#morphology#of#the#gyri#
and#sulci#can#alter#results.#For#instance,#differences#in#the#folding#pattern#of#the#sulcus#in#one#
group# could# result# in# a# difference# in# apparent# grey# matter# volume.# Furthermore,#
transformation#of#images#to#a#standardized#space,#in#order#to#be#able#to#accurately#compare#
on#a#voxelAwise#level#(important#if#findings#are#to#be#generalised),#can#in#some#cases#reduce#
the# accuracy# of# interpretation.# Aligning# them# too# perfectly# or# not# perfectly# enough# will#









and#hippocampus# in#patients# that#have# lost#weight# through#bariatric# surgery# compared# to#
unoperated#patients#of# similar#BMI# is# novel.# Future# longitudinal# studies,# utilising# a# control#
group# for# nonAsurgical# weight# loss# are# required# to# confirm# whether# a# reduction# in# grey#
matter#volume#is#a#result#of#the#surgery,#and#whether#this#finding# is#a#result#of#weight# loss#
per# se,#or# specific# to# the#effects#of#bariatric# surgery.# The# lack#of#difference# in# grey#matter#
volume#and#white#matter#integrity#between#groups#should#be#interpreted#with#caution#due#




































1. After# RYGB,# obese# patients# have# a# markedly# different# gutAbrainAhedonic# response# to#
food#than#after#BAND#surgery#in#the#fasted#state.#RYGB#patients#have#lower#activation#in#
several# brain# regions# to# food,# particularly# highAcalorie# foods,# including# the# OFC,#
amygdala,#caudate#nucleus,#nucleus#accumbens#and#hippocampus,#key#areas#involved#in#
reward,# emotion,# memory# and# cognitive# responses.# This# is# the# first# time# such# a#
comparison#has#been#made#and#these#findings#are#therefore#novel.##
2. This#was#associated#with#a#more#beneficial#profile#of# food#preference,# food# intake#and#
subjective# ratings# of# highAcalorie# food# palatability# in# RYGB# patients.# RYGB# subjects#
consume#less#energy#from#dietary#fat#and#find#ice#cream#less#palatable#than#after#BAND.#
They#rate#highAcalorie#food#pictures#as#less#appealing#and#have#healthier#eating#behavior#
such# as# lower# dietary# restraint# and# lower# external# eating# than# the# BAND# and/or# BMIA
matched#unoperated#controls.##




BAND# patients# but# there#were# no# difference# in# acyl# ghrelin# levels.# RYGB# patients# also#






response# in# RYGB# by# administration# of# Octreotide,# reduces# nucleus# accumbens#
activation#to# lowAcalorie# food#pictures#and#reduces#food#appeal# in#RYGB#but#not#BAND#
subjects.#These#preliminary#results#warrant#further#investigation#with#larger#numbers#of#
subjects.##
6. These# differences# in# food# hedonics# were# not# explained# by# differences# in# grey#matter#
density#or#volume#or#white#matter#tract#integrity#between#the#RYGB#and#BAND#groups.##
7. However,#the#novel#finding#of#reduced#grey#matter#volume#in#the#amygdala#in#RYGB#and#
BAND# subjects# compared# to# BMIAmatched# unoperated# controls# adding# to# previous#
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examined$ the$ potential$ mechanism$ underlying$ these$ differences$ in$ food$ reward$ processing$
between$RYGB$and$BAND$surgery,$ and$hence$ the$preliminary$ results$ from$Chapter$4,$ in$which$
reversal$ of$ gut$ hormone$ responses$ by$ administration$ of$ Octreotide,$ led$ to$ partial$ increases$ in$
reward$ activation$ to$ and$ appeal$ of$ food,$ specifically$ lowPcalorie$ foods,$ are$ novel$ and$warrant$
further$investigation$(see$Section$4.5.1$and$4.5.2).$$
$
The$ findings$ are$ also$ in$ agreement$ with$ animal$ and$ human$ studies$ of$ RYGB$ which$ have$





















has$ directly$ compared$ RYGB$ and$ BAND$ with$ regards$ to$ eating$ disorder$ psychopathology$ and$
body$ image$ satisfaction.$ The$ finding$ of$ lower$ dietary$ restraint$ and$ less$ weight$ and$ shape$
concerns$in$RYGB$compared$to$BAND$subjects,$despite$similar$BMI$is$therefore$novel,$but$may$be$
explained$by$the$greater$weight$loss$following$RYGB$compared$to$BAND.$Dietary$restraint$can$be$
complex$ to$ interpret.$ As$ a$ general$ rule,$ obesity$ is$ associated$ with$ particularly$ rigid$ dietary$
restraint,$ interpreted$ as$ an$ attempt$ to$maintain$ rigid$ control$ over$ dietary$ intake.$ However,$ in$
obesity,$ dietary$ restraint$ is$ often$ accompanied$ by$ dietary$ disinhibition,$ or$ loss$ of$ control$ over$
dietary$intake,$resulting$in$overeating$when$a$fast$is$broken,$or$emotional$or$external$cues$act$as$
triggers$ (Polivy$ et$ al.$ 2008).$ The$ novel$ finding$ that$ RYGB$ subjects$ have$ lower$ dietary$ restraint$
scores,$and$a$tendency$toward$lower$external$eating$than$BAND$subjects$suggests$a$therefore$a$










Differences$ in$ food$ hedonics$ between$ the$ groups$ they$ were$ not$ explained$ by$ differences$ in$
hunger$and$therefore$appear$to$be$isolated$to$nonPhomeostatic$systems.$However$Octreotide$did$
reduce$feelings$of$satiety$in$the$RYGB$group.$Most$studies$agree$that$increasing$the$palatability$
or$ hedonic$ appeal$ of$ food$ increases$ the$ consumption$ of$ food,$ increases$ subjective$ ratings$ of$
hunger,$ at$ least$ initially$ after$ presentation$of$ the$ food$ cue,$ and$ slows$ the$ rate$of$ satiety$ after$
consumption$ (Blundell$ et$ al.$ 2004).$ However,$ hunger$ does$ not$ have$ a$ symmetrical$ effect$ on$
palatability.$ Whilst$ hunger$ does$ increase$ the$ hedonic$ response$ to$ and$ appeal$ of$ high$ calorie$
foods$ (Goldstone$ et$ al.$ 2009),$ satiety$ does$ not$ necessarily$ reduces$ the$ hedonic$ appeal$ of$
palatable$foods$to$the$same$extent$(Yeomans$et$al.$1997).$This$dissociation$has$been$implicated$
in$ the$ pathogenesis$ of$ obesity$ (Berthoud$ 2012).$ The$ fact$ that$ hunger$ and$ satiety$ ratings$were$
equal$ between$ the$ groups$ in$ the$ fasted$ state,$ therefore$makes$ the$ interpretation$ of$ the$ fMRI$




As$ in$previous$ studies$postPprandial$plasma$GLPP1$and$PYY$gut$hormone$ levels,$ as$well$ as$preP
lunch$GLPP1$ levels,$were$higher$ in$ the$RYGB$ than$ the$BAND$group$ in$Chapter$3$ (le$Roux$et$ al.$
2006;$Tadross$et$al.$2009).$Although$ these$hormones$are$known$ to$alter$brain$ reward$systems$
and$dopaminergic$signaling$(Batterham$et$al.$2007;$De$Silva$et$al.$2011;$Skibicka$et$al.$2011)$and$
increased$levels$are$associated$with$shifts$in$food$preference$toward$healthier$choices,$(Martin$et$
al.$ 2009;$ Miras$ et$ al.$ 2010;$ Acosta$ et$ al.$ 2011)$ and$ reduction$ in$ uncontrolled$ and$ emotional$
eating$ after$ RYGB$ (Bryant$ et$ al.$ 2012),$ their$ role$ in$ altering$ BOLD$ signal$ in$ RYGB$ and$ BAND$
patients$has$not$been$examined$before.$The$finding$therefore$that$BOLD$signal$response$to$food$
pictures$ is$ increased$ in$ RYGB$ patients$ after$ administration$ of$ Octreotide$ is$ novel$ and$ further$
364$
$




possible$mechanism$ for$ reduced$ food$ reward$ in$ this$ group,$ since$ they$ too$ reduce$ food$ intake,$
potentially$ mediated$ by$ improved$ glucose$ metabolism,$ modulation$ of$ gut$ hormone$ secretion$
and$direct$or$indirect$action$on$FGF19$or$bile$acid$receptors$in$the$brain$(Ryan$et$al.$2013)$(see$





Other$ factors$ not$ measured$ by$ this$ paradigm$may$ have$ also$ been$ shown$ to$ be$ important$ in$
altering$ eating$ behaviour$ after$ RYGB$ (see$ Fig.$ 6.1).$ For$ instance$ oxyntomodulin,$ another$
anorexogenic$ gut$ hormone,$ has$ also$ been$ shown$ to$ be$ increased$ after$ RYGB$ and$ not$ BAND$
surgery,$to$cross$the$bloodPbrain$barrier$and$to$exert$its$affects$in$the$brain$via$GLPP1$receptors.$
Similarly$ other$ gut$ hormones$ such$ as$ CCK$ may$ have$ played$ a$ role,$ although$ less$ convincing$
evidence$of$their$contribution$to$reduced$appetite$in$RYGB$has$been$found$(see$Section$1.3.6).$It$
is$ therefore$ possible$ that$ any$ effects$ seen$ on$ food$ reward$ systems$ may$ be$ as$ a$ result$ of$



























2006{Kullmann,$ 2012;$ Kullmann$ et$ al.$ 2012).$ In$ this$ particular$ study$ insulin$ resistance$ had$ a$
tendency$to$be$lower$in$the$RYGB$group,$who$also$had$a$greater$prevalence$of$past$T2DM.$It$ is$
difficult$to$interpret$how$these$factors$may$have$influenced$the$results,$but$possible$that$reduced$
activation$ to$ food$ pictures$ in$ the$ RYGB$ group$may$ be$ due$ to$ greater$ insulin$ sensitivity$ in$ this$
group.$$
$
Further$ factors$not$measured$by$ this$ study$potentially$differentially$ influence$weight$ loss$ after$






This$ is$ the$ first$ study$ to$examine$brain$volume$differences$between$different$ types$of$bariatric$
surgery,$ or$ to$ compare$ BMIPmatched$ controls$ to$ bariatric$ surgery$ subjects.$ There$ were$ no$












The$ implications$ of$ these$ findings$ are$ twoPfold.$ They$ suggest$ firstly$ that$ our$ fMRI$ findings$ of$
differences$in$food$reward$processing$between$RYGB$and$BAND$subjects$are$not$associated$with$










results,$ and$ longitudinal$ studies$ are$ required$ to$ confirm$ the$ differences$ between$ groups$ and$
examine$causality$and$mechanism$of$the$findings.$$
$
Furthermore,$ although$ many$ preP$ and$ postPoperative$ confounding$ variables$ were$ similar$
between$surgical$groups,$patient$allocation$to$surgery$was$not$randomized.$Nevertheless,$clinical$
practice$ within$ the$ centre$ where$ recruitment$ took$ place,$ does$ not$ differ$ from$ other$ bariatric$
centers$ in$ that$ the$ choice$ of$ surgical$ procedures$ is$ not$ influenced$ by$ prePoperative$ food$
hedonics.$If$anything$subjects$who$chose$RYGB$surgery$tended$to$be$heavier$prePoperatively$and$
therefore$less$likely$to$have$healthier$food$hedonics$than$the$BAND$subjects.$However$they$did$





The$ choice$of$operation$ is$ also$not$ influenced$by$ clinicians$working$ in$ the$ centre.$Although$an$
early$ study$had$suggested$ that$sweet$eating$subjects$may$do$ less$well$after$another$ restrictive$
procedure,$ the$ vertical$ banded$ gastroplasty,$ it$ has$ never$ been$ the$ practice$ of$ the$majority$ of$
centers$ including$ our$ own$ to$ deter$ such$ subjects$ from$ BAND,$ and$ furthermore$ subsequent$
research$has$refuted$this$earlier$finding$(Hudson$et$al.$2002).$
$
The$ study$ was$ fairly$ robust$ in$ its$ exclusion$ criteria.$ In$ this$ way$ care$ was$ taken$ to$ reduce$ the$
number$ of$ confounding$ variables$ that$may$ have$ been$ present.$ Furthermore$ the$ effect$ of$ the$
stage$of$menstrual$cycle$on$BOLD$response$to$food$was$controlled$for$by$only$scanning$female$
prePmenopausal$ subjects$ in$ the$ follicular$phase,$although$ recent$ restriction$ to$ the$ luteal$phase$
may$ have$ been$ better$ (AlonsoPAlonso$ et$ al.$ 2011).$ Attempts$ were$ also$ made$ to$ reduce$ the$
influence$of$variability$ in$possible$confounders$on$BOLD$response$to$food$by$standardizing$preP







of$ psychological$ and$ eating$ behavior,$ measurement$ of$ physiological$ markers,$ including$ gut$













observed$on$ a$neural$ level,$may$ translate$ into$ actual$ behaviour$ and$ improves$ the$ chance$ that$
subjects$ were$ paying$ attention$ to$ the$ pictures$ whilst$ in$ the$ scanner.$ Furthermore,$ conscious$
evaluation$of$a$test$meal’s$palatability$showed$similar$differences$between$the$RYGB$and$BAND$
group,$comparable$to$and$correlating$with$the$fMRI$data,$even$though$actual$intake$did$not$differ$
between$ the$ groups,$ suggesting$ that$ in$ this$ study,$ fMRI$ holds$ some$ validity$ in$ terms$ of$ its$
association$with$perceived$food$reward.$$$
$
fMRI$ is$ increasingly$ being$ used$ to$ investigate$ particularly$ nonPhomeostatic$ control$ of$ eating$
behaviour$in$the$brain.$The$sample$size$of$scanned$subjects,$although$small$by$general$standards,$
in$ both$Chapter$ 3$ and$4$ is$ comparable$ to$other$phenotyping$ studies$ after$ bariatric$ surgery$ (le$
Roux$et$al.$2006;$Laferrere$et$al.$2011),$and$fMRI$studies$investigating$food$reward$(Fletcher$et$al.$
2010;$De$Silva$et$al.$2011).$The$possibility$that$a$type$1$error$may$have$occurred$for$some$of$the$
results$ cannot$ be$ excluded.$ The$ study$ employed$ a$ number$ of$ complimentary$ behavioral$
measures$ and$notably$ their$ results$were$ in$ the$ same$direction$ as$ the$primary$ fMRI$ end$point.$
Similarly,$ the$numbers$ included$ in$ the$VBM$and$DTI$ study$may$have$been$ too$ small$ to$ detect$
differences$between$groups.$$
$
In$ our$ fMRI$ paradigm$we$ studied$ the$differences$ in$ BOLD$activation$ to$ food$pictures$ between$
surgical$groups,$rather$than$food$receipt$itself.$However,$such$fMRI$paradigms$with$food$pictures$





the$ subjects$ to$ more$ complex,$ realPlife$ food$ stimuli$ than$ can$ be$ achieved$ with$ the$ restricted$
nature$of$tastants$used$in$fMRI$experiments$such$as$milkshakes.$Our$use$of$active$evaluation$of$
the$pictures$during$the$fMRI$task$may$have$enhanced$our$ability$to$detect$differences$in$the$OFC$
response$ (Bender$ et$ al.$ 2009).$ Indeed$ our$ behavioural$ analysis$ did$ demonstrate$ that$ subjects$
after$RYGB$found$icePcream$less$palatable$than$after$BAND,$and$so$ it$will$be$of$ interest$to$next$
examine$differences$ in$ fMRI$ responses$ to$ taste$of$ such$high$ fat/sweet$ foods$between$ the$ two$
surgical$groups.$
$
It$ was$ a$ surprising$ finding$ that$ there$ was$ not$ lower$ consumption$ of$ ice$ cream$ in$ the$ RYGB$
compared$ to$ BAND$ group.$ A$ possible$ explanation$ is$ that$ the$ test$ meal$ was$ not$ specifically$
designed$to$examine$food$preference,$as$subjects$were$not$given$a$choice$of$foods$of$different$
caloric$ density.$ Use$ of$ a$ food$ choice$ paradigm$ in$ the$ test$ meal$ may$ have$ found$ more$
complimentary$results$to$the$fMRI$data.$However,$analysis$of$macronutrient$intake$outside$of$the$
laboratory$ did$ reveal$ lower$ total$ caloric$ and$ particularly$ fat$ intake$ after$ RYGB$ compared$ to$
BAND.$
$
At$ this$ stage$ it$ is$ not$ possible$ to$ confirm$ which,$ if$ any,$ of$ the$ associated$ changes$ in$ gut$












Having$ established$ a$ difference$ in$ hedonic$ response$ to$ food$ between$ obese$ patients$ who$






BAND$surgery$ leads$ to$ restriction$of$ food$that$can$be$eaten$at$a$given$time,$and$hence$certain$
foods$ are$ difficult$ to$ eat,$ and$ avoided.$ For$ example,$meat$ that$ is$ not$minced,$ vegetables$ and$
salad$and$bread$products$are$often$avoided.$On$the$other$hand,$ice$cream,$dairy$products,$sweet$
drinks$and$ ‘melting’$ foods$such$as$crisps$and$chocolate$are$easily$ tolerated.$ It$ is$not$difficult$ to$
imagine$ therefore$ that$ within$ the$ limited$ repertoire$ of$ foods$ easily$ tolerated$ after$ BAND$
insertion,$ that$ calorie$dense,$ palatable$ foods$might$ actually$ increase$ in$ their$ appeal.$ Relatively$
little$is$known$about$how$food$preference$changes$after$restrictive$procedures.$Sugarman’s$early$
study$ suggested$ that$ sweet$ eaters$ in$ particular$ may$ not$ benefit$ from$ restrictive$ surgery$
(Sugerman$ et$ al.$ 1987),$ but$ due$ to$ methodological$ limitations$ of$ the$ study$ in$ question,$ and$




Thus$ far$ longitudinal$ studies$ of$ hedonic$ response$ to$ food$ in$ RYGB$ surgery$ have$ also$ not$
examined$gut$hormone$responses$in$conjunction.$Replication$of$Chapter$3,$longitudinally$in$RYGB$
and$BAND$patients$would$allow$comparison$of$ the$directionality$of$hedonic$ fMRI$response$and$
its$ association$with$ gut$ hormone$ responses.$ Furthermore$ if$ a$ correlation$ between$weight$ loss$
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A$ control$ group$ of$ lean$ subjects,$ matched$ for$ age,$ gender,$ ethnicity$ and$ possibly$ also$ socioP
economic$class$and$education$level$would$be$difficult$to$achieve$due$to$the$association$of$obesity$
with$lower$socioPeconomic$class$and$lower$education$levels$(WHO$2005).$However,$if$comparison$
with$ a$ lean$ control$ group$were$ to$ be$ valid,$ it$ would$ be$ essential$ that$ they$were$matched$ for$
these$confounding$variables.$The$addition$of$a$ lean$control$group$ in$a$ longitudinal$study$would$
allow$examination$of$whether$RYGB$was$in$fact$returning$hedonic$responses$to$that$of$a$healthy$
weight$individual,$despite$possibly$remaining$in$an$overweight/obese$category.$This$is$especially$




that$ lean$ individuals$ at$ risk$ for$ obesity$may$ also$ have$ a$ higher$ hedonic$ response$ to$ food,$ and$






current$ treatments$ for$ obesity.$ There$ have$ already$ been$ fMRI$ studies$ examining$ brain$ food$
reward$ system$ responses$ following$ administration$ of$ drugs$ designed$ to$ reduce$ food$ intake$
(Fletcher$ et$ al.$ 2010;$Horder$ et$ al.$ 2010).$ fMRI$ in$ this$way$ acts$ as$ a$ useful$ proxy$measure$ for$
373$
$
success,$ and$ particularly$ if$ comparison$ is$ made$ with$ RYGB,$ the$ most$ successful$ established$
treatment$of$obesity$to$date.$$
$
Comparison$with$ lowPcalorie$ dieting$ and$other$ dietary$manipulations,$ as$well$ as$ other$ surgical$
procedures,$ such$as$ sleeve$gastrectomy$and$ the$endobarrier,$will$also$provide$ insights$ into$ the$
mechanisms$ of$ these$ as$ far$ as$ food$ hedonics$ go.$ RYGB$ is$ a$ complex$ procedure$ with$multiple$
possible$ synergistic$ or$ additive$mechanisms$which$may$ all$ play$ a$ role$ in$ reducing$ the$ hedonic$
response$to$food$(see$Fig.$6.2).$$
$
Since$ procedures$ such$ as$ the$ endobarrier$ and$ sleeve$ gastrectomy$ have$ potentially$ simpler$
underlying$ mechanisms$ which$ essentially$ isolate$ one$ part$ of$ the$ anatomical$ manipulation$ in$
RYGB,$these$in$themselves$will$provide$insights$into$how$RYGB$potentially$works.$In$other$words,$
the$effect$on$food$hedonics$of$early$delivery$of$food$to$the$distal$ileum$and$reduction$in$stomach$





























system$ (OFC,$ amygdala,$ insula,$ nucleaus$ accumbens$ and$ caudate),$ 59%$ power$ to$ determine$ a$
mean$difference$of$0.026$change$in$BOLD$signal$in$the$amygdala,$and$100%$power$to$determine$








gut$ hormone$ infusion$ (PYY$ and$ GLPP1)$ on$ food$ hedonics$ in$ normal$ weight$ individuals,$ which$
should$ be$ replicated$ in$ obese$ subjects.$ There$ appear$ to$ be$ distinct$ advantages$ to$ using$
combinations$ of$ gut$ hormones$ to$ obtain$ synergistic$ and$ additive$ effects,$ as$ evidenced$ from$
animal$ and$ human$ studies$ (Sadry$ et$ al.$ 2013).$ $ Similarly$ the$ additive$ role$ of$ gut$ hormone$
infusions$or$agonists$in$increasing$the$effect$of$RYGB$(or$indeed$another$bariatric$operation$such$





generalized$ effect$ on$ nonPfood$ reward.$ This$ can$ be$ tested$with$ alternative$ paradigms$ such$ as$
those$used$to$measure$decisionPmaking,$such$as$food$or$monetary$related$GoPNoGo$tasks,$choice$
paradigms,$progressive$ratio$tasks,$monetary$and$food$incentive$delay$tasks$to$test$anticipation$












On$ the$ face$ of$ it,$ a$ reduced$ hedonic$ response$ to$ food$ seems$ positive,$ particularly$ if$ it$ is$
associated$ with$ improved$ eating$ behaviour.$ However$ it$ does$ raise$ the$ question$ of$ whether$
hedonic$ responses$ to$ other$ emotionPregulating$ substances$may$ therefore$ be$ heightened.$ This$
may$have$particular$relevance$to$obese$patient$undergoing$RYGB$who$have$a$history$of$drug$or$
alcohol$addiction$or$misuse,$or$who$use$the$rewarding$aspects$of$food$as$a$way$to$manage$stress,$
anxiety$ or$ depression.$ Studies$ have$ shown$ that$ RYGB$ is$ associated$with$ increased$ alcohol$ and$
other$drug$misuse$and$dependency$(King$et$al.$2012;$Conason$et$al.$2013)$and$that$this$finding$
seems$ to$ be$ specific$ to$ RYGB$ compared$ to$ restrictive$ procedures$ (VBG)$ (Ostlund$ et$ al.$ 2013).$$
There$is$also$the$suggestion$that$RYGB$may$actually$increase$suicide$rates$from$a$crossPsectional$
study$ comparing$ approximately$ 9000$ patients$ who$ had$ undergone$ RYGB$ compared$ to$ BMIP
matched$unoperated$obese$individuals$(Adams$et$al.$2007).$
$
$On$a$psychological$ level,$ if$ food$is$used$to$manage$affect,$removal$of$the$affective$response$to$
food,$may$ in$ fact$make$ an$ individual$more$ vulnerable$ to$ psychological$ stress,$ depression$ and$
even$ suicide.$ If$on$ the$other$hand,$ the$ reduction$of$ the$hedonic$appeal$of$ food$ is$ generalized,$






being$ underpowered.$ Longitudinal$ studies$ in$ a$ larger$ cohort$ are$ indicated$ to$ demonstrate$
whether$RYGB$or$BAND$surgery$differentially$alter$white$matter$tract$ integrity$ in$reward$areas,$
which$ might$ lead$ to$ an$ artefactual$ difference$ in$ hedonic$ response$ to$ food.$ In$ addition,$ since$







matter$ rewardPbased$ tracts$ which$ link$ the$ areas$ in$ which$ differences$ were$ seen$ in$ the$ RYGB$
group,$ e.g.$ amygdala$ and$ OFC,$ can$ be$ compared$ between$ groups,$ or$ changes$ observed$
longitudinally$in$the$same$subjects.$$
$
Functional$ connectivity$ analyses$ using$ independent$ component$ analysis$ (ICA)$ techniques$ may$
give$further$information$about$the$connectivity$between$regions$of$interest,$between$groups,$or$
as$influenced$by$Octreotide.$$Connectivity$has$been$shown$to$be$altered$in$obesity$(Stoeckel$et$al.$




be$made$about$how$bariatric$ surgery$or$RYGB$may$alter$cognitive$networks$ in$ the$brain$which$







These$ findings$ emphasize$ the$ underPrecognized$ differences$ in$ the$mechanisms$ underlying$ the$
success$ of$ these$ two$ surgical$ treatments$ of$ obesity.$ These$ can$ now$ be$ expanded$ to$ include$
differences$ in$ food$ reward$ and$ hedonics,$ potentially$mediated$ in$ part$ by$ acute$ effects$ of$ gut$
hormones$ in$ RYGB.$ This$ may$ prompt$ the$ development$ of$ more$ personalized$ approaches$ to$
surgical$ choices$ that$ might$ use$ prePoperative$ assessment$ of$ food$ preference$ and$ craving$ and$
consider$ how$ the$ loss$ of$ food$ reward$may$ impact$ on$ an$ individual.$ In$ addition,$ patients$ seen$
after$RYGB$and$BAND$surgery$can$be$approached$with$a$greater$understanding$of$how$surgery$
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Robert Steiner MRI Unit  
MRC Clinical Sciences Centre, Imperial College London 
Hammersmith Hospital Campus 
Du Cane Road, London W12 0NN 
 
 
THIS INFORMATION SHEET IS VALID FOR USE UNTIL: 1 October 2011 
 
INFORMATION SHEET FOR RESEARCH PARTICIPANTS 
 
You will be given a copy of this Information Sheet and a signed copy of your consent 
form to keep, should you decide to participate in the study. 
 
STUDY TITLE: OBESITY SURGERY AND FUNCTIONAL MAGNETIC 
RESONANCE IMAGING OF APPETITE. 
 
You are being invited to take part in a research study. Before you decide, it is important for 
you to understand why the research is being done and what it will involve. Please take time to 
read the following information carefully and discuss it with friends, relatives and your GP if 
you wish. Ask us if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part. 
 
If you do decide to take part, please let us know beforehand if you have been involved in any 
other study during the last year. You are free to withdraw at any time without explanation. 
Thank you for reading this. 
 
WHAT IS THE PURPOSE OF THE STUDY? 
 
We do not understand fully why people with obesity overeat. Obesity surgery reduces 
appetite, which leads to weight loss. How this happens is not fully understood. 
 
We do know that restriction of stomach size after surgery may play some part, but it is 
likely that changes in hormones released from the gut play a role by acting on the appetite 
and reward centers in the brain. 
 
This study aims to see how obesity alters the brain’s response to food and how obesity 
surgery changes this by comparing people who have undergone obesity surgery and those 
that have not. Participants will undergo brain scans while looking at pictures of food, after 
fasting overnight or after having eaten. They will also be injected under the skin either with 
Octreotide, a hormone that temporarily reduces the release of hormones from your gut, or 
with water as a dummy injection for comparison. 
 
This study is an important step towards finding out how appetite is altered in obesity and how 
obesity surgery works. This will help with the development of new treatments for obesity, 
which are as successful as obesity surgery. 
 
 
WHY HAVE I BEEN CHOSEN? 
 
We are recruiting the following groups of people:  
1. Healthy individuals who are not obese   
2. People who are obese but have not had surgery.   




You should not take part in this study if you: 
 
1) Have any illnesses which we feel make you unsuitable   
2) If you take any medication which we feel make you unsuitable   
3) If you are pregnant or breast feeding   
4) If you have donated blood in the last three months  
 
It is important that you should not become pregnant during the course of the study or for one 
month after. It is therefore important that you have adequate and reliable contraception during this 
period. 
 
DO I HAVE TO TAKE PART? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you will be given this 
information sheet to keep and be asked to sign a consent form. If you decide to take part you are still 
free to withdraw at any time and without giving a reason. 
 




If you agree to take part in this study, you will first be examined by one of the research doctors and 
have a number of blood tests after an overnight fast (no more than 30ml blood equivalent to around 2 
tablespoons), a pregnancy test (if female) and a heart recording (ECG) to ensure you are fit and 
healthy enough to take part. 
 
You will be asked to complete some questionnaires about your eating habits, personality and mood. 
This information will be related to the results from your brain scans. Individual differences in these 
factors between people have been shown to influence appetite and how the brain responds to 
looking at pictures, such as food. You will also be asked to look at some pictures of food and say 
which ones you prefer to eat. It will take about 30-40 minutes to complete these questionnaires. A 
researcher will be available to assist you with this if necessary. 
 
You will also be asked to taste the meal that will be used later on in the study. We will also ask you to 
keep a record of all food and drink consumed for three days. 
 
You will also have your height and weight taken and your body fat content measured using a ‘bio-
electrical impedance’ machine. This is a painless safe method that involves measuring the electrical 
current from your body and takes only about 5 minutes. As long as these medical checks are 
satisfactory and you are still happy to participate, you will then be asked to attend for the first of up to 
4 study visits. 
 
With your permission, we will also take a sample of DNA from blood or saliva to look for changes in 
your genes that may be involved in the how the body controls appetite and body weight and 
responds to gut hormones. This will enable us to see what effect such changes may have on your 
brain scans. 
 
Number of visits 
 
You will be asked to attend the Clinical Investigation Ward at Hammersmith Hospital as an outpatient 
on up to another 4 occasions, following your screening visit, each separated by at least 3 days. 
These will be completed on dates convenient to you and the investigators, but should usually be 





On each study visit you will be asked to have nothing to eat and only water to drink from 8 pm on the 
evening before the study. You will be asked to attend in the morning and each visit will last around 5 
hours. You will be asked to abstain from alcohol and strenuous exercise for 24 hours before the visit. 
We will also ask you to keep a record of all food and drink consumed for one day before the visit, the 
day of the visit and for one day afterwards. You will also have a pregnancy test on each visit (if 
female), and have your height, weight and body fat content measured. You will also complete 
questionnaires about your mood on each study visit. These questionnaires should take about 5 
minutes to complete. 
 
On each study day you will have a small plastic cannula tube inserted into a vein in one arm. A vein 
is the type of blood vessel commonly used for taking blood samples. You may feel some discomfort 
whilst the cannula is being inserted. After the cannula tube has been inserted this will be used to take 
blood samples. 
 
On each of the visits, you will then receive either a saline (salt water) or Octreotide injection under the 
skin on the thigh or tummy. You may fell some slight discomfort at the time of the injection. You will 
also receive at the same time another injection under the skin on the thigh or tummy of either saline 
(salt water) or a small dose of insulin. The insulin injection is to prevent your sugar level going too 
high after the Octreotide injection. 
 
What is Octreotide? 
 
Octreotide is a man-made hormone that is very similar to a substance that occurs naturally in the 
body, called somatostatin. It temporarily reduces the release of some hormones in the body including 
those from the gut that reduce appetite. We have used this substance in other studies to investigate 
appetite without problems. Only very mild side effects are occasionally seen, such as abdominal 
discomfort and bloating, loose stools or nausea, increase in blood sugar level after eating. These 
effects of Octreotide are not expected to last longer than 6 hours. Octreotide is widely prescribed as 
a medicine for certain intestinal conditions. 
 
What is saline? 
 
The saline is a placebo or dummy treatment that is commonly used in studies of this nature. It 
contains no active ingredient and is not expected to alter your appetite. The saline treatment will 
serve as a baseline measurement to which all active treatments are compared. This is a randomised, 
double-blind trial. This means that neither you, nor your research doctors, will know what substance 
you are being given on some visits (although, if your doctor needs to find out, he/she can do so). 








You will be given a solution of paracetamol in water with breakfast. The levels of paracetamol in your 
blood will then be measured. This will allow us to have an accurate measure of the rate at which your 
stomach is emptying. We do not expect that you will suffer any side effects from this. You should not 






Blood samples will be taken from the cannula in your arm. The total amount of blood taken on each 
study visit will not be more than 150 ml (about 10 tablespoonfuls). The total amount of blood taken 
over all your visits will not be more than 630 ml (a little less than a pint and the same amount taken 
when making a single donation of blood for blood transfusion). During blood testing, you will be 
seated or lying on a couch, and can read or watch television. 
 
Visual analogue scales 
 
Over the morning, we will regularly ask you to score how you are feeling (e.g. rating your hunger) 




You will have magnetic resonance imaging (MRI) brain scans by lying in an MRI scanner for up to 1 
hour. This will take place in the Robert Steiner Magnetic Resonance Imaging Unit, nearby the Clinical 
Investigation Ward. This will enable us to look at the structure and activity of your brain. 
 
During the functional brain scans we look at the activity of the brain at rest, while you look at a 
variety of pictures on a screen, and perform simple tasks like viewing a flashing light, pressing a 
button, reading, listening, speaking, recalling, thinking about words or numbers. You will be asked to 
make responses to the pictures while in the scanner using a keypad. You will have the opportunity 
to practice lying in the scanner while looking at various pictures on the screen. This will enable us to 
ensure that you can follow the instructions and lie still while in the scanner. While in the scanner 




At the end of the brain scan, you will be taken back to the Clinical Investigation Ward. At this stage, 
you will be presented with a meal and you will be asked to eat as much as you want of the meal until 
you feel comfortably full. 
 
We will continue to monitor you for another 2 hour after the scan, after which you are free to go. At 
the end of the final visit you will also be asked to score how much you usually like to eat the 
foodstuffs shown in the food pictures using a visual analogue scale. 
 
WHAT DO I HAVE TO DO? 
 
The only restrictions on your lifestyle are that you will be asked to have nothing to eat and only water 
to drink from 8pm on the night before the meal days. You will need to keep a record of all food and 
drinks consumed in the day before every study and for a day afterwards. For twenty-four hours 
before each study meal you will be asked to refrain from taking strenuous exercise and drinking 
alcohol. 
 
Female volunteers should have adequate contraception for the period of the study and for one month 
afterwards. Pregnancy tests will be carried out to confirm that women of child bearing age are not 
pregnant on the morning before each study day. 
 
WHAT IS THE DRUG THAT IS BEING USED? 
 
Octreotide is a synthetic copy of the naturally occurring hormone found in the blood, called 
somatostatin. Octreotide has been used acutely in several other research studies in our department 
and worldwide, in men and women, without harmful effects. It is also widely prescribed to patients 
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with intestinal problems for long term use. The dose of Octreotide that you will be given is small and 
will decrease the levels of gut hormones in your body. 
 
Insulin is a naturally occurring hormone found in the blood that regulates your blood sugar and is 
used to treat people with sugar diabetes. When we give you an injection of Octreotide you will also 
have a single injection of insulin since the Octreotide may temporarily suppress you body’s own 
production of insulin which may cause your sugar to rise for a few hours. The injection of insulin will 
prevent the sugar rising too much. Your sugar levels will be monitored. 
 
 
WHAT ARE THE SIDE EFFECTS OF TAKING PART? 
 
Some people experience mild abdominal discomfort, loose stools, nausea and flatulence after having 
Octreotide, but these symptoms are usually mild and settle within a few hours. If your sugar levels 
rise after the Octreotide injection you may feel thirsty, pass more urine than usual, or feel a little 
sleepy, but this will settle within a few hours and you will be able to drink water if you wish. 
 
From our previous studies we do not expect any significant side effects, but the unexpected can 
occur. During the study, at least one experienced doctor will monitor you closely. If you suffer from 
any ill effects during the study you should report them to the doctors monitoring you immediately. If 
you suffer from any ill effects afterwards you should report them to one of the research doctors at the 
contact number below or when you next see them. You may ask for the study to stop at any time 
without giving a reason. If any unexpected side effects occur, the study will be stopped. 
 
MRI is a powerful, diagnostic body scanning technique, which is used in hospitals worldwide to 
create images of the inside of the body. MRI has been used safely for several decades and has no 
known side-effects. Each scan is directed to the specific requirements of your referring doctor or to 
research study in which you are taking part. 
 
 
WHAT ARE THE POSSIBLE DISADVANTAGES AND RISKS OF TAKING PART? 
 
Octreotide has been administered in several studies by our laboratory and therefore we do not 
anticipate any problems with the injection. Insertion of the cannula (drip) into your arm on each of the 
study days may cause minor discomfort or superficial bruising, as may the injection of saline or 
Octreotide under the skin. 
 
Magnetic resonance imaging (MRI) is a procedure that allows doctors to look inside the body by 
using a scanner that sends out a strong magnetic field and radio waves. MRI does not use X-rays. 
This procedure is used routinely for medical care and is very safe for most people, but you will be 
monitored during the entire MRI scan in case any problems occur. The risks of having an MRI scan 
are: 
 
• The MRI scanner contains a very strong magnet. Therefore, you will not be able to have the MRI 
if you have any type of metal implanted in your body, for example, any pacing device (such as a 
heart pacer), any metal in your eyes, or certain types of heart valves or brain aneurysm clips. 
Someone will ask you questions about this before you have the MRI. If you have previously 
undergone gastric bypass or banding surgery, then the devices used in your surgery will have 
been approved as safe for MRI.  
 
• There is not much room inside the MRI scanner. You may be uncomfortable if you do not like to 
be in close spaces (“claustrophobia”). During the procedure, you will be able to talk to and hear 
the MRI staff through a speaker and earphone system, and, in the event of an emergency, you  
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can tell them to stop the scan. You will be closely monitored and repeatedly checked on to make sure 
you are as comfortable as possible. While your head is in the scanner, we will support it, so you can’t 
move it. If this upsets you, you will be able to signal and speak to the investigator and stop the scan 
through the use of a radio system and a signaling button. You will have the opportunity during the 
first MRI scan to ensure that you can tolerate having the scan before the next scans are done. 
 
• The MRI produces a “hammering noise”. You will wear earplugs and headphones to prevent 
discomfort or damage to hearing. The headphones will also allow you to be able to hear us talk to 
you.  
 
• You will be fully awake during the MRI scan and will not be sedated at any time. We will make 
every effort to ensure your comfort during this experiment.  
 
It should be noted that the MRI brain scan cannot be viewed as a comprehensive health screening 
procedure. However, vary rarely, unexpected information can be detected which may warrant further 
investigation. In this event, you will be informed and a report will be sent to your GP, who will arrange 
further tests and coordinate your further care. In the rare event that we find a significant abnormality 
on your structural brain scan on the first visit this may exclude you from continuing with the rest of the 
study. 
 
It is possible that if the treatment is given to a pregnant woman it will harm the unborn child. Pregnant 
women must therefore not take part in this study; neither should women who plan to become 
pregnant during the study. Women who are at risk of pregnancy will be asked to have a pregnancy 
test before taking part, to exclude the possibility of pregnancy. Women who could become pregnant 
must use an effective contraceptive during the course of this study. Any woman who finds that she 




WHAT ARE THE POSSIBLE BENEFITS OF TAKING PART? 
 
The information that we get from this study will help us to better understand appetite regulation and 
may help us to better treat future patients who suffer from being overweight or obese. 
 
If any of the screening questionnaires or blood tests reveal any medical problems (e.g. depression, 
diabetes, high cholesterol, thyroid, kidney or liver problems), your GP will be informed so that they 
can coordinate your further care, arrange any further tests, and refer you on to Hospital Doctors if 
necessary. 
 
WHAT IF NEW INFORMATION BECOMES AVAILABLE? 
 
Sometimes during the course of a research project, new information becomes available about the 
treatment that is being studied. If this happens, your research doctor will tell you about it and discuss 
with you whether you want to continue in the study. If you decide to continue in the study you will be 
asked to sign an updated consent form. Also, on receiving new information your research doctor 
might consider it to be in your best interests to withdraw you from the study. 
 
 
WHAT HAPPENS WHEN THE RESEARCH STUDY STOPS? 
 
Once the study has finished, the results of the study can be made available to you and/or your GP 
should you wish. If you have any problems immediately following the study, then you should 
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contact one of the research doctors on the numbers provided below. 
 
WHAT IF SOMETHING GOES WRONG? 
 
Imperial College London holds insurance policies which apply to this study. If you experience harm 
or injury as a result of taking part in this study, you may be eligible to claim compensation without 
having to prove that Imperial College is at fault. This does not affect your legal rights to seek 
compensation. 
 
If you are harmed due to someone’s negligence, then you may have grounds for a legal action. 
Regardless of this, if you wish to complain, or have any concerns about any aspect of the way you 
have been treated during the course of this study then you should immediately inform the 
Investigator Dr. Goldstone (Tel: 020 8383 1029). 
 
WILL MY TAKING PART IN THIS STUDY BE KEPT CONFIDENTIAL? 
 
All information which is collected about you during the course of the research will be kept strictly 
confidential. Any information about you which leaves the hospital will have your name and address 
removed so that you cannot be recognised from it. 
 
It is a requirement that your GP is informed, with your consent, of your participation in this study, at 
the start of the study. 
 
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? 
 
The results are likely to be published in the year following the study. Your confidentiality will be 
ensured at all times and you will not be identified in any publication. At the end of the study, the 
results of the study can be made available to you and/or your GP should you wish. 
 
WHO IS ORGANISING AND FUNDING THE RESEARCH? 
 
This study is being organised and funded by the MRC Clinical Sciences Centre and the Department 




You will receive a fixed payment to cover expenses including travel costs. This sum of £20 for the 
screening visit and £50 for each study visit (total £220) will be paid when you have completed your 
visits. 
 
WHO HAS REVIEWED THE STUDY? 
 
This study has been reviewed by the Hammersmith Hospitals Research Ethics Committee (Ref 
08/H0707/139). 
 
CONTACT FOR FURTHER INFORMATION 
 
If you experience any problems during the study, you may withdraw at any stage. The doctors 
involved in the study, Dr Scholtz and Dr. Goldstone, will be available by telephone during working 
hours (020 8383 1029 or via the paging system). The hospital switchboard (020 8383 1000) has 
home and mobile phone numbers for all the doctors involved in the study and can contact them at 
any time outside normal working hours. 
 
If you agree to take part in the trial, you will also be given the mobile phone numbers of the doctors.  





Ref: 08/H0707/139 Version 2, 02/10/2008. Valid until 1st October 2011 
 
Robert Steiner MRI Unit  
MRC Clinical Sciences Centre, Imperial College London 
Hammersmith Hospital Campus, Du Cane Road, London W12 0NN 
 
Participant Consent Form 
 
Title of project:  Obesity surgery and functional magnetic resonance imaging of appetite. 
 
Name of Principal Investigator: Dr. A.P.Goldstone.  Please tick and initial each statement:  
 
1. I confirm that I have read and understand the subject information sheet Protocol Version3……… 
dated …..03/08/2009…. for the above study. 
 
2. I have had the opportunity to ask questions and discuss this study. 
 
3. All my questions have been answered fully. 
 
4. I have received enough information about the study. 
   
5. I understand that my participation is voluntary and I am free to withdraw at any time, without giving 
any reason, without my medical care or legal rights being affected.   
 
6. I understand that my images and sections of any of my medical notes may be looked at by 
responsible individuals from Imperial College London or from regulatory authorities where it is 
relevant to my taking part in this research.  
 
7. I give permission for these individuals to access my records that are relevant to this research.  
  
8. I give permission for my General Practitioner to be informed of my participation in this study and 
the results of any medical tests from my visits and brain scans.  
 
9. I give permission for my images to be used for research by responsible individuals from Imperial 
College London and Imperial College Healthcare NHS Trust so long as they do not contain 
identifying personal information. 
 
10. I agree for a DNA sample to be taken and stored to look for changes that may be involved in 
obesity and the control of appetite. 
 
11. The compensation arrangements have been discussed with me.  
 
12. I agree to take part in the above study.    
 
 
________________________  ________________   ________________  
Name of Subject (block capitals)  Signature    Date  
 
_________________________  ________________   ________________  
Principal Investigator    Signature    Date  
  
_______________________            ________________  
________________ 





DUTCH EATING QUESTIONNAIRE 
 
Volunteer Initials:  Date: 
Volunteer No.   
 
Please place an (!) in the box which applies best to each of the numbered statements. All of 
the results will be strictly confidential. Most of the questions directly relate to food or eating, 
although other types of questions have been included. Please answer each question carefully. 
Thank you. 
 
1. If you have put on weight, do you eat less than you usually do?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
2. Do you try to eat less at mealtimes than you would like to eat?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
3. How often do you refuse food or drink offered because you are concerned about your 
weight? 
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
4.  Do you watch exactly what you eat?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
5.  Do you deliberately eat foods that are slimming?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
6.  When you have eaten too much, do you eat less than usual the following days?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
7. Do you deliberately eat less in order not to become heavier?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
8. How often do you try not to eat between meals because you are watching your weight?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
9.  How often in the evening do you try not to eat because you are watching your weight?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
10. Do you take into account your weight with what you eat?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
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11. Do you have the desire to eat when you are irritated?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
12. Do you have a desire to eat when you have nothing to do?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
13. Do you have a desire to eat when you are depressed or discouraged?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
14. Do you have a desire to eat when you are feeling lonely?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
15. Do you have a desire to eat when somebody lets you down?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
16. Do you have a desire to eat when you are cross?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
17. Do you have a desire to eat when you are approaching something unpleasant to happen?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
18. Do you get the desire to eat when you are anxious, worried or tense?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
19. Do you have a desire to eat when things are going against you or when things have gone wrong?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
20. Do you have a desire to eat when you are frightened?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
21. Do you have a desire to eat when you are disappointed?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
22. Do you have a desire to eat when you are bore or restless?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
 
 
23. Do you have a desire to eat when you are emotionally upset?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often‰Not Relevant 
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24. If food tastes good to you, do you eat more than usual?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
25. If food smells and looks good do you eat more than usual?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
26. If you see or smell something delicious, do you have the desire to eat it?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
27. If you have something delicious to eat, do you eat it straight away?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
28. If you walk past the baker do you have the desire to buy something delicious?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
29. If you walk past a snackbar or a café, do you have the desire to buy something delicious?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
30. If you see others eating, do you also have the desire to eat?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
31. Can you resist eating delicious foods?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
32. Do you eat more than usual, when you see others eating?  
‰ Never ‰Seldom‰Sometimes‰Often‰Very Often 
 
 
33. When preparing a meal are you inclined to eat something?  
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This scale consists of a number of words that describe different feelings and emotions. 
Read each item and then mark [x] the appropriate answer in the space next to the word. 
Indicate to what extent you have felt this way on average during the past week. 




a little moderately quite a bit extremely  or not at all        
 
1 interested      
 
        
2 distressed      
 
        
3 excited      
 
        
4 upset      
 
        
5 strong      
 
        
6 guilty      
 
        
7 scared      
 
        
8 hostile      
 
        
9 enthusiastic      
 
        
10 proud      
 
        
11 irritable      
 
        
12 alert      
 
        
13 ashamed      
 
        
14 inspired      
 
        
15 nervous      
 
        
16 determined      
 
        
17 attentive      
 
        
18 jittery      
 
        
19 active      
 
        
20 afraid      
 

















































































Please answer each question by putting a circle around the 'YES' or the 'NO' following the question. 
 
There are no right or wrong answers, and no trick questions. 
 
Work quickly and do not think too long about the exact meaning of the questions. 
 
 PLEASE REMEMBER TO ANSWER EACH QUESTION  
1. Do you have many different hobbies? …………………………………………...…………………………………. YES NO 
2. Do you stop to think things over before doing anything? …………………………………………………. YES NO 
3. Does your mood often go up and down? ……………………………………………………………………………. YES NO 
4. Have you ever taken the praise for something you knew someone else had really done?. YES NO 
5. Do you take much notice of what people think? ………………………………………………………..……… YES NO 
6. Are you a talkative person? ……………………………………………………………………………..…………………. YES NO 
7. Would being in debt worry you? ……………………………………………………………………………..….……… YES NO 
8. Do you ever feel ‘just miserable' for no reason? ……………………………………………………….………. YES NO 
9. Do you give money to charities? ……………………………………………………………………………..…………. YES NO 
10. Were you ever greedy by helping yourself to more than your share of anything? ………..… YES NO 
11. Are you rather lively? ……………………………………………………………………………………………………….…. YES NO 
12. Would it upset you a lot to see a child or animal suffer? ………………………………………………..… YES NO 
13. Do you often worry about things you should not have done or said? …………………………….… YES NO 
14. Do you dislike people who don’t know how to behave themselves? …………………………………. YES NO 
15. lf you say you will do something , do you always keep your promise no matter how  
 inconvenient it might be? ……………………………………………………………………………………………………. YES NO 
16. Can you usually let yourself go and enjoy yourself at a lively party? ………………………………. YES NO 
17. Are you an irritable person? …………………………………………………………………………………………....…. YES NO 
18. Should people always respect the law? ………………………………………………………………………………. YES NO 
19. Have you ever blamed someone for doing something you knew was really your fault? ….. YES NO 
20. Do you enjoy meeting new people? ……………………………………………………………………………..…….. YES NO 
21. Are good manners very important? …………………………………………………………………………………….. YES NO 
22. Are your feelings easily hurt? ……………………………………………………………………………..………………. YES NO 
23. Are all your habits good and desirable ones? ……………………………………………………………………… YES NO 
24. Do you tend to keep in the background on social occasions? ……………………………………………. YES NO 
25. Would you take drugs which may have strange or dangerous effects? …………………………….. YES NO 
26. Do you often feel ‘fed-up’? ……………………………………………………………………………..…………………… YES NO 
27. Have you ever taken anything (even a pin or button) that belonged to someone else? …. YES NO 
28. Do you like going out a lot? ……………………………………………………………………………..…………………. YES NO 
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30. Do you enjoy hurting people you love? ………………………………………………………………………………. YES NO 
31. Are you often troubled about feelings of guilt? ………………………………………..………………………… YES NO 
32. Do you sometimes talk about things you know nothing about? ………………………………………… YES NO 
33. Do you prefer reading to meeting people? …………………………………………………………………………. YES NO 
34. Do you have enemies who want to harm you? ………………………………………………………………..… YES NO 
35. Would you call yourself a nervous person? …………………………………………………………………………. YES NO 
36. Do you have many friends? ……………………………………………………………………………………………….… YES NO 
37. Do you enjoy practical jokes that can sometimes really hurt people? ………………………………. YES NO 
38. Are you a worrier? ………………………………………………………………………………………………………..…..… YES NO 
39. As a child did you do us you were told immediately and without grumbling? …………………… YES NO 
40. Would you call yourself happy-go-lucky? ……………………………………………………………………………. YES NO 
41. Do good manners and cleanliness matter much to you? …………………………………………………… YES NO 
42. Have you often gone against your parents' wishes? …………………………………………………………… YES NO 
43. Do you worry about awful things that might happen? ……………………………………………………….. YES NO 
44. Have you ever broken or lost something belonging to someone else? ……………………………… YES NO 
45. Do you usually take the initiative in making new friends? …………………………………………………. YES NO 
46. Would you call yourself tense or 'highly-strung’? ….………………………………………………………..… YES NO 
47. Are you mostly quiet when you are with other people? …………………………………………………….. YES NO 
48. Do you think marriage is old-fashioned and should be done away with? …………………………. YES NO 
49. Do you sometimes boast a little? ……………………………………………………………………………………..… YES NO 
50. Are you more easy-going about right and wrong than most people? ………………………………… YES NO 
51. Can you easily get some life into a rather dull party? ………………………………………………………… YES NO 
52. Do you worry about your health? ……………………………………………………………………………..………… YES NO 
53. Have you ever said anything bad or nasty about anyone? ………………………………………………… YES NO 
54. Do you enjoy co-operating with others? …………………………………………………………………………….. YES NO 
55. Do you like telling jokes and funny stories to your friends? ………………………………………………. YES NO 
56. Do most things taste the same to you? ………………………………………………………………………………. YES NO 
57. As a child were you ever cheeky to your parents? ……………………………………………………………… YES NO 
58. Do you like mixing with people? ……………………………………………………………………………..………….. YES NO 
59. Does it worry you if you know there are mistakes in your work? ……………………………………… YES NO 
60. Do you suffer from sleeplessness? …………………………………………………………………………………….… YES NO 
61. Have people said that you sometimes act too rashly? …………………………………………………….… YES NO 
62. Do you always wash before a meal? …………………………………………………………………………………… YES NO 
63. Do you nearly always have a 'ready answer' when people talk to you? ………………………...… YES NO 
64. Do you like to arrive at appointments in plenty of time? …………………………………………………… YES NO 
65. Have you often felt listless and tired for no reason? ………………………………………………………….. YES NO 
66. Have you ever cheated at a game? ……………………………………………………………………………..…….. YES NO 
67. Do you like doing things in which you have to act quickly? ………………………………………………. YES NO 
68. Is (or was) your mother a good woman? …………………………………………………………………………… YES NO 
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69. Do you often make decisions on the spur of the moment? ………………………………………………… YES NO 
70. Do you often feel life is very dull? …………………………………………………………………………………….… YES NO 
71. Have you ever taken advantage of someone? ………………………………………………………………..… YES NO 
72. Do you often take on more activities than you have time for? …………………………………………. YES NO 
73. Are there several people who keep trying to avoid you? …………………………………………………… YES NO 
74. Do you worry a lot about your looks? ……………………………………………………………………………..…. YES NO 
75. Do you think people spend too much time safeguarding their future with savings  
 and insurance? ……………………………………………………………………………..……………………………………… YES NO 
76. Have you ever wished that you were dead? ………………………………………………………………………. YES NO 
77. Would you dodge paying taxes if you were sure you could never be found out? …………….. YES NO 
78. Clan you get a party going? ……………………………………………………………………………..…………………. YES NO 
79. Do you try not to be rude to people? ……………………………………………………………………………..….. YES NO 
80. Do you worry too long after an embarrassing experience? ……………………………………………….. YES NO 
81. Do you generally 'look before you leap'? ……………………………………………………………………………. YES NO 
82. Have you ever insisted on having your own way? ……………………………………………………………… YES NO 
83. Do you suffer from 'nerves'? ……………………………………………………………………………..……………….. YES NO 
84. Do you often feel lonely? ……………………………………………………………………………..……………………… YES NO 
85. Can you on the whole trust people to tell the truth? …………………………………………………………. YES NO 
86. Do you always practice what you preach? ………………………………………………………………………….. YES NO 
87. Are you easily hurt when people find fault with you or the work you do? ………………………… YES NO 
88. Is it better to follow society's rules than go your own way? ……………………………………………… YES NO 
89. Have you ever been late for an appointment or work? ……………………………………………………… YES NO 
90. Do you like plenty of bustle and excitement around you? ……………………………………………...… YES NO 
91. Would you like other people to be afraid of you? ……….…………………………………………………..… YES NO 
92. Are you sometimes bubbling over with energy and sometimes very sluggish? ………………… YES NO 
93. Do you sometimes put off until tomorrow what you ought to do today? ……………………….… YES NO 
94. Do other people think of you as being very lively? ……………………………………………………………. YES NO 
95. Do people tell you a lot of lies? ……………………………………………………………………………..……………. YES NO 
96. Do you believe one has special duties to one's family? ……………………………………………………… YES NO 
97. Are you touchy about some things? ……………………………………………………………………………..……. YES NO 
98. Are you always wiling to admit it when you have made a mistake? …………………………………. YES NO 
99. Would you feel very sorry for an animal caught in a trap? ……………………………………………….. YES NO 
100. When your temper rises, do you find it difficult to control? ………………………………………………. YES NO 
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